https://www.ambrygen.com/company 2026-04-02T12:29:42-07:00 daily 0.8 https://www.ambrygen.com/company/our-people 2026-04-02T12:29:42-07:00 daily 0.8 https://www.ambrygen.com/company/our-story 2026-04-02T12:29:42-07:00 daily 0.8 https://www.ambrygen.com/company/press-releases 2026-04-02T12:29:42-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/160/ambry-s-contributions-to-maves-support-thousands-of-patient-reclassifications-and-expand-to-new-genes 2026-01-30T11:40:18-08:00 daily 0.8 https://www.ambrygen.com/company/press-release/159/ambry-genetics-announces-one-millionth-test-leveraging-rna-to-improve-diagnostic-accuracy-and-yield 2026-01-30T11:43:20-08:00 daily 0.8 https://www.ambrygen.com/company/press-release/158/genetics-in-medicine-study-demonstrates-the-benefits-of-proactive-exome-reanalysis-for-healthcare-equity 2025-10-20T06:35:52-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/157/ambry-genetics-announces-improved-ehr-integrated-breast-cancer-risk-assessment-solution 2025-10-01T05:36:05-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/156/ambry-genetics-care-program-validated-for-accuracy-in-identifying-high-risk-patients-for-hereditary-cancer-testing 2025-06-25T13:19:37-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/155/new-study-shows-impact-of-ambry-genetics-patient-for-life-program-on-rare-disease-diagnosis 2025-05-26T16:43:53-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/154/ambry-genetics-data-supports-functional-study-of-brca2-helping-improve-variant-classification-for-hereditary-brca2-linked-cancers 2025-01-08T09:08:17-08:00 daily 0.8 https://www.ambrygen.com/company/press-release/153/ambry-genetics-expands-its-award-collection-with-three-new-comparably-best-place-to-work-honors-for-2024 2024-12-13T07:23:14-08:00 daily 0.8 https://www.ambrygen.com/company/press-release/152/letter-from-tom-schoenherr 2024-11-07T15:49:40-08:00 daily 0.8 https://www.ambrygen.com/company/press-release/151/ambry-genetics-announces-new-hereditary-cancer-test-menu-at-nsgc-annual-conference 2024-09-17T00:50:47-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/150/ambry-genetics-announces-new-multiomic-exome-test-for-improved-rare-disease-detection 2024-08-19T06:16:34-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/149/ambry-genetics-and-pacbio-announce-collaboration-to-sequence-up-to-7-000-human-genomes-aimed-at-providing-answers-for-families-battling-rare-diseases-consortium-selects-leading-genomics-companies-to-support-pediatric-mendelian-genomics-research-center-program 2024-05-15T07:02:14-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/148/ambry-genetics-announces-a-collaboration-with-tempus-to-advance-paired-germline-and-somatic-testing-services-for-medical-oncologists 2024-03-11T13:17:56-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/147/ambry-genetics-unveils-new-insights-ashg 2023-11-02T09:10:59-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/146/lifestrands-genomics-and-ambry-provide-lab-testing-for-singapores-national-precision-medicine-programme 2023-04-19T07:11:35-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/145/unilabs-and-ambry-agreement 2023-01-26T08:08:59-08:00 daily 0.8 https://www.ambrygen.com/company/press-release/143/ambrys-new-reproductive-health-program 2022-10-19T08:04:23-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/142/ambry-genetics-publishes-43-000-patient-study-showing-combined-rna-and-dna-analysis-identifies-patients-who-are-high-risk-for-cancer-but-would-have-been-missed-by-dna-testing-alone 2022-09-09T12:02:33-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/141/konica-minolta-precision-medicine-announces-name-change-to-realm-idx 2021-09-16T09:49:49-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/132/best-company-women-culture-2020 2020-12-17T15:28:35-08:00 daily 0.8 https://www.ambrygen.com/company/press-release/128/first-prospective-study-shows-rnainsight-identifies-more-patients-with-increased-risk-for-hereditary-cancer-than-dna-only-testing 2020-02-27T15:46:24-08:00 daily 0.8 https://www.ambrygen.com/company/press-release/124/ambry-genetics-receives-new-york-state-approval-rnainsight 2020-12-08T11:05:55-08:00 daily 0.8 https://www.ambrygen.com/company/press-release/123/new-data-from-ambry-genetics-showed-concurrent-rna-and-dna-testing-identified-more-patients-with-hereditary-breast-cancer-than-dna-testing-alone 2019-12-10T08:44:58-08:00 daily 0.8 https://www.ambrygen.com/company/press-release/122/caris-life-sciences-and-ambry-genetics-partner-to-advance-cancer-care 2019-12-03T13:18:18-08:00 daily 0.8 https://www.ambrygen.com/company/press-release/121/new-data-from-ambry-genetics-show-substantial-increase-in-diagnostic-yield-further-supporting-the-routine-use-of-rna-genetic-testing-for-hereditary-cancer-panels 2019-11-05T09:47:50-08:00 daily 0.8 https://www.ambrygen.com/company/press-release/120/ambry-genetics-published-data-that-finds-adding-rna-genetic-testing-provides-more-accurate-actionable-results-for-patients-who-receive-dna-testing-for-hereditary-cancer-risk 2019-10-23T09:31:43-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/119/new-data-from-ambry-genetics-demonstrates-impact-of-first-major-advancement-in-over-10-years-to-increase-diagnostic-yield-in-genetic-testing-for-hereditary-cancer-risk 2019-10-15T12:50:41-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/118/ambry-genetics-makes-scientific-breakthrough-and-launches-paired-rna-and-dna-testing-for-hereditary-cancer 2019-10-01T08:30:27-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/117/ambry-genetics-data-reveal-that-expanding-genetic-testing-guidelines-could-identify-more-patients-with-increased-risks-of-cancer 2019-08-26T09:07:32-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/114/research-from-ambry-genetics-amp-mayo-clinic-reveals-differences-in-the-prevalence-of-breast-cancer-genes-among-racial-and-ethnic-populations 2019-05-29T14:32:09-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/113/ambry-genetics-research-highlights-need-for-expanded-genetic-testing-payer-coverage-for-patients-at-risk-for-hereditary-breast-and-ovarian-cancer 2019-10-31T15:19:34-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/112/intalere-teams-with-ambry-genetics-to-offer-healthcare-providers-advanced-genetic-testing-for-cancer-risk-assessment 2019-05-13T15:27:41-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/109/my-gene-counsel-and-ambry-genetics-join-forces-to-bridge-the-gap-between-direct-to-consumer-testing-and-medical-grade-genetic-testing 2025-04-24T15:34:45-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/106/ambry-genetics-presents-research-on-the-importance-of-reclassifying-disease-causing-genes-at-the-national-society-of-genetic-counselors-nsgc-annual-meeting 2019-05-07T17:11:04-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/105/jama-oncology-publishes-ambry-s-results-detailing-genes-associations-with-hereditary-breast-and-ovarian-cancer 2019-05-07T17:11:10-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/102/ambry-genetics-in-collaboration-with-mayo-clinic-and-northshore-university-healthsystem-announce-important-research-contributing-to-breast-cancer-risk-prediction 2019-05-07T17:12:02-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/99/ambry-presents-research-expanding-our-understanding-of-gene-disease-relationships-at-the-san-antonio-breast-cancer-symposium 2019-05-07T17:12:30-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/96/ambry-genetics-mitochondrial-disease-research-may-help-develop-treatments-sooner 2019-05-07T17:12:35-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/95/ambry-genetics-advances-patient-care-through-telemedicine-genetic-counseling-services-amp-pwnhealth-partnership 2019-05-07T17:12:41-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/94/ambry-presents-scientific-discovery-to-enhance-clinical-practice-at-american-society-for-human-genetics-annual-meeting-ashg 2019-05-07T17:12:45-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/93/ambry-genetics-announces-integration-with-fdna-to-advance-precision-medicine 2019-05-07T17:14:25-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/92/ambry-announces-new-research-grant-program-in-their-commitment-towards-advancing-science-and-research-at-nsgc-2017 2019-05-07T17:14:28-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/91/ambry-genetics-amp-northshore-university-healthsystem-partner-to-accelerate-precision-medicine-in-preventive-care 2019-05-07T17:14:33-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/89/ambry-launches-innovative-tumor-germline-testing-to-help-clinicians-guide-patient-treatment 2019-05-07T17:14:46-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/88/progeny-genetics-names-new-chief-executive-officer 2019-05-07T17:14:51-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/87/ambry-genetics-recruits-patient-cohorts-to-discover-new-links-between-genes-and-autism 2019-05-07T17:14:58-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/86/ambry-genetics-celebrates-translational-research-at-acmg-2017-presents-13-abstracts-and-plans-to-launch-a-personalized-genomic-test 2019-05-07T17:15:02-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/85/ambry-genetics-launches-new-site-for-cohort-recruitment 2019-05-07T17:15:07-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/84/ambry-genetics-big-data-sharing-program-now-available-for-public-download 2019-05-07T17:15:11-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/83/ambry-genetics-publishes-data-from-20-000-cases-supporting-sanger-sequencing-of-variants-following-ngs 2017-06-01T14:58:50-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/82/ambry-genetics-launches-comprehensive-multi-gene-test-for-hereditary-prostate-cancer 2017-06-01T14:46:35-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/81/ambry-genetics-ceo-aaron-elliott-receives-oc-business-journal-s-innovator-of-the-year-award 2017-06-01T14:44:55-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/80/ambry-genetics-donates-125-000-in-breast-cancer-genetic-testing-vouchers-to-mauli-ola-foundation 2017-06-01T15:00:05-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/79/ambry-genetics-and-collaborators-publish-vital-processes-and-data-to-better-understand-new-gene-associated-with-unexplained-neurodevelopmental-disorder 2017-06-01T15:00:49-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/78/ambry-genetics-and-prominent-oncology-research-collaborators-to-share-new-hereditary-cancer-data-at-upcoming-american-society-of-clinical-oncology-asco-annual-meeting 2017-06-01T14:30:01-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/77/charles-dunlop-of-ambry-genetics-assumes-role-of-president-dr-aaron-elliott-named-ceo 2017-06-01T15:02:00-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/76/ambry-genetics-shares-new-data-on-genetic-causes-for-neurodevelopmental-conditions-further-adding-to-growing-body-of-evidence-in-neurology 2017-06-01T15:02:55-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/75/ambry-genetics-launches-ambryshare-the-largest-disease-specific-public-database-of-sequenced-human-genomes-increasing-the-understanding-of-hereditary-breast-and-ovarian-cancer-10-fold 2017-06-01T14:24:48-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/74/ambry-genetics-to-present-seven-abstracts-at-upcoming-acmg-annual-clinical-genetics-meeting 2017-06-01T14:23:26-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/73/ambry-genetics-unveils-its-super-lab-one-of-the-largest-most-state-of-the-art-commercial-laboratories-in-the-world 2017-06-01T14:21:06-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/72/ambry-genetics-launches-new-neurodevelopmental-genetic-testing 2017-06-01T14:15:26-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/71/ambry-genetics-launches-cost-free-cloud-based-software-to-help-clinicians-and-researchers-maximize-genetic-and-family-history-data 2017-06-01T14:13:13-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/70/surfing-champion-coco-ho-wins-50-000-donation-in-hereditary-breast-cancer-testing-vouchers-for-cancer-foundation-as-part-of-mauli-ola-foundation-s-battle-for-the-breasts 2017-06-01T14:11:19-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/69/standup-for-the-cure-miami-event-on-november-7-to-raise-awareness-and-funding-for-breast-cancer-research 2017-06-01T14:10:08-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/68/ambry-genetics-launches-new-epilepsy-genetic-testing-panels 2017-06-01T15:04:42-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/67/ambry-genetics-shows-expanded-tp53-testing-identifies-more-carriers-raising-questions-about-clinical-definition-of-li-fraumeni-syndrome 2017-06-01T14:05:27-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/66/ambry-genetics-unveils-comprehensive-educational-resource-supporting-people-with-hereditary-breast-and-ovarian-cancer 2017-06-01T14:04:09-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/65/worlds-top-female-surfers-compete-for-125-000-donation-in-genetic-testing-vouchers-to-clinics-in-the-battle-for-the-breasts 2017-06-01T13:55:10-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/64/ey-announces-award-winners-for-entrepreneur-of-the-year-r-2015-orange-county 2017-06-01T15:06:38-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/63/ambry-genetics-acquires-progeny-software-llc 2017-06-01T13:48:28-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/62/ambry-announces-newly-published-data-on-hereditary-ovarian-cancer-and-multi-gene-panels 2017-06-01T13:46:18-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/61/ambry-genetics-announces-settlement-in-brca1-2-gene-patent-infringement-case 2017-06-01T13:44:36-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/60/ambry-genetics-launches-clinically-valuable-new-approach-to-cardiovascular-genetic-testing 2017-06-01T15:08:56-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/59/ambry-publishes-data-on-high-detection-rates-for-their-clinical-exome-sequencing-assay 2017-06-01T13:41:34-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/58/ambry-genetics-partners-in-hereditary-cancer-research-registry-prompt 2017-06-01T12:35:24-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/57/ambry-genetics-announces-title-sponsorship-for-battle-for-the-breasts-to-raise-awareness-in-the-fight-against-breast-cancer 2017-06-01T12:32:49-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/56/ambry-genetics-to-be-featured-on-innovations-with-ed-begley-jr 2017-06-01T12:30:59-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/55/researchers-suggest-payors-and-clinicians-should-choose-brca-labs-that-behave-ethically-make-data-available 2017-06-01T12:29:03-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/54/ambry-genetics-publishes-data-supporting-use-of-hereditary-cancer-panel-testing 2017-06-01T12:26:24-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/53/ambry-genetics-launches-a-new-generation-of-clinical-exome-sequencing 2017-06-01T12:24:25-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/52/ambry-genetics-prevails-in-preliminary-injunction-motion-filed-by-myriad-genetics 2017-06-01T15:13:05-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/51/ambry-genetics-sues-myriad-genetics-for-violating-federal-antitrust-laws 2017-06-01T12:15:10-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/50/ambry-genetics-reaffirms-status-as-worldwide-leader-in-hereditary-cancer-testing-with-new-renal-pancreatic-and-pgl-pcc-panels 2017-06-01T15:09:59-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/49/ambry-genetics-will-vigorously-defend-against-brca1-and-brca2-gene-patent-infringement-suit 2017-06-01T12:10:23-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/48/ambry-genetics-launches-brca-1-amp-2-single-genes-and-ngs-panel-offerings 2017-06-01T12:06:35-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/47/ceocfo-magazine-interview-with-charles-dunlop 2017-06-01T12:05:11-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/46/ambry-genetics-leading-the-way-with-clinical-next-generation-sequencing 2017-06-01T12:03:46-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/45/somatic-mutation-analysis 2017-06-01T12:01:54-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/44/milestone-10-000-diagnostic-amp-100-000-genomic-ngs-samples 2017-06-01T12:00:43-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/43/diagnosing-rare-disorders-using-next-generation-sequencing 2017-06-01T11:59:14-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/42/ambry-genetics-chairman-and-ceo-charles-dunlop-honored-with-rare-champion-award-at-global-genes-project-s-champions-of-hope-gala 2017-06-01T11:53:53-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/41/the-clinical-exome-the-brass-ring-of-molecular-testing 2017-06-01T11:49:27-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/40/ambry-genetics-catches-the-clinical-sequencing-wave 2017-06-01T11:47:44-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/39/ernst-amp-young-announces-finalists-for-the-2012-entrepreneur-of-the-year-awards-in-orange-county 2017-06-01T11:45:41-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/38/ambry-genetics-initiates-fluidigm-based-genomic-research-services-for-gene-expression-snp-genotyping-and-sample-prep-for-targeted-sequencing 2017-06-01T11:40:22-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/37/ambry-genetics-introduces-first-tier-exome-sequencing-test 2017-06-01T11:36:00-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/36/ambry-genetics-reports-specific-results-from-clinical-diagnostic-exome-testing-of-patients-at-kennedy-krieger-institute 2017-06-01T11:34:08-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/35/ambry-genetics-reports-results-from-clinical-diagnostic-exome-testing-of-three-patients 2017-06-01T11:32:18-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/34/ambry-genetics-launches-illumina-miseq-next-gen-sequencing-services 2017-06-01T11:30:10-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/33/ambry-genetics-turns-to-emc-isilon-for-next-generation-storage-of-gene-sequencing 2017-06-01T11:28:37-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/32/agilent-technologies-signs-agreement-to-supply-target-enrichment-system-to-ambry-genetics-for-exome-sequencing 2017-06-01T15:10:34-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/31/raindance-technologies-and-ambry-genetics-launch-industry-s-most-comprehensive-dna-sequencing-panel-for-adme-research 2017-06-01T15:11:06-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/30/ambry-genetics-first-to-offer-exome-sequencing-service-for-clinical-diagnostics 2017-06-01T11:14:41-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/28/ambry-genetics-raindance-s-new-thunderstorm-system-for-high-throughput-next-generation-targeted-sequencing-services 2017-06-01T11:09:58-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/29/ambry-genetics-raindance-s-new-thunderstorm-system-for-high-throughput-next-generation-targeted-sequencing-services-1 2017-06-01T11:09:59-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/27/ambry-genetics-announces-launch-of-their-cancerarray-product-and-services-utilizing-acgh-technology 2017-06-01T11:05:22-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/26/cell-line-genetics-and-ambry-genetics-announce-exclusive-global-agreement-for-sales-of-ambry-genetics-stemarray-and-related-services 2017-06-01T10:56:54-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/25/ambry-genetics-adds-certification-of-roche-nimblegen-cgh-dna-methylation-gene-expression-and-chip-chip-to-service-portfolio 2017-06-01T10:43:05-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/24/ambry-genetics-is-first-authorized-customer-service-provider-in-new-ion-torrent-csp-program 2017-06-01T10:37:57-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/23/labs-inc-announces-alliance-with-ambry-genetics-to-expand-testing-solutions-for-the-reproductive-health-industry 2017-06-01T10:33:35-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/22/ambry-genetics-amp-raindance-technologies-expand-collaboration-to-address-adme-analysis 2017-06-01T10:29:36-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/21/ambry-genetics-announces-launch-of-illumina-hiseq-2000-next-gen-sequencing-services 2017-06-01T10:24:07-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/20/the-mauli-ola-foundation-mof-announced-as-agent-of-change-award-recipients-for-2010-surfer-poll-presented-by-samsung-and-verizon-wireless 2017-06-01T10:22:32-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/19/ambry-genetics-becomes-first-certified-service-provider-in-us-for-nimblegen-seqcap-ez-exome 2017-06-01T10:19:46-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/18/ambry-genetics-announces-the-addition-of-illumina-hiseq-2000-and-first-510-k-approved-beadexpress-r-to-its-sequencing-and-genotyping-capabilities 2017-06-01T10:18:01-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/17/ambry-genetics-launches-first-x-linked-intellectual-disabilities-diagnostics-using-next-generation-sequencing 2017-06-01T10:15:11-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/16/ambry-genetics-and-raindance-technologies-announce-partnership-for-diagnostics-and-genomics-services-utilizing-the-rdt-1000-for-sequence-enrichment-and-targeted-resequencing-validation 2017-06-01T10:12:59-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/15/ambry-genetics-announces-launch-of-their-stemarray-product-and-services-for-high-resolution-characterization-of-human-stem-cells 2017-06-01T10:10:52-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/14/ambry-genetics-and-softgenetics-form-exclusive-alliance-for-extended-bioinformatics-support-for-next-generation-sequencing-projects 2017-06-01T10:07:56-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/13/agilent-technologies-appoints-ambry-genetics-as-first-certified-service-provider-for-agilent-s-target-enrichment-system-for-next-gen-sequencing 2017-06-01T09:51:34-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/12/ambry-genetics-announces-certified-service-provider-status-for-agilent-microarrays 2017-06-01T09:48:52-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/11/ambry-genetics-announces-launch-of-chromosomal-microarray-to-offer-whole-genome-analysis 2017-05-31T14:46:19-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/10/ambry-genetics-announces-the-addition-of-array-cgh-services-through-partnership-with-baylor-college-of-medicine 2017-05-31T14:44:29-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/9/ambry-genetics-announces-illumina-cspro-certification-for-ga-sequencing 2017-05-31T14:42:56-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/8/ambry-genetics-introduces-sequence-capture-for-high-throughput-sequencing-applications-on-multiple-next-gen-sequencing-platforms 2017-05-31T14:41:08-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/7/ambry-genetics-announces-next-generation-sequencing-services-for-support-of-pharmacogenomics-research 2017-05-31T14:38:42-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/6/ambry-genetics-creates-new-business-division-to-support-biopharmaceutical-research 2017-05-31T14:37:00-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/5/first-clinical-genetic-test-for-idiopathic-pulmonary-fibrosis-launched-by-ambry-genetics 2017-05-31T14:34:57-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/4/surfing-leads-to-medical-breakthrough-ambry-genetics-amp-newport-surf-camp-team-up-to-get-children-with-cystic-fibrosis-surfing 2017-05-31T14:33:03-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/3/ambry-genetics-expands-services-to-diagnose-life-threatening-lung-diseases-1 2017-05-31T14:31:28-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/2/ambry-genetics-expands-services-to-diagnose-life-threatening-lung-diseases 2017-05-31T14:27:02-07:00 daily 0.8 https://www.ambrygen.com/company/press-release/1/ambry-genetics-announces-508-first-r-cystic-fibrosis-test-59-assay-detects-the-most-common-cystic-fibrosis-mutation 2019-05-06T13:23:08-07:00 daily 0.8 https://www.ambrygen.com/company/community-outreach 2026-04-02T12:29:42-07:00 daily 0.8 https://www.ambrygen.com/company/testimonials 2026-04-02T12:29:42-07:00 daily 0.8 https://www.ambrygen.com/company/careers 2026-04-02T12:29:42-07:00 daily 0.8 https://www.ambrygen.com/company/careers/recruitment-fraud-alert 2026-04-02T12:29:42-07:00 daily 0.8 https://www.ambrygen.com/conferences 2026-04-02T12:29:42-07:00 daily 0.8 https://www.ambrygen.com/conference/588/aes-2026 2025-11-24T16:02:06-08:00 daily 0.8 https://www.ambrygen.com/conference/587/nsgc-2026 2025-11-24T15:55:18-08:00 daily 0.8 https://www.ambrygen.com/conference/593/cga-igc 2025-12-04T08:50:31-08:00 daily 0.8 https://www.ambrygen.com/conference/586/sdbp-2026 2025-11-24T15:49:53-08:00 daily 0.8 https://www.ambrygen.com/conference/585/ashg-2026 2025-11-24T15:43:54-08:00 daily 0.8 https://www.ambrygen.com/conference/584/cns-2026 2025-11-24T15:37:11-08:00 daily 0.8 https://www.ambrygen.com/conference/583/reuters-total-health-2026 2025-11-24T15:32:19-08:00 daily 0.8 https://www.ambrygen.com/conference/582/aap-2026 2025-11-24T15:42:55-08:00 daily 0.8 https://www.ambrygen.com/conference/600/asco-2026 2026-02-21T14:52:54-08:00 daily 0.8 https://www.ambrygen.com/conference/595/american-urological-association-2026 2026-02-21T12:25:49-08:00 daily 0.8 https://www.ambrygen.com/conference/592/acog-2026 2025-12-17T11:31:50-08:00 daily 0.8 https://www.ambrygen.com/conference/594/asbrs 2026-01-12T13:03:14-08:00 daily 0.8 https://www.ambrygen.com/conference/599/aan-2026 2026-02-21T14:47:35-08:00 daily 0.8 https://www.ambrygen.com/conference/598/aacr-2026 2026-02-21T14:34:05-08:00 daily 0.8 https://www.ambrygen.com/conference/591/sbi-2026 2025-12-04T08:49:32-08:00 daily 0.8 https://www.ambrygen.com/conference/590/ncobc-2026 2025-12-04T08:47:08-08:00 daily 0.8 https://www.ambrygen.com/conference/596/mutational-scanning-symposium-2026 2026-02-21T12:41:11-08:00 daily 0.8 https://www.ambrygen.com/conference/581/napnap-2026 2025-11-24T15:22:17-08:00 daily 0.8 https://www.ambrygen.com/conference/580/acmg 2026-03-06T15:38:22-08:00 daily 0.8 https://www.ambrygen.com/conference/597/insight-2026 2026-02-21T14:18:31-08:00 daily 0.8 https://www.ambrygen.com/conference/574/sabcs-2025 2025-02-12T11:06:11-08:00 daily 0.8 https://www.ambrygen.com/conference/573/aes-2025 2025-10-07T17:42:46-07:00 daily 0.8 https://www.ambrygen.com/conference/572/nsgc-2025 2025-09-04T13:41:03-07:00 daily 0.8 https://www.ambrygen.com/conference/571/total-health-2025 2025-09-19T20:08:58-07:00 daily 0.8 https://www.ambrygen.com/conference/570/ashg-2025 2025-07-28T12:22:28-07:00 daily 0.8 https://www.ambrygen.com/conference/569/cga-igc-2025 2025-07-22T08:34:07-07:00 daily 0.8 https://www.ambrygen.com/conference/568/cns-2025 2025-07-28T12:23:06-07:00 daily 0.8 https://www.ambrygen.com/conference/567/sdbp-2025 2025-07-28T12:23:54-07:00 daily 0.8 https://www.ambrygen.com/conference/589/gregor-annual-meeting-2026 2025-12-01T08:19:58-08:00 daily 0.8 https://www.ambrygen.com/conference/578/rasopathies-symposium-2025 2025-06-20T07:48:20-07:00 daily 0.8 https://www.ambrygen.com/conference/576/ccg-2025 2025-05-15T11:03:03-07:00 daily 0.8 https://www.ambrygen.com/conference/577/mss-2025 2025-05-15T11:18:01-07:00 daily 0.8 https://www.ambrygen.com/conference/566/acog-2025 2025-05-12T08:01:24-07:00 daily 0.8 https://www.ambrygen.com/conference/565/brca-2025 2025-01-30T14:56:41-08:00 daily 0.8 https://www.ambrygen.com/conference/564/asbrs 2025-02-11T18:43:47-08:00 daily 0.8 https://www.ambrygen.com/conference/575/basser-scientific-symposium-2025 2025-04-03T08:46:24-07:00 daily 0.8 https://www.ambrygen.com/conference/563/ncobc 2024-12-17T15:05:52-08:00 daily 0.8 https://www.ambrygen.com/conference/562/acmg-2025 2025-03-11T14:25:12-07:00 daily 0.8 https://www.ambrygen.com/conference/559/sabcs-2024 2024-07-19T15:29:43-07:00 daily 0.8 https://www.ambrygen.com/conference/558/cga-igc-annual-meeting 2024-09-04T06:31:33-07:00 daily 0.8 https://www.ambrygen.com/conference/554/cns-2024 2024-07-19T15:24:08-07:00 daily 0.8 https://www.ambrygen.com/conference/557/tme 2024-06-20T14:37:05-07:00 daily 0.8 https://www.ambrygen.com/conference/556/ashg-2024 2024-07-19T15:32:12-07:00 daily 0.8 https://www.ambrygen.com/conference/555/nsgc-2024 2024-06-14T15:39:43-07:00 daily 0.8 https://www.ambrygen.com/conference/561/scgdb-2024 2024-09-03T10:11:38-07:00 daily 0.8 https://www.ambrygen.com/conference/560/agbt-precision-health 2024-09-03T03:02:11-07:00 daily 0.8 https://www.ambrygen.com/conference/553/nf-2024 2024-06-03T09:33:25-07:00 daily 0.8 https://www.ambrygen.com/conference/550/insight-2024 2024-06-03T08:48:46-07:00 daily 0.8 https://www.ambrygen.com/conference/552/igclc-2024 2024-06-13T10:41:16-07:00 daily 0.8 https://www.ambrygen.com/conference/545/asco-2024 2024-03-31T14:27:52-07:00 daily 0.8 https://www.ambrygen.com/conference/551/eshg-2024 2024-06-03T07:39:58-07:00 daily 0.8 https://www.ambrygen.com/conference/549/ddw-2024 2024-03-22T06:36:58-07:00 daily 0.8 https://www.ambrygen.com/conference/544/acog-2024 2024-03-31T14:24:18-07:00 daily 0.8 https://www.ambrygen.com/conference/548/ccg-2024 2024-03-22T06:28:21-07:00 daily 0.8 https://www.ambrygen.com/conference/546/aacr-2024 2024-01-08T08:59:42-08:00 daily 0.8 https://www.ambrygen.com/conference/512/ncbc-2024 2024-12-17T15:02:28-08:00 daily 0.8 https://www.ambrygen.com/conference/543/acmg-2024 2024-01-26T14:22:27-08:00 daily 0.8 https://www.ambrygen.com/conference/484/ashg-2023 2024-01-29T19:12:02-08:00 daily 0.8 https://www.ambrygen.com/conference/483/cga-igc-2023 2024-01-29T13:36:33-08:00 daily 0.8 https://www.ambrygen.com/conference/482/acg-2023 2024-01-29T20:42:30-08:00 daily 0.8 https://www.ambrygen.com/conference/481/nsgc-2023 2024-01-29T20:49:39-08:00 daily 0.8 https://www.ambrygen.com/conference/485/cns-2023 2024-01-29T20:59:55-08:00 daily 0.8 https://www.ambrygen.com/conference/480/tme-2023 2024-01-29T13:44:21-08:00 daily 0.8 https://www.ambrygen.com/conference/486/nf-2023 2024-01-29T21:08:15-08:00 daily 0.8 https://www.ambrygen.com/conference/487/eshg-2023 2024-01-29T13:42:41-08:00 daily 0.8 https://www.ambrygen.com/conference/488/asco-2023 2024-01-29T21:13:42-08:00 daily 0.8 https://www.ambrygen.com/conference/477/acog-2023 2023-01-19T12:15:58-08:00 daily 0.8 https://www.ambrygen.com/conference/478/city-of-hope-conference-2023 2024-01-29T21:20:07-08:00 daily 0.8 https://www.ambrygen.com/conference/479/brca-2023 2023-09-26T08:15:53-07:00 daily 0.8 https://www.ambrygen.com/conference/476/acmg-2023 2022-12-30T14:21:06-08:00 daily 0.8 https://www.ambrygen.com/conference/501/san-antonio-breast-cancer-symposium 2024-01-29T20:34:10-08:00 daily 0.8 https://www.ambrygen.com/conference/472/nsgc-2022 2024-01-29T20:50:05-08:00 daily 0.8 https://www.ambrygen.com/conference/475/cga-igc-2022 2024-01-29T13:36:02-08:00 daily 0.8 https://www.ambrygen.com/conference/473/acg-2022 2024-01-29T20:42:55-08:00 daily 0.8 https://www.ambrygen.com/conference/474/tme-2022 2024-01-29T13:45:03-08:00 daily 0.8 https://www.ambrygen.com/conference/440/pmwc-2022 2024-01-29T21:20:57-08:00 daily 0.8 https://www.ambrygen.com/conference/471/asco-2022 2024-01-29T21:14:10-08:00 daily 0.8 https://www.ambrygen.com/conference/470/ddw-2022 2024-01-29T21:22:47-08:00 daily 0.8 https://www.ambrygen.com/conference/469/acog-2022 2024-01-29T21:25:39-08:00 daily 0.8 https://www.ambrygen.com/conference/468/asbrs-2022 2024-01-29T21:28:11-08:00 daily 0.8 https://www.ambrygen.com/conference/547/acmg-2022 2024-01-10T17:57:48-08:00 daily 0.8 https://www.ambrygen.com/conference/499/sabcs-2021 2024-01-29T20:34:54-08:00 daily 0.8 https://www.ambrygen.com/conference/493/cga-igc-2021 2024-01-29T13:34:53-08:00 daily 0.8 https://www.ambrygen.com/conference/496/nanets-2021 2024-01-29T21:32:03-08:00 daily 0.8 https://www.ambrygen.com/conference/492/ashg-2021 2024-01-29T19:12:24-08:00 daily 0.8 https://www.ambrygen.com/conference/500/nsgc-2021 2024-01-29T20:50:44-08:00 daily 0.8 https://www.ambrygen.com/conference/495/esc-2021 2024-01-29T21:37:20-08:00 daily 0.8 https://www.ambrygen.com/conference/494/ean-2021 2024-01-29T21:47:33-08:00 daily 0.8 https://www.ambrygen.com/conference/491/asco-2021 2024-01-29T21:17:09-08:00 daily 0.8 https://www.ambrygen.com/conference/498/nla-2021 2024-01-29T21:50:00-08:00 daily 0.8 https://www.ambrygen.com/conference/489/aan-2021 2024-01-29T21:56:30-08:00 daily 0.8 https://www.ambrygen.com/conference/490/acmg-2021 2024-01-29T19:26:53-08:00 daily 0.8 https://www.ambrygen.com/conference/497/nccn-2021 2024-01-29T21:58:22-08:00 daily 0.8 https://www.ambrygen.com/conference/502/sabcs-2020 2024-01-29T20:35:38-08:00 daily 0.8 https://www.ambrygen.com/conference/503/hgsa-2020 2024-01-29T22:01:52-08:00 daily 0.8 https://www.ambrygen.com/conference/504/nsgc-2020 2024-01-29T20:51:11-08:00 daily 0.8 https://www.ambrygen.com/conference/505/cga-igc-2020 2024-01-29T13:34:25-08:00 daily 0.8 https://www.ambrygen.com/conference/506/ashg-2020 2024-01-29T19:12:49-08:00 daily 0.8 https://www.ambrygen.com/conference/507/hfsa-2020 2024-01-29T22:08:45-08:00 daily 0.8 https://www.ambrygen.com/conference/509/ats-2020 2024-01-29T22:10:53-08:00 daily 0.8 https://www.ambrygen.com/conference/508/asco-2020 2024-01-29T21:17:28-08:00 daily 0.8 https://www.ambrygen.com/conference/465/acmg-2020 2024-01-29T19:26:07-08:00 daily 0.8 https://www.ambrygen.com/conference/453/sabcs-2019 2024-01-29T20:36:01-08:00 daily 0.8 https://www.ambrygen.com/conference/448/nsgc-2019 2024-01-29T20:52:23-08:00 daily 0.8 https://www.ambrygen.com/conference/463/cga-igc-2019 2024-01-29T13:33:49-08:00 daily 0.8 https://www.ambrygen.com/conference/457/cns-2019 2024-01-29T21:00:16-08:00 daily 0.8 https://www.ambrygen.com/conference/454/fh-summit-2019 2024-01-29T22:15:29-08:00 daily 0.8 https://www.ambrygen.com/conference/451/ashg-2019 2024-01-29T19:13:16-08:00 daily 0.8 https://www.ambrygen.com/conference/458/mayo-clinic-the-genetics-of-heart-amp-vascular-disease-2019 2024-01-29T22:16:43-08:00 daily 0.8 https://www.ambrygen.com/conference/459/nla-2019 2024-01-29T21:49:38-08:00 daily 0.8 https://www.ambrygen.com/conference/447/iec-2019 2024-01-29T22:22:10-08:00 daily 0.8 https://www.ambrygen.com/conference/446/icml-2019 2024-01-29T22:24:44-08:00 daily 0.8 https://www.ambrygen.com/conference/444/asco-2019 2024-01-29T21:17:47-08:00 daily 0.8 https://www.ambrygen.com/conference/445/curating-the-clinical-genome 2022-06-16T16:02:54-07:00 daily 0.8 https://www.ambrygen.com/conference/455/nla-2019 2024-01-29T21:51:52-08:00 daily 0.8 https://www.ambrygen.com/conference/450/hrs-2019 2024-01-29T22:27:01-08:00 daily 0.8 https://www.ambrygen.com/conference/438/aua-2019 2024-01-29T22:29:19-08:00 daily 0.8 https://www.ambrygen.com/conference/439/asbrs-2019 2024-01-29T21:28:41-08:00 daily 0.8 https://www.ambrygen.com/conference/437/acmg-2019 2024-01-29T19:26:33-08:00 daily 0.8 https://www.ambrygen.com/conference/436/insight-2019 2024-01-29T22:31:16-08:00 daily 0.8 https://www.ambrygen.com/conference/449/ncobc-2019 2024-01-29T22:35:42-08:00 daily 0.8 https://www.ambrygen.com/conference/443/miami-breast-cancer-conference 2022-06-16T15:59:09-07:00 daily 0.8 https://www.ambrygen.com/conference/412/sabcs-2018 2024-01-29T20:36:26-08:00 daily 0.8 https://www.ambrygen.com/conference/315/aes-2018 2024-01-29T22:38:11-08:00 daily 0.8 https://www.ambrygen.com/conference/349/nsgc-2018 2024-01-29T20:52:50-08:00 daily 0.8 https://www.ambrygen.com/conference/314/aha-2018 2024-01-29T22:41:17-08:00 daily 0.8 https://www.ambrygen.com/conference/312/ashg-2018 2024-01-29T19:13:42-08:00 daily 0.8 https://www.ambrygen.com/conference/311/cns-2018 2024-01-29T21:01:53-08:00 daily 0.8 https://www.ambrygen.com/conference/410/cga-igc-2018 2024-01-29T13:33:09-08:00 daily 0.8 https://www.ambrygen.com/conference/309/asco-2018 2024-01-29T21:18:34-08:00 daily 0.8 https://www.ambrygen.com/conference/397/aacr-2018 2024-01-29T22:50:00-08:00 daily 0.8 https://www.ambrygen.com/conference/278/acmg-2018 2024-01-29T22:44:53-08:00 daily 0.8 https://www.ambrygen.com/conference/262/sgo-2018 2024-01-29T22:48:12-08:00 daily 0.8 https://www.ambrygen.com/conference/303/miami-breast-cancer-conference-2018 2024-01-29T23:22:07-08:00 daily 0.8 https://www.ambrygen.com/conference/228/sabcs-2017 2024-01-29T22:50:50-08:00 daily 0.8 https://www.ambrygen.com/conference/85/aes-2017 2024-01-29T22:52:37-08:00 daily 0.8 https://www.ambrygen.com/conference/84/sno-2017 2024-01-29T22:53:48-08:00 daily 0.8 https://www.ambrygen.com/conference/83/aha-2017 2024-01-29T22:54:47-08:00 daily 0.8 https://www.ambrygen.com/conference/297/cga-icc-2017 2024-01-29T22:55:44-08:00 daily 0.8 https://www.ambrygen.com/conference/81/ashg-2017 2024-01-29T22:57:00-08:00 daily 0.8 https://www.ambrygen.com/conference/93/nsgc-2017 2024-01-29T23:23:12-08:00 daily 0.8 https://www.ambrygen.com/conference/348/pancreasfest-2017 2024-01-29T23:23:40-08:00 daily 0.8 https://www.ambrygen.com/conference/75/nf-2017 2024-01-29T23:24:58-08:00 daily 0.8 https://www.ambrygen.com/conference/139/asco-2017 2024-01-31T12:24:03-08:00 daily 0.8 https://www.ambrygen.com/conference/72/ats-2017 2024-01-31T12:25:40-08:00 daily 0.8 https://www.ambrygen.com/conference/156/aua-2017 2024-01-31T12:26:37-08:00 daily 0.8 https://www.ambrygen.com/conference/238/ddw-2017 2024-01-31T12:28:11-08:00 daily 0.8 https://www.ambrygen.com/conference/65/aan-2017 2024-01-31T12:29:08-08:00 daily 0.8 https://www.ambrygen.com/conference/230/aacr-2017 2024-01-31T12:31:08-08:00 daily 0.8 https://www.ambrygen.com/conference/63/acmg-2017 2024-01-29T23:02:21-08:00 daily 0.8 https://www.ambrygen.com/conference/59/sgo-2017 2024-01-29T23:15:32-08:00 daily 0.8 https://www.ambrygen.com/conference/60/ncobc 2024-01-31T12:32:49-08:00 daily 0.8 https://www.ambrygen.com/conference/58/miami-breast-cancer-conference-2017 2024-01-29T23:06:18-08:00 daily 0.8 https://www.ambrygen.com/conference/54/asco-gi-symposium-2017 2024-01-31T12:35:17-08:00 daily 0.8 https://www.ambrygen.com/conference/517/sabcs-2016 2024-01-29T20:36:50-08:00 daily 0.8 https://www.ambrygen.com/conference/31/sno-2016 2024-01-29T22:54:08-08:00 daily 0.8 https://www.ambrygen.com/conference/514/cagc-2016 2024-01-31T12:36:15-08:00 daily 0.8 https://www.ambrygen.com/conference/2/ashg-2016 2024-01-29T19:14:08-08:00 daily 0.8 https://www.ambrygen.com/conference/513/cga-igc-2016 2024-01-29T13:31:38-08:00 daily 0.8 https://www.ambrygen.com/conference/516/nsgc-2016 2024-01-29T20:55:22-08:00 daily 0.8 https://www.ambrygen.com/conference/283/the-festival-of-genomics-amp-biodata-2016 2023-12-04T14:02:51-08:00 daily 0.8 https://www.ambrygen.com/conference/284/curating-the-clinical-genome-2016 2024-01-31T12:39:21-08:00 daily 0.8 https://www.ambrygen.com/conference/276/asco-2016 2024-01-31T12:24:44-08:00 daily 0.8 https://www.ambrygen.com/conference/143/eshg-2016 2024-01-31T12:41:42-08:00 daily 0.8 https://www.ambrygen.com/conference/515/brca-symposium-2016 2023-12-04T10:01:13-08:00 daily 0.8 https://www.ambrygen.com/conference/277/ascrs-2016 2024-01-31T12:42:43-08:00 daily 0.8 https://www.ambrygen.com/conference/287/hrs-2016 2024-01-29T23:18:36-08:00 daily 0.8 https://www.ambrygen.com/conference/510/aan-2016 2024-01-29T21:57:05-08:00 daily 0.8 https://www.ambrygen.com/conference/289/asbrs-2016 2024-01-29T23:20:07-08:00 daily 0.8 https://www.ambrygen.com/conference/291/acc-2016 2024-01-29T23:18:00-08:00 daily 0.8 https://www.ambrygen.com/conference/293/sgo-2016 2024-01-29T23:15:54-08:00 daily 0.8 https://www.ambrygen.com/conference/272/acmg-2016 2024-01-29T23:02:26-08:00 daily 0.8 https://www.ambrygen.com/conference/294/genetic-task-force-of-illinois-gtfi-2016 2024-01-29T23:13:01-08:00 daily 0.8 https://www.ambrygen.com/conference/295/cancer-survivorship-symposium-2016 2024-01-29T23:12:27-08:00 daily 0.8 https://www.ambrygen.com/conference/528/sabcs-2015 2024-01-29T20:37:38-08:00 daily 0.8 https://www.ambrygen.com/conference/518/aes-2015 2024-01-29T22:38:29-08:00 daily 0.8 https://www.ambrygen.com/conference/522/nsgc-2015 2024-01-29T20:56:59-08:00 daily 0.8 https://www.ambrygen.com/conference/527/cga-igc-2015 2024-01-29T13:30:34-08:00 daily 0.8 https://www.ambrygen.com/conference/521/cns-2015 2024-01-29T21:03:27-08:00 daily 0.8 https://www.ambrygen.com/conference/520/ashg-2015 2024-01-29T19:18:37-08:00 daily 0.8 https://www.ambrygen.com/conference/526/breast-cancer-symposium-2015 2023-12-07T10:59:26-08:00 daily 0.8 https://www.ambrygen.com/conference/519/apshg-2015 2024-01-29T23:00:20-08:00 daily 0.8 https://www.ambrygen.com/conference/525/asco-2015 2024-01-29T21:18:54-08:00 daily 0.8 https://www.ambrygen.com/conference/332/acmg-2015 2024-01-29T23:05:18-08:00 daily 0.8 https://www.ambrygen.com/conference/524/ncobc-2015 2024-01-29T22:33:41-08:00 daily 0.8 https://www.ambrygen.com/conference/523/miami-breast-cancer-conference-2015 2024-01-29T23:07:14-08:00 daily 0.8 https://www.ambrygen.com/conference/533/sabcs-2014 2024-01-29T20:38:08-08:00 daily 0.8 https://www.ambrygen.com/conference/529/aes-2014 2024-01-29T22:38:46-08:00 daily 0.8 https://www.ambrygen.com/conference/535/nafc-2014 2024-01-29T23:07:57-08:00 daily 0.8 https://www.ambrygen.com/conference/532/ashg-2014 2024-01-29T19:18:16-08:00 daily 0.8 https://www.ambrygen.com/conference/536/fannp-2014 2024-01-29T23:09:19-08:00 daily 0.8 https://www.ambrygen.com/conference/537/aap-2014 2024-01-29T23:10:39-08:00 daily 0.8 https://www.ambrygen.com/conference/531/nsgc-2014 2024-01-29T20:58:42-08:00 daily 0.8 https://www.ambrygen.com/conference/534/cga-igc-2014 2024-01-29T13:29:48-08:00 daily 0.8 https://www.ambrygen.com/conference/530/acmg-2014 2024-01-29T19:27:16-08:00 daily 0.8 https://www.ambrygen.com/conference/539/ashg-2013 2024-01-29T19:17:38-08:00 daily 0.8 https://www.ambrygen.com/conference/540/nsgc-2013 2024-01-29T20:59:20-08:00 daily 0.8 https://www.ambrygen.com/conference/542/umdf-2013 2024-01-29T13:39:57-08:00 daily 0.8 https://www.ambrygen.com/conference/541/eshg-2013 2024-01-29T13:43:34-08:00 daily 0.8 https://www.ambrygen.com/conference/538/acmg-2013 2024-01-29T19:27:41-08:00 daily 0.8 https://www.ambrygen.com/ 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/contact-us 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/media 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/licenses 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/gene/search-results 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/legal/terms-and-conditions 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/legal/cookie-policy 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/legal/notice-of-privacy-practices 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/legal/notice-of-nondiscrimination 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/legal/privacy-policy 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/legal/care/care-user-access-policy 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/legal/new-york-state-exceptions 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/legal/information-security-statement 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/legal/reporting-policy 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/legal/care-terms-and-conditions 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/partners 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/partners/care 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/partners/care/cancer 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/partners/sponsored-testing 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/partners/genome-medical 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/partners/pharma-services 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/partners/pharma-services/test-menu 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/partners/pharma-services/clinical-trial-support 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/partners/pharma-services/real-world-data-services 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/billing-and-insurance 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/understand-more 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/genetics-101 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/resources-and-support 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/take-action 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/understand-more/brain-cancer 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/understand-more/breast-cancer 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/understand-more/colon-cancer 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/understand-more/gynecologic-cancer 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/understand-more/skin-cancer 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/understand-more/pancreatic-cancer 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/understand-more/endocrine-cancer 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/understand-more/prostate-cancer 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/understand-more/kidney-cancer 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/understand-more/hereditary-cardiovascular-conditions 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/understand-more/exome-sequencing 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/understand-more/cystic-fibrosis 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/understand-more/neurological-disorders 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/genetic-testing-faqs 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/cancer 2026-04-03T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/cardiology 2026-04-03T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/neurology 2026-04-03T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/patients/exome-and-general-genetics 2026-04-03T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/providers 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/providers/telemedicine 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/providers/ordering-process 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/providers/order-sample-kit 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/providers/specimen-requirements 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/providers/forms 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/providers/patient-for-life 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/providers/billing-and-insurance 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/providers/billing-and-insurance/payor-relations 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/providers/resources/clinical-materials 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/providers/resources/exome 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/providers/billing-and-insurance/insurance-preverification 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/providers/resources/prevalence-tool 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/providers/bringing-clarity 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/providers/advancing-science 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/providers/postmortem 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/providers/re-requisitioning-policy 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/rna 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/science 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/science/collaborations 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-posters 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/549/clinical-impact-of-integrating-brca2-mave-data-for-variant-reclassification-a-real-world-evaluation 2026-03-31T08:33:04-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/539/a-10-year-old-male-with-four-genetic-diagnoses-and-a-complex-multisystem-presentation 2026-02-18T08:56:03-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/540/use-of-pangenome-reference-improves-variant-calling-in-clinical-genome-sequencing 2026-03-12T07:54:48-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/541/never-stop-looking-dual-diagnoses-due-to-updated-gene-disease-relationships-in-exome-patients 2026-03-12T08:13:51-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/536/obesity-among-patients-with-chromosome-22q11-duplication-syndrome 2026-02-18T08:27:51-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/538/multiple-variant-men1-haplotypes-observed-in-multiple-endocrine-neoplasia-type-1 2026-02-18T08:45:41-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/543/hifi-long-read-wgs-sequencing-performance-of-buccal-and-saliva-samples-and-estimation-of-non-human-dna-contamination-from-unaligned-hifi-reads 2026-03-12T08:08:56-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/542/the-other-half-of-the-story-high-rates-of-unique-parental-secondary-finding 2026-02-18T12:25:45-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/544/case-report-with-biallelic-variants-in-gcnt2-implicates-exon-1b-in-congenital-cataracts 2026-03-12T09:01:53-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/546/impact-of-structural-biology-assessment-on-variant-interpretation-and-patient-outcomes-over-ten-years-in-a-clinical-diagnostic-laboratory 2026-03-12T08:05:00-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/537/piloting-the-forthcoming-acmg-amp-cap-clingen-standards-for-sequence-variant-classification 2026-02-18T08:38:35-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/545/to-fibroblast-or-not-to-fibroblast-outcomes-and-clinical-features-of-patients-pursuing-confirmatory-germline-testing-following-tp53-positive-results 2026-02-18T12:40:32-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/547/characterization-of-tmem127-related-tumor-predisposition-in-a-hereditary-cancer-cohort 2026-03-12T08:10:19-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/548/heterogeneity-of-pancreatic-cancer-risk-across-germline-susceptibility-genes-and-sex 2026-03-05T06:02:28-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/534/partially-functional-hypomorphic-missense-variants-in-brca2-are-reduced-penetrance-pathogenic-variants 2025-12-10T10:39:51-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/529/exploring-the-yield-of-rasopathy-variants-in-individuals-with-presumed-nonsyndromic-hypertrophic-cardiomyopathy 2025-11-07T06:06:52-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/533/impact-of-gnomad-v4-on-bs1-application 2025-11-07T06:33:24-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/528/the-missing-piece-targeted-rna-studies-reduce-uncertainty-and-increase-diagnostic-yield 2025-11-07T05:48:36-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/532/atypical-risk-variants-in-oncology-and-rare-disease-findings-from-a-review-of-laboratory-case-studies-and-over-6000-clinvar-submissions 2025-11-07T06:49:17-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/530/time-to-testing-for-hereditary-cancer-a-comparison-of-age-at-cancer-diagnosis-and-genetic-testing 2025-11-07T06:48:58-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/531/germline-sdha-related-tumor-risks-a-cohort-of-558-sdha-positive-patients-from-a-single-reference-laboratory 2025-11-07T06:13:39-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/523/long-read-genome-sequencing-resolves-genetic-cases-missed-by-short-read-sequencing 2025-10-14T11:19:16-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/522/targeted-rna-studies-offer-new-opportunities-to-reduce-uncertainty-and-increase-diagnostic-yield 2025-10-14T11:44:02-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/517/low-allele-fraction-high-stakes-discerning-germline-mosaic-tp53-variants-from-clonal-hematopoiesis-of-indeterminate-potential-chip 2025-10-14T11:24:04-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/520/isoform-specific-loss-of-function-variants-in-cdkn2a-and-their-association-with-cancer-phenotypes 2025-10-14T11:14:24-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/516/a-comprehensive-clinically-calibrated-mave-multiplex-assay-of-variant-effect-for-the-human-mutla-complex-genes-mlh1-and-pms2 2025-10-14T10:48:53-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/519/the-limits-of-mendelian-assumptions-in-genomic-diagnostics-evidence-from-longread-whole-genome-sequencing-and-exome-analysis 2025-10-14T13:30:50-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/525/expanding-and-automating-the-calibration-of-computational-tools-for-clinical-variant-classification 2025-10-14T12:34:05-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/518/an-update-on-apc-p-i1307k-homozygosity-observations-from-74-individuals-from-a-large-multigene-panel-testing-cohort-1 2025-10-14T11:05:59-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/513/revelations-uncovering-hidden-heterogeneity-lurking-in-the-generalized-calibration-of-computational-tools 2025-10-14T11:40:33-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/524/conversational-ai-in-cancer-genetic-education-a-critical-review-of-assessment-metrics-and-methodologies 2025-10-14T12:24:59-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/514/uniparental-disomy-mysteries-how-chromosomal-microarray-and-exome-sequencing-can-provide-upd-clues-that-influence-the-diagnostic-odyssey 2025-10-14T11:52:25-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/527/rna-splicing-analysis-reclassified-two-variants-of-uncertain-significance-in-an-autosomal-recessive-noonan-syndrome-case 2025-10-14T13:08:09-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/512/dont-judge-a-variant-by-its-position-2t-gt-c-and-the-splicing-surprise 2025-10-14T13:33:29-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/526/characterization-of-the-genetic-and-phenotypic-spectrum-of-a-novel-neurodevelopmental-syndrome-tcf7l2-related-neurodevelopmental-disorder-trnd 2025-10-14T13:00:50-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/515/advancing-clinical-validity-curation-and-disease-naming-in-hereditary-cancer-a-comprehensive-recuration-of-breast-ovarian-colon-cancer-and-polyposis-disease-genes 2025-10-14T10:56:50-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/508/cancer-prevalence-in-msh3-heterozygotes 2025-10-09T10:00:14-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/507/an-update-on-apc-p-i1307k-homozygosity-observations-from-74-individuals-from-a-large-multigene-panel-testing-cohort 2025-10-09T10:07:51-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/510/rna-and-reclassification-assessing-rna-data-in-rare-disease-1 2025-10-09T09:37:40-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/511/laboratory-driven-exome-reanalysis-increases-diagnostic-yield-and-decreases-burden-on-clinicians 2025-10-09T09:30:42-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/509/what-comes-first-the-exome-or-the-array-a-comparative-study-of-results-from-chromosomal-microarrays-and-exome-sequencing-1 2025-09-24T06:34:56-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/506/what-comes-first-the-exome-or-the-array-a-comparative-study-of-results-from-chromosomal-microarrays-and-exome-sequencing 2025-07-28T12:14:57-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/535/hifi-long-read-wgs-sequencing-performance-of-buccal-saliva-samples-and-estimation-of-non-human-dna-contamination-from-unaligned-hifi-reads 2025-12-01T08:30:13-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/505/updates-from-the-international-nf-swn-genes-variant-curation-expert-panel-vcep-to-improve-genetic-testing-of-neurofibromatosis-and-schwannomatosis 2025-07-23T12:14:14-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/502/applying-a-ps4-likelihood-ratio-methodology-lr-calc-for-integrating-enriched-case-data-from-national-laboratory-testing-nhs-glh-laboratories-ambry-genetics-into-large-scale-case-control-analyses 2025-06-11T10:05:06-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/504/development-of-population-frequency-thresholds-specific-for-rare-neurodevelopmental-disorders 2025-06-17T09:40:53-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/501/quantifying-phenotypic-specificity-pp4-of-rare-germline-fh-variants-from-diagnostic-laboratory-testing-for-hlrcc-and-renal-cancer 2025-06-11T09:56:09-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/497/breast-cancer-prevalence-in-ctnna1-heterozygotes-identified-via-hereditary-cancer-multigene-panel-testing 2025-05-09T06:58:22-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/498/paired-dna-and-rna-sequencing-from-450-000-consecutive-individuals-impact-on-yield-in-hereditary-breast-ovarian-pancreatic-and-prostate-hbop-cancer-genes 2025-05-06T06:19:23-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/496/large-scale-integration-of-functional-assay-data-for-the-resolution-of-germline-brca1-and-brca2-variants-of-uncertain-significance 2025-05-06T06:08:00-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/499/the-dual-nature-of-alternative-splicing-how-alternative-transcripts-rescue-or-attenuate-the-tumor-suppressor-activity-of-palb2-variants 2025-05-06T06:25:11-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/500/paired-dna-and-rna-sequencing-from-450-000-consecutive-individuals-impact-on-yield-in-hereditary-breast-ovarian-pancreatic-and-prostate-hbop-cancer-genes-1 2025-04-22T08:30:48-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/491/rna-and-reclassification-assessing-rna-data-in-rare-disease 2025-03-20T09:08:43-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/492/diagnostic-yield-of-exome-sequencing-in-adults-with-rare-disease-an-eight-year-retrospective-study 2025-03-20T09:25:31-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/489/over-representation-of-pms2cl-pseudogene-interference-in-pms2-testing-in-a-non-european-cohort 2025-03-20T09:20:42-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/494/characterization-of-rps20-related-colorectal-cancer-predisposition-a-case-series-from-a-multigene-panel-testing-cohort 2025-04-03T13:18:12-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/487/the-impact-of-discrepant-payor-policies-from-one-lab-benefits-manager-on-patient-access-to-genetic-testing 2025-03-20T09:00:40-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/488/bs1-ba1-thresholds-derived-from-disease-specific-genetic-architectures-result-in-decreased-rates-of-vus-in-clinically-relevant-genes 2025-03-20T09:34:14-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/495/initial-findings-of-the-clingen-monogenic-systemic-and-incomplete-lupus-gene-curation-expert-panel 2025-03-20T09:49:43-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/493/rna-analysis-and-long-read-sequencing-identify-causative-apc-complex-rearrangement-in-unsolved-fap-case 2025-03-20T09:15:17-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/490/beyond-ngs-detailed-analysis-of-sanger-mlpa-and-rna-confirms-tuberous-sclerosis-complex-in-clinically-diagnosed-patients 2025-03-21T09:59:31-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/484/enhancing-patient-care-a-digital-approach-improves-universal-breast-cancer-risk-stratification-in-imaging-centers 2024-12-16T10:24:27-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/476/msh2-variant-causing-atypical-cmmrd-and-atypical-ls 2024-10-02T07:58:16-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/474/dont-miss-the-mark-rare-missense-variants-in-apc-associated-with-polyposis-phenotypes 2024-10-02T07:59:16-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/475/paired-dna-rna-genetic-testing-to-uncover-a-cryptic-pten-pathogenic-variant-pv-associated-with-diffuse-colonic-ganglioneuromatosis 2024-12-19T10:00:42-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/485/from-last-resort-to-first-choice-the-ascension-of-exome-sequencing-in-isolated-ndd-diagnostics 2024-11-12T11:21:07-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/486/how-many-diseases-can-one-gene-cause-why-mechanism-matters-for-gene-curation-variant-classification-and-patient-counseling 2024-11-12T11:23:56-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/471/impact-of-gene-disease-validity-on-variant-of-unknown-significance-rates-in-hereditary-cancer-panels 2024-09-25T09:27:12-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/470/saturation-genome-editing-based-functional-evaluation-and-clinical-classification-of-brca2-single-nucleotide-variants 2024-09-25T09:28:34-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/472/integrating-emerging-data-into-genomic-testing-outcomes-from-an-evidence-based-reanalysis-initiative 2024-09-25T09:18:43-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/483/specification-of-frequency-criteria-for-secondary-findings-genes-to-improve-classification-concordance 2024-11-07T06:43:42-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/479/additional-findings-amongst-relatives-pursuing-oncology-multigene-panel-cascade-testing 2024-09-24T08:11:18-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/482/enhancing-clinical-relevance-in-hereditary-cancer-panels-an-evidence-based-approach-for-dicer1-amp-smarca4 2024-09-17T11:30:12-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/480/increased-compliance-of-patients-referred-to-genetic-counseling-after-introduction-of-a-webbased-risk-stratification-tool 2024-09-17T11:18:21-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/478/rna-guided-clarity-the-potential-for-resolving-variant-uncertainty-in-clinical-exome-sequencing 2024-09-24T08:07:19-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/481/getting-to-the-source-of-the-matter-evidence-driven-reanalysis-in-exome-sequencing 2024-09-17T11:23:44-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/477/recurrent-mutation-n383s-and-rare-variants-in-prkci-are-causal-for-orofacial-clefting-and-other-phenotypes 2024-09-11T12:09:45-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/473/non-linear-machine-learning-models-to-improve-variant-prediction-among-clinical-breast-cancer-patients 2024-09-05T18:55:08-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/469/low-variant-allele-fraction-in-germline-genetic-testing-predicts-pathogenicity-of-nf1-variants 2024-06-22T10:16:55-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/468/current-work-of-the-apc-subcommittee-of-the-insight-clingen-hereditary-crc-polyposis-variant-curation-expert-panel-interpretation-of-selected-apc-variants-based-on-the-apc-specific-acmg-amp-variant-classification-criteria 2024-06-17T09:47:51-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/466/long-read-sequencing-elucidates-complex-germline-variants-in-individuals-undergoing-hereditary-gastrointestinal-cancer-testing 2024-06-17T09:21:03-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/467/importance-of-accurate-epcam-deletion-characterization-to-prevent-misdiagnosis-of-lynch-syndrome-1 2024-06-17T09:28:41-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/465/systematic-application-of-clingen-insight-apc-specific-acmg-amp-variant-classification-criteria-alleviates-the-burden-of-variants-of-uncertain-significance-in-clinvar-and-lovd-databases 2024-06-03T08:09:44-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/464/clinically-significant-variant-classification-resulting-from-the-use-of-rna-sequencing-experience-at-a-high-volume-cancer-genetics-center 2024-05-28T08:00:42-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/463/pushing-the-limit-ed-s-modifications-to-a-gene-validity-framework-for-common-diseases-and-the-impact-on-clinical-utility-of-genetic-testing 2024-05-08T12:18:41-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/462/clingen-hbop-vcep-curation-of-atm-variants-associated-with-ataxia-telangiectasia 2024-05-09T06:04:59-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/461/integration-of-functional-data-to-classify-brca1-2-missense-variants-an-enigma-project 2024-03-22T09:13:05-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/456/clinical-utility-of-prenatal-exome-sequencing-insights-from-a-10-year-cohort 2024-05-12T10:27:24-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/457/optimizing-diagnostic-potential-impact-of-familial-sample-configurations-on-exome-sequencing 2024-05-28T06:07:56-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/454/unlocking-the-code-when-spliceai-falls-short-in-variant-assessment 2024-02-09T12:35:43-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/455/prenatal-diagnosis-of-a-novel-biallelic-arfgef1-related-disorder-due-to-uniparental-isodisomy-a-case-report 2024-05-12T10:16:27-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/459/characterization-of-complex-hereditary-cancer-associated-germline-variants-with-long-read-sequencing 2024-05-12T10:37:17-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/458/integration-of-protein-stability-and-structural-context-scores-improves-bioinformatics-predictions-for-brca1-and-tp53-gene-variants 2024-06-05T22:40:25-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/460/use-of-a-patient-facing-digital-platform-to-aid-in-genetic-test-result-delivery-and-connection-to-genetic-counseling-services 2024-05-16T12:46:49-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/308/a-genotype-first-approach-identifies-high-incidences-of-nf1-pathogenic-variants-with-distinct-disease-associations 2023-12-13T12:54:54-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/306/high-throughput-allele-specific-expression-analysis-can-detect-allelic-imbalance-in-clinical-patient-samples-as-a-proxy-for-quantitative-measures-of-gene-expression 2024-05-12T09:53:47-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/307/building-the-clingen-pathogenicity-calculator-version-2-0-by-leveraging-clingen-api-microservices 2023-12-13T12:58:42-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/301/do-candidate-genes-increase-clinical-utility-of-hereditary-cancer-panels-when-less-is-more 2023-10-17T13:49:56-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/302/the-clingen-insight-mutyh-variant-curation-expert-panel-lessons-learned-and-a-call-to-action 2024-05-12T10:05:03-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/303/batch-clinvar-submission-support-in-clingens-variant-curation-interface-vci 2023-12-13T12:56:10-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/304/application-of-deep-mutational-scanning-data-for-mlh1-variant-interpretation-1 2024-05-12T10:02:20-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/305/splice-mutations-and-digital-anomalies-extend-the-genotypic-and-phenotypic-spectrum-of-kim-gusella-syndrome-in-phf21a-patients 2024-05-12T09:55:34-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/292/atm-and-palb2-variant-curation-guidelines-progress-update-clingen-hereditary-breast-ovarian-and-pancreatic-cancer-variant-curation-expert-panel-1 2024-01-10T13:40:27-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/295/importance-of-accurate-epcam-deletion-characterization-to-prevent-misdiagnosis-of-lynch-syndrome 2023-12-18T09:23:29-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/291/a-novel-insertion-deletion-in-apc-gene-promotor-1b-is-associated-with-both-stomach-and-colon-polyposis 2023-12-18T09:21:53-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/296/a-novel-missense-variant-in-cdh1-causes-hereditary-diffuse-gastric-and-lobular-breast-cancer-syndrome-independently-of-splicing 2023-12-18T09:20:03-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/294/splicing-it-all-together-discovery-of-a-novel-likely-pathogenic-cdh1-variant-using-rna-analysis 2023-12-18T09:18:32-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/293/application-of-deep-mutational-scanning-data-for-mlh1-variant-interpretation 2023-12-18T09:20:19-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/298/splicing-up-the-diagnosis-using-targeted-rna-studies-to-reclassify-exome-sequencing-variants 2023-10-03T09:51:19-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/299/validation-of-patient-facing-digital-tool-risk-stratification-of-those-at-risk-for-hereditary-cancer-syndrome-the-care-program-accurately-identifies-high-risk-individuals 2023-10-08T13:23:52-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/297/always-better-when-were-together-a-novel-collaborative-multi-stakeholder-coalition-enhances-national-guidelines-for-hereditary-cancer-testing-and-detection 2023-10-03T09:45:38-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/300/if-we-build-it-patients-will-come-a-healthcare-systems-approach-to-improve-identification-of-at-risk-individuals-increase-genetic-counseling-referrals-and-build-patient-management-using-a-digital-tool-and-emr 2023-10-03T09:58:03-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/309/consider-the-net-you-cast-multigene-panel-testing-misses-15-of-diagnostic-results-compared-to-exome-sequencing 2023-10-03T09:34:40-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/310/dominant-negative-pathogenic-variants-in-lztr1-related-schwannomatosis 2023-10-12T08:45:49-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/311/genetic-and-brain-imaging-phenotype-joint-prediction-of-longitudinal-parkinsons-disease-subtypes 2023-10-12T09:07:24-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/312/the-power-of-collaboration-a-case-study-on-tnxb-and-its-clinical-association 2023-12-18T09:29:06-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/313/a-scalable-approach-to-democratizing-cancer-risk-stratification-one-healthcare-systems-approach-using-a-patient-facing-digital-platform 2023-12-18T09:30:05-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/314/digital-cancer-genetic-risk-assessment-in-a-gynecologic-oncology-clinic 2023-10-13T07:59:54-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/286/small-cell-carcinoma-of-the-ovary-hypercalcemic-type-sccoht-has-approximately-20-30-penetrance-in-individuals-carrying-loss-of-function-mutations-in-smarca4 2023-12-18T09:34:38-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/288/substantially-different-penetrance-of-different-pathogenic-variants-in-brca1-exon-20-18-not-all-pathogenic-variants-are-equal 2023-12-18T09:35:19-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/289/beyond-the-colon-do-biallelic-variants-in-nthl1-predispose-to-breast-cancer 2023-12-18T09:31:09-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/285/reduced-risk-brca1-and-brca2-variants-insight-into-classification-of-concordant-variants-between-two-commercial-laboratories 2023-12-18T09:33:42-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/287/identification-of-brca1-biallelic-pathogenic-variants-in-a-fanconi-anemia-patient-and-the-clinical-implications-of-variant-location 2023-12-18T09:32:46-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/290/brca1-frameshift-variants-leading-to-extended-incorrect-protein-termini 2023-12-18T09:31:44-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/283/the-clingen-enigma-brca1-2-expert-panel-a-dynamic-framework-for-evidence-based-recommendations-to-improve-classification-criteria-for-variants-in-brca1-2 2024-01-10T13:52:56-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/284/atm-and-palb2-variant-curation-guidelines-progress-update-clingen-hereditary-breast-ovarian-and-pancreatic-cancer-variant-curation-expert-panel 2024-01-10T13:39:59-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/281/a-plot-twist-when-rna-evidence-challenges-our-expectations-of-dna-results 2023-12-18T09:43:04-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/282/variant-reclassification-in-a-large-cardiogenetic-testing-cohort-the-importance-of-disease-specific-variant-classification-criteria 2023-12-18T09:44:30-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/336/expanding-the-reach-of-germline-genetic-testing-use-of-web-based-risk-assessment-to-inform-medical-management-amongst-patients-at-breast-and-imaging-centers 2023-11-26T13:43:54-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/280/new-and-known-biases-ordering-trends-and-diagnostic-rates-of-exome-based-neurology-panels-reveal-patient-sex-based-skewing 2023-12-18T10:08:19-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/279/towards-improved-equity-in-genetic-testing-the-role-of-high-throughput-functional-evidence-in-reducing-population-specific-disparities-in-variant-interpretation 2022-09-09T11:59:11-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/276/no-nonsense-when-a-premature-termination-is-not-what-it-appears 2023-11-26T13:50:17-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/277/biallelic-variants-in-nthl1-and-msh3-in-individuals-ascertained-from-a-multigene-panel-testing-mgpt-cohort-a-descriptive-analysis 2023-12-18T10:14:36-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/278/truncating-variants-in-5-exons-of-apc-are-associated-with-highly-attenuated-phenotypes-and-emphasize-the-need-for-genotype-phenotype-correlation 2023-12-18T10:13:38-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/315/double-jeopardy-a-closer-look-at-cancer-histories-of-individuals-with-multiple-germline-pathogenic-variants 2023-11-13T09:44:21-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/452/expanding-cohort-of-individuals-with-p-v142i-homozygous-alterations-suggests-presentation-onset-similar-to-heterozygotes 2024-01-10T18:09:24-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/453/a-systematic-approach-for-applying-disease-specific-phenotype-in-clinical-variant-interpretation 2024-01-10T18:22:05-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/333/inequitable-access-to-genetic-testing-leads-to-missed-screening-and-prevention-opportunities-for-individuals-at-risk-for-hereditary-breast-and-ovarian-cancer 2023-11-25T18:41:23-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/332/pathogenic-variants-among-female-breast-cancer-patients-with-a-subsequent-cancer-demonstrate-preventable-cancer-burden 2023-11-25T18:36:10-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/323/n-terminal-truncating-variants-in-apc-in-tatients-without-overt-familial-adenomatous-polyposis 2023-11-20T20:19:33-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/324/comparison-of-colorectal-cancer-patients-with-lynch-syndrome-double-somatic-mutations-and-mlh1-promoter-hypermethylation 2023-11-20T20:33:59-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/328/succinate-dehydrogenase-pathogenic-variants-are-not-associated-with-non-canonical-cancers 2023-11-25T13:02:35-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/322/paired-dna-and-rna-genetic-testing-improves-variant-detection-and-classification-independently-of-personal-history-of-cancer 2023-11-20T19:56:55-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/334/more-than-95-of-positive-genetic-results-for-inherited-cardiomyopathies-and-arrhythmias-have-medical-management-implications 2023-11-26T13:19:44-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/335/ongoing-clinical-validity-assessment-leads-to-efficient-genetic-test-development-for-patients-with-movement-disorders-and-hypotonia 2023-11-26T13:24:55-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/327/clinical-characteristics-of-patients-with-hereditary-transthyretin-mutations-primarily-associated-with-cardiomyopathy-and-other-rare-transthyretin-mutations-insights-from-a-genetic-testing-programme 2023-11-25T12:44:47-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/325/characteristics-of-patients-with-p-v50m-and-p-t80a-mutations-associated-with-hereditary-transthyretin-amyloidosis 2023-11-25T12:08:01-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/326/hereditary-transthyretin-amyloidosis-and-other-neuromuscular-diseases 2023-11-25T12:18:52-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/330/rna-studies-demonstrate-that-the-ldlr-c-2389-4a-gt-g-intronic-variant-causes-familial-hypercholesterolemia-through-an-rna-splicing-impact 2023-11-25T18:12:50-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/331/ordering-trends-and-report-outcomes-for-lipid-genes-on-a-comprehensive-cardiovascular-genetics-menu 2023-11-25T18:16:30-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/321/closing-the-gap-trends-in-inconclusive-rates-in-hereditary-cancer-testing-across-racial-ethnic-groups 2023-11-20T16:04:00-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/316/clinical-and-epidemiological-characteristics-of-patients-with-ttr-mutations-and-polyneuropathy-manifestations-of-hereditary-transthyretin-amyloidosis-insights-from-a-genetic-testing-program 2023-11-20T11:14:12-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/319/broad-implications-of-sustained-proactive-clinical-validity-curation 2023-11-20T13:53:37-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/320/multi-gene-panel-testing-results-prompt-frequent-and-guideline-adherent-changes-to-cancer-risk-management-recommendations-based-on-clinician-report 2023-11-20T15:07:44-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/318/universal-multi-gene-panel-testing-for-individuals-with-pheochromocytomas-and-paragangliomas 2023-11-20T13:38:24-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/275/divergent-payor-medical-policy-leads-to-gross-disparities-in-access-to-hereditary-breast-and-ovarian-cancer-genetic-testing 2023-12-18T10:20:07-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/317/divergent-payor-medical-policy-leads-to-gross-disparities-in-access-to-hereditary-breast-and-ovarian-cancer-genetic-testing-1 2023-11-20T13:25:05-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/329/quantitative-evaluation-of-methods-designed-to-improve-the-accuracy-and-quality-of-multi-gene-panel-testing-for-hereditary-cancer 2023-11-25T17:54:59-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/341/unblurring-the-ultrasound-lines-45-of-infants-with-prenatal-findings-receive-a-reportable-result-on-diagnostic-exome-sequencing 2023-11-26T15:05:04-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/339/expanding-the-detection-range-of-dna-multigene-panel-testing-with-concurrent-rna-sequencing 2023-11-26T14:35:31-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/340/melanoma-risk-in-pot1-mutation-carriers-from-a-mgpt-cohort 2023-11-26T14:49:46-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/337/rna-genetic-testing-improves-detection-of-patients-with-hereditary-breast-cancer 2023-11-26T14:11:30-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/338/low-variant-allele-fraction-as-a-predictor-of-tp53-variant-pathogenicity 2023-11-26T14:25:38-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/343/expanding-the-limits-of-dna-based-testing-simultaneous-rna-analysis-identifies-pathogenic-variants-in-apc-that-may-otherwise-not-be-identified 2023-11-26T15:29:54-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/344/estimating-sensitivity-of-the-international-gastric-cancer-linkage-consortiums-igclc-2020-hereditary-diffuse-gastric-cancer-hdgc-genetic-testing-criteria 2023-11-26T15:43:00-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/342/identification-of-an-alu-insertion-in-msh2-by-next-generation-sequencing-in-a-family-with-lynch-syndrome-an-8-year-diagnostic-odyssey-1 2023-11-26T15:19:55-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/345/automated-hpo-terms-matching-reduces-analysis-time-but-does-not-completely-eliminate-the-requirement-for-manual-review-of-exome-sequencing-results 2023-11-26T16:18:37-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/346/closing-the-gap-systematic-clinical-integration-of-multiplexed-functional-data-to-resolve-variants-of-uncertain-significance 2023-11-26T16:25:58-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/347/genotypic-and-phenotypic-differences-and-similarities-among-patients-with-inherited-cardiovascular-diseases-insights-from-a-genetic-testing-program 2023-11-26T16:42:30-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/349/effect-of-genetic-testing-results-on-patient-reported-quality-of-life-among-patients-undergoing-panel-testing-for-newly-diagnosed-ovarian-cancer 2023-11-26T18:15:10-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/348/development-and-validation-of-the-premmplus-clinical-prediction-model-for-multigene-hereditary-cancer-risk-assessment 2023-11-26T18:07:28-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/271/identification-of-an-alu-insertion-in-msh2-by-next-generation-sequencing-in-a-family-with-lynch-syndrome-an-8-year-diagnostic-odyssey 2023-12-18T10:24:24-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/273/exome-reanalysis-results-in-an-8-reclassification-rate 2023-12-18T10:25:59-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/272/genetic-testing-utilization-management-saving-time-saving-money-and-maximizing-clinical-utility-for-patients-a-commercial-lab-experience 2023-12-18T10:25:20-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/270/diagnostic-exome-sequencing-in-adults-with-neurological-disorders 2023-12-18T10:26:51-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/267/creating-an-open-source-gene-curation-database-from-the-gene-curation-coalition-gencc 2023-12-18T10:27:32-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/264/practical-applications-of-rna-genetic-testing-for-variant-detection-and-interpretation-a-case-series 2023-12-18T10:23:38-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/261/impact-of-multigene-panel-testing-on-medical-management-preliminary-results-of-a-pre-and-post-test-clinician-survey 2023-12-18T10:28:35-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/265/concurrent-dna-and-rna-genetic-testing-identifies-more-patients-with-lynch-syndrome-than-dna-testing-alone 2023-12-18T10:33:27-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/260/concurrent-dna-and-rna-genetic-testing-identifies-more-patients-with-hereditary-breast-cancer-than-dna-testing-alone 2019-09-27T13:09:56-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/263/germline-mutations-in-cancer-predisposition-genes-in-patients-with-invasive-lobular-carcinoma-of-the-breast 2019-10-22T11:18:16-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/262/performance-of-a-polygenic-risk-score-combined-with-clinical-assessment-for-breast-cancer-risk 2019-10-09T10:21:38-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/258/better-than-the-guidelines-pre-amp-post-genetic-testing-data-suggests-change-in-management-trends 2019-10-09T10:18:20-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/259/what-should-i-order-genetic-testing-ordering-trends-for-autism-spectrum-disorder 2023-12-18T10:30:08-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/256/a-nationwide-multi-center-study-provides-insight-into-the-increase-in-clinically-actionable-results-from-concurrent-dna-and-rna-genetic-testing 2023-12-18T10:31:50-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/257/investigating-variants-of-uncertain-significance-reclassification-triggers-and-drivers-in-breast-cancer-predisposition-genes 2023-12-18T10:30:43-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/268/impact-of-multigene-panel-testing-on-medical-management-preliminary-results-of-a-pre-and-post-genetic-testing-clinician-survey 2023-12-18T10:34:03-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/269/rna-testing-increases-the-diagnostic-yield-in-an-unresolved-cohort-of-patients-with-paired-lynch-syndrome-dna-testing 2023-12-18T10:34:54-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/266/possible-founder-mutation-in-cdkn2a-in-the-latino-population 2023-12-18T10:34:35-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/255/accounting-for-splicing-effects-in-known-missense-variants-improves-in-silico-prediction-of-deleterious-effect 2019-10-09T10:28:14-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/253/rna-seq-identifies-structural-variants-in-hereditary-cancer-genes 2023-12-18T11:06:09-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/254/leveraging-tumor-characteristics-to-predict-germline-variant-pathogenicity-in-mismatch-repair-genes 2019-10-07T15:54:18-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/250/racial-and-ethnic-differences-in-the-results-of-multigene-panel-testing-of-inherited-cancer-predisposition-genes-in-breast-cancer-patients 2019-04-16T07:56:30-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/252/neurodevelopmental-defects-due-to-haploinsufficiency-of-kmt2e-1 2023-12-18T11:08:17-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/251/neurodevelopmental-defects-due-to-haploinsufficiency-of-kmt2e 2023-12-18T11:08:05-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/249/exome-secondary-findings-identify-an-incidental-fh-prevalence-rate-of-1-in-500 2023-12-18T11:07:18-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/246/discrepancies-between-payer-coverage-and-consensus-guidelines-for-personalizing-hereditary-cancer-risk 2023-12-18T11:11:25-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/238/by-the-way-the-incidental-benefit-of-exome-sequencing-to-enable-life-saving-intervention-via-secondary-findings 2023-12-18T11:13:29-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/243/an-analysis-of-clinical-documentation-submitted-with-diagnostic-exome-sequencing-orders-and-the-added-burden-or-benefit-of-insurance-billing 2023-12-18T11:12:48-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/236/lifetime-risk-of-breast-cancer-from-polygenic-risk-scores-combined-with-clinical-assessment-in-women-referred-for-genetic-testing 2023-12-18T11:18:15-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/240/discrepancies-in-payer-coverage-and-practice-guidelines-for-genetic-testing-of-acmg-cardiovascular-genes 2023-12-18T11:16:25-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/237/join-the-paraganglioma-more-support-for-fh-in-hereditary-pgl-pcc 2023-12-18T11:17:38-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/241/clinical-diagnostic-exome-sequencing-in-patients-with-neuromuscular-disorders-genetic-testing-challenges-for-complex-conditions 2023-12-18T11:14:23-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/244/has-anything-changed-reclassification-of-epilepsy-genetic-variants 2023-12-18T11:17:04-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/245/n-of-one-is-the-loneliest-number-how-a-lack-of-corroborating-case-reports-is-hindering-the-classification-of-genes 2023-12-18T11:25:24-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/247/csnk2b-a-novel-cause-of-neurodevelopmental-disease-and 2023-12-18T11:15:46-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/242/vhl-information-sharing-international-consortium-vision-a-clingen-expert-panel-to-evaluate-vhl-gene-specific-criteria-for-variant-interpretation-1 2019-01-17T12:22:10-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/239/rna-genetic-testing-in-hereditary-cancer-improves-variant-classification-and-patient-management 2023-12-18T11:26:09-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/235/incorporating-paired-germline-tumor-analyses-into-a-universal-lynch-syndrome-screening-program-decreasing-unexplained-mismatch-repair-deficiency-incidence 2023-12-18T11:30:43-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/248/genetic-predisposition-to-invasive-lobular-carcinoma 2023-12-18T11:31:19-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/231/double-take-mosaic-li-fraumeni-syndrome-in-monozygotic-twins 2023-12-18T11:37:28-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/229/characteristics-of-patients-with-a-primary-brain-tumor-undergoing-panel-genetic-testing 2018-10-17T11:15:32-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/233/beyond-fbn1-multigene-panel-testing-for-marfan-syndrome 2023-12-18T11:36:29-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/234/when-do-clinicians-cast-a-wider-net-utilization-of-the-largest-comprehensive-cancer-panel-at-one-commercial-laboratory 2023-12-18T11:34:20-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/230/csnk2b-phenotypes-include-infantile-epilepsy-with-myoclonic-seizures 2023-12-18T11:36:42-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/232/genetic-testing-alters-care-for-von-hippel-lindau-syndrome-phenocopy 2023-12-18T11:38:02-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/221/automating-variant-assessment-using-structural-features 2018-08-29T10:20:11-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/223/the-road-to-atomistic-pathology 2018-08-29T10:27:03-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/227/bayesdel-and-revel-outperform-other-in-silico-meta-predictors-for-variant-classification 2018-08-29T10:39:54-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/220/validation-of-a-prostate-cancer-genetic-risk-score-for-clinical-use 2018-08-29T10:18:23-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/225/vhl-information-sharing-international-consortium-vision-a-clingen-expert-panel-to-evaluate-vhl-gene-specific-criteria-for-variant-interpretation 2019-08-14T07:59:27-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/228/scaling-the-resolution-of-sequence-variant-classification-discrepancies-in-clinvar 2019-01-08T10:48:13-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/226/clinical-and-molecular-characteristics-of-somatic-nf1-mutations-identified-on-hereditary-cancer-multi-gene-panels 2018-10-12T07:12:46-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/224/integrated-bayesian-analysis-outperforms-existing-methods-for-variant-classification 2018-08-29T10:29:30-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/222/de-novo-missense-variants-in-the-alternative-exon-5-of-scn2a-are-a-rare-cause-of-neurodevelopmental-disorders-with-or-without-seizures 2018-08-29T10:24:57-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/219/tumor-germline-analysis-for-early-onset-colorectal-cancer-resolution-for-high-risk-patients 2018-08-29T10:13:56-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/218/reducing-unnecessary-screening-in-lynch-like-syndrome-with-tumor-sequencing 2018-10-04T09:18:15-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/213/automated-homology-modelling-for-genetic-variant-assessment-with-rosetta 2018-07-27T13:06:34-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/214/using-rosetta-to-assess-the-structural-impacts-of-genetic-variants 2018-07-27T13:07:59-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/216/de-novo-missense-variants-in-rhobtb2-cause-a-developmental-and-epileptic-encephalopathy-in-humans-and-altered-levels-cause-neurological-defects-in-drosophila 2023-12-18T11:39:25-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/215/de-novo-variants-in-snap25-cause-a-spectrum-of-developmental-and-epileptic-encephalopathy 2023-12-18T11:39:36-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/217/multiple-findings-in-diagnostic-exome-sequencing 2023-12-18T11:40:09-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/208/paired-somatic-and-germline-genetic-testing-for-ovarian-cancer-patients-observations-benefits-and-implications-for-treatment 2023-12-18T11:42:47-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/210/facilitated-referral-pathway-for-genetic-testing-at-the-time-of-ovarian-cancer-diagnosis-uptake-of-genetic-assessment-and-testing-and-impact-on-patient-reported-stress-anxiety-and-depression 2023-12-18T11:41:42-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/209/expanding-brca1-2-testing-criteria-to-include-other-confirmed-breast-and-ovarian-cancer-susceptibility-genes 2023-12-18T11:41:24-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/202/accuracy-of-electronic-health-record-family-history-in-predicting-genetic-susceptibility-to-pancreatic-ductal-adenocarcinoma 2023-12-18T11:40:40-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/211/increased-detection-of-germline-cancer-susceptibility-mutations-subsequent-to-tumor-profiling 2023-12-18T11:42:14-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/212/clinical-and-molecular-characteristics-of-nf1-mutations-identified-on-hereditary-cancer-multi-gene-panels 2023-12-18T11:41:07-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/199/performance-of-multigene-panel-testing-in-hereditary-prostate-cancer 2023-12-18T11:44:04-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/204/racial-and-ethnic-differences-in-hereditary-cancer-multi-gene-panel-testing-results-among-breast-cancer-patients 2018-05-15T08:09:05-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/198/multi-gene-panel-testing-increases-yield-of-surgically-actionable-results-among-breast-cancer-patients 2018-05-15T08:08:34-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/203/genetic-testing-for-familial-hypercholesterolemia 2023-12-18T11:47:29-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/207/majority-of-epilepsy-mutations-are-in-genes-with-therapeutic-associations 2018-03-20T12:08:32-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/205/diagnostic-exome-sequencing-in-adolescents-with-neurological-and-neurodevelopmental-disorders 2018-03-20T13:36:50-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/206/clinical-phenotypic-data-is-a-key-factor-necessary-to-improve-molecular-interpretation-of-de-novo-alterations-in-neurodevelopmental-genetic-testing 2018-03-20T12:06:07-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/186/clinical-diagnostic-exome-sequencing-in-dystonia-the-challenges-of-genetic-testing-for-complex-conditions 2018-01-15T15:29:07-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/187/genetic-testing-for-epilepsy-in-adults 2018-01-15T15:31:00-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/194/proband-only-diagnostic-exome-sequencing-trends-in-diagnostic-yield-at-one-commercial-company 2018-01-15T16:53:49-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/195/what-you-can-get-and-what-would-be-missed-a-side-by-side-comparison-of-panels-vs-exome-testing-for-neurodevelopmental-disorders 2018-01-15T16:55:30-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/184/brca1-2-testing-criteria-offer-high-clinical-sensitivity-for-atm-palb2-and-chek2-carriers-in-a-multigene-panel-cohort 2019-04-16T09:12:49-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/192/personalized-genomic-testing-pgt-reporting-preferences-among-over-2-500-individuals-and-healthcare-providers-hcps-healthy-individuals-deem-medical-risk-factors-as-the-most-important-reason-to-pursue-genetic-testing 2018-02-16T06:42:02-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/189/dna-breakpoint-assay-reveals-a-majority-of-gross-duplications-occur-in-tandem-reducing-vus-classifications-in-breast-cancer-predisposition-genes 2018-09-04T08:37:20-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/183/variable-rates-of-reclassification-based-on-clinical-indication-among-patients-referred-for-diagnostic-exome-sequencing 2018-01-15T15:32:14-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/191/biallelic-gene-disrupting-variants-in-pkdcc-cause-a-skeletal-disorder-characterized-by-rhizomelic-shortening-of-extremities-and-distinctive-facial-features 2018-01-15T16:28:42-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/190/biallelic-and-not-monoallelic-loss-of-function-variants-in-trim63-most-likely-cause-cardiomyopathy 2018-01-15T16:25:21-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/193/microcephaly-and-tracheoesophageal-fistula-in-a-newborn-with-pnkp-mutation 2018-01-15T16:46:09-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/196/genes-with-therapeutic-associations-responsible-for-majority-of-epilepsy-mutations-and-minority-of-epilepsy-vus 2018-01-16T14:07:52-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/185/isolated-loss-of-pms2-expression-in-colorectal-and-endometrial-tumors-explained-with-paired-tumor-and-germline-testing 2018-01-15T15:31:48-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/188/the-impact-of-high-and-moderate-penetrance-breast-cancer-gene-alterations-on-familial-cascade-testing-in-multi-gene-panel-positive-probands 2018-02-16T12:15:15-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/182/rna-based-approach-identifies-pathogenic-tandem-duplications-in-hereditary-cancer-genes 2018-01-15T15:17:14-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/197/integrating-functional-and-structural-analyses-improves-the-assessment-of-brca1-missense-variants-of-unknown-significance 2018-07-27T13:12:10-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/178/concordance-of-germline-multigene-panel-testing-with-prior-microsatellite-instability-and-immunohistochemistry-analyses-in-endometrial-cancer-patients 2018-07-27T13:11:54-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/179/paired-tumor-germline-testing-for-lynch-syndrome-in-endometrial-cancers-a-comprehensive-testing-approach 2018-02-20T10:22:40-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/180/multigene-panel-testing-increases-the-detection-of-clinically-actionable-mutations-in-ovarian-cancer-patients 2018-07-27T13:12:26-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/181/women-with-breast-and-uterine-cancer-are-at-increased-risk-for-hereditary-cancer-predisposition 2017-11-29T17:48:56-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/201/germline-mutation-likelihood-in-breast-cancer-patients-navigating-the-nuances-of-multi-gene-panel-testing 2018-07-27T13:15:24-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/200/automation-for-agilent-microarray-based-comparative-genomic-hybridization-acgh-assays-a-costeffective-approach-to-increased-sample-throughput-and-reliability 2018-02-20T14:29:27-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/176/associations-between-hereditary-cancer-panel-predisposition-genes-and-breast-cancer-histological-subtypes 2019-10-09T10:29:21-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/174/triple-negative-breast-cancer-predisposition-genes 2017-10-10T17:29:51-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/175/moderate-risk-genes-matter-multigene-testing-for-hereditary-breast-cancer 2017-11-17T13:39:24-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/173/targeted-genetic-testing-of-sixteen-epilepsy-genes-with-known-therapeutic-associations-high-mutation-frequency-rate-and-impact-on-clinical-management 2017-10-10T17:26:22-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/177/hereditary-brain-tumors-are-more-common-than-you-think-germline-mutations-in-benign-and-malignant-primary-brain-tumors 2017-11-20T15:06:58-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/169/postmortem-genetic-testing-contributions-to-revealing-cause-of-death-and-familial-cascade-testing 2018-02-15T10:42:13-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/170/genetic-testing-as-an-effective-diagnostic-tool-for-familial-hypercholesterolemia 2018-02-15T10:43:20-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/164/concordance-of-multi-gene-panel-testing-with-prior-microsatellite-instability-and-immunohistochemistry-analyses-1 2017-10-26T16:33:18-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/165/phenotype-and-colorectal-cancer-risk-in-apc-i1307k-homozygotes 2017-10-04T18:07:01-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/166/bridging-the-gap-in-gapps-clinical-testing-characteristic-features-and-gastric-cancer-screening 2017-10-04T18:08:08-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/167/prevalence-of-mutations-in-hamartomatous-mixed-polyposis-genes-in-patients-with-multiple-colon-polyps-stratified-by-age 2017-09-19T13:37:55-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/168/paired-tumor-germline-testing-for-lynch-syndrome-a-comprehensive-testing-approach 2017-10-04T18:08:58-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/150/comparison-of-variant-classification-algorithms-incorporating-clinical-and-family-history-for-breast-and-ovarian-cancer 2017-10-04T18:09:24-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/153/tumor-characteristics-provide-evidence-for-mmr-variant-pathogenicity 2017-10-04T18:10:26-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/157/diagnostic-exome-sequencing-des-coupled-with-rules-based-candidate-gene-analysis-identifies-a-causative-rras-lesion-in-a-patient-with-a-novel-rasopathy 2017-10-04T18:10:51-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/151/role-of-hoxb13-in-breast-and-ovarian-cancer-preliminary-data-from-a-laboratory-based-multigene-panel-testing-cohort 2019-04-16T09:13:05-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/152/beyond-the-nmd-boundary-characterizing-the-phenotypes-of-c-terminal-cdh1-mutations 2017-10-04T18:11:39-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/149/type-2-diabetes-susceptibility-variants-contribute-to-breast-cancer-risk 2017-10-04T18:12:06-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/171/gene-specific-criteria-for-pten-variant-curation-1 2017-10-04T18:16:56-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/159/diagnostic-yield-and-mutation-spectrum-of-multigene-panel-testing-for-hypertrophic-cardiomyopathy 2018-02-15T10:43:07-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/158/a-novel-de-novo-alteration-in-slc12a6-in-a-patient-with-early-onset-severe-progressive-sensorimotor-polyneuropathy-and-abnormal-eeg 2017-10-04T18:05:44-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/163/parental-variant-study-is-informative-for-variant-classification-in-significant-number-of-neurodevelopment-genes 2017-10-04T18:13:13-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/160/clinical-exome-sequencing-identifies-a-homozygous-whole-gene-deletion-of-dpy19l2-that-was-not-detected-by-a-high-density-single-nucleotide-polymorphism-snp-array 2017-10-04T18:13:37-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/161/hitting-the-target-an-analysis-of-noncoding-alterations-as-captured-by-panels-and-diagnostic-exome-sequencing-at-a-commercial-lab 2017-10-04T18:14:03-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/155/attacking-a-vus-from-multiple-angles-an-integrated-and-functional-approach-for-reclassifying-variants-of-uncertain-significance 2017-10-04T18:14:33-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/154/exploration-of-germline-mutation-burden-in-a-hereditary-cancer-panel-cohort-identifies-gaps-in-cancer-risk-associations-and-testing-and-management-guidelines 2019-04-16T09:13:22-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/156/all-in-the-family-how-family-history-affects-diagnostic-yield-of-hypertrophic-cardiomyopathy-multigene-panel-testing 2018-02-15T10:44:52-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/162/a-model-averaging-approach-for-improved-in-silico-variant-prediction 2017-10-04T18:05:21-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/148/parental-co-segregation-analysis-significantly-reduces-but-does-not-eliminate-vus-rate-in-multi-gene-panel-testing 2017-10-04T18:15:39-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/147/concurrent-parental-analysis-on-neurodevelopmental-multi-gene-panels-results-in-fewer-variants-of-unknown-significance-reported 2017-10-04T18:15:59-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/135/multi-gene-panel-testing-for-prostate-cancer-what-have-we-learned-so-far 2017-08-21T21:10:21-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/137/results-of-multi-gene-panel-testing-in-a-gastric-cancer-cohort-it-s-not-all-cdh1 2017-08-21T21:12:35-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/142/experience-of-a-genetic-testing-laboratory-with-customizable-hereditary-cancer-panels 2017-08-21T21:11:22-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/146/down-the-rabbit-hole-tales-of-a-tiered-approach-to-genetic-testing-for-hcm 2018-02-15T10:43:14-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/133/preventing-sudden-cardiac-death-exome-secondary-findings-in-cardiovascular-genes 2017-09-28T16:10:17-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/134/analysis-of-differences-in-detection-rates-between-parent-proband-trios-and-non-parent-trios-in-diagnostic-exome-sequencing 2017-08-21T21:13:59-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/139/prenatal-genetic-counseling-for-a-novel-genetic-etiology-identified-in-a-fetus-with-compound-heterozygous-alterations-in-myh6 2017-08-21T21:15:03-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/140/after-6-years-diagnostic-exome-sequencing-expands-to-the-non-geneticists-and-is-becoming-a-first-line-test 2017-08-21T21:15:44-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/136/is-bigger-always-better-an-updated-comparison-of-multi-gene-panel-results-for-common-cancers 2017-08-21T21:16:48-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/144/family-communication-fc-of-test-results-among-an-unselected-pancreatic-ductal-adenocarcinoma-pc-cohort-who-underwent-germline-genetic-testing 2017-08-21T21:20:09-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/143/consumer-and-healthcare-provider-hcp-motivations-and-concerns-in-personalized-genomic-sequencing-among-over-2-500-individuals 2017-08-21T21:21:57-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/132/understanding-characteristics-of-industry-genetic-counselors-to-inform-ongoing-workforce-discussions 2017-09-20T14:27:16-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/138/the-results-are-in-who-is-testing-positive-for-nf1-on-hereditary-cancer-multi-gene-panels 2017-08-21T21:20:50-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/145/gene-characterization-a-scientific-approach-to-multi-gene-panel-testing-design 2017-08-21T21:21:16-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/131/pancreatitis-due-to-de-novo-prss1-pathogenic-mutations-the-ambry-genetics-experience 2017-08-21T21:24:20-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/118/to-reflex-or-not-to-reflex-genetic-testing-patterns-for-neurofibromatosis-1-nf1-and-legius-syndrome 2017-07-27T15:21:19-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/119/diagnosing-nf1-using-multi-gene-cancer-panels-an-emerging-trend-and-the-implications-for-nf-clinicians 2017-07-27T15:37:10-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/122/clinical-diagnostic-pms2-testing-in-a-single-commercial-laboratory-challenges-in-grossdeletion-duplication-analysis-due-to-pms2cl-interference 2017-08-21T21:32:37-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/123/to-nmd-and-beyond-identifying-mutations-in-the-3-terminus-of-mismatch-repair-genes 2017-08-21T21:33:18-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/121/concordance-of-multi-gene-panel-testing-with-prior-microsatellite-instability-and-immunohistochemistry-analyses 2017-08-21T21:59:52-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/117/germline-mutation-spectrum-and-cancer-risk-what-we-ve-learned-from-pancreatic-cancer-patients-undergoing-multigene-panel-testing 2019-10-09T10:29:37-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/124/a-scientific-approach-to-multi-gene-panel-testing-design-an-overview-of-hereditary-cardiovascular-testing 2017-08-21T22:09:11-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/130/integrated-cnv-and-structural-variant-analysis-leads-to-improved-clinical-yield 2017-09-20T14:06:33-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/128/n-1-cases-in-genematcher-reporting-alterations-in-truly-novel-disease-genes 2017-08-21T22:09:53-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/129/clinical-validity-scoring-guides-updates-to-expanded-secondary-findings-comparison-with-babyseq-scores 2017-08-21T22:10:24-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/125/optimization-of-the-acmg-amp-criteria-for-cdh1-variant-classification 2019-01-08T10:51:07-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/126/gene-specific-criteria-for-pten-variant-curation 2017-07-27T21:57:41-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/127/developing-optimized-acmg-amp-criteria-for-classification-of-variants-in-tp53 2019-04-16T07:59:34-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/120/role-of-smarca4-mutations-in-ovarian-carcinoma-preliminary-data-from-a-laboratory-based-multigene-panel-testing-cohort 2017-08-21T22:11:57-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/20/germline-mutations-in-cancer-predisposition-genes-among-patients-with-thyroid-cancer 2017-08-17T23:11:30-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/95/exploring-a-possible-relationship-of-germline-cdkn2a-mutations-with-breast-cancer-in-a-multi-gene-panel-cohort 2017-07-27T16:18:39-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/96/comparing-actionable-results-for-breast-and-colorectal-cancer-patients-across-multigene-panels 2017-08-21T22:12:53-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/21/phox2b-non-polyalanine-repeat-expansion-mutations-in-congenital-central-hypoventilation-syndrome-advancing-understanding-of-phenotype-by-mutation-type-through-industry-academic-medicine-collaboration 2017-06-16T16:38:00-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/22/gender-disparity-overlooking-hereditary-prostate-cancer-and-implications-for-urology-practice 2017-06-19T09:57:58-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/24/inherited-susceptibility-to-biliary-tract-and-ampullary-cancers 2017-06-19T12:48:07-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/23/prevalence-of-germline-mutations-in-consecutive-unselected-patients-with-newly-diagnosed-adenocarcinoma-of-the-pancreas 2017-06-19T09:59:32-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/26/molecular-diagnosis-for-neurodevelopmental-disorders-an-overview-of-multi-gene-panels-and-whole-exome-sequencing 2017-06-19T09:56:16-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/25/phenotype-is-not-always-a-positive-predictor-of-detection-rate-in-epilepsy-panels 2017-06-19T09:55:23-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/27/many-testing-roads-can-lead-to-kcnq2-diagnosis 2017-06-15T12:19:41-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/31/multigene-panel-testing-and-risk-estimates-in-10-233-ovarian-cancer-cases 2019-10-09T10:31:08-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/28/hereditary-risks-of-male-breast-cancer-in-a-multi-gene-panel-testing-cohort 2017-06-13T18:21:16-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/29/alternative-splicing-analysis-identifies-mutation-hotspots-in-hereditary-breast-and-ovarian-cancer-genes 2017-06-13T18:27:30-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/42/know-fh-mutation-spectrum-and-utilization-of-cascade-testing-for-familial-hypercholesterolemia 2017-08-21T22:13:46-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/32/characteristics-of-genetic-counselors-in-industry-based-roles-considerations-for-ongoing-workforce-discussions 2017-06-14T11:39:27-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/43/a-minor-problem-hereditary-cancer-multi-gene-panel-testing-for-individuals-lt-18 2017-06-14T12:46:20-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/33/wrestling-the-giant-experience-with-ttn-testing-for-cardiomyopathies-american-college-of-medical-genetics 2018-02-15T10:42:51-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/35/exome-sequencing-identifies-new-disease-phenotypes-in-characterized-genes 2017-06-14T12:04:09-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/36/expansion-and-further-delineation-of-the-phenotype-of-setd5 2017-06-19T09:57:09-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/38/two-approaches-to-reclassifying-results-from-previously-reported-diagnostic-exome-sequencing 2017-07-05T14:26:25-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/40/mosaic-genome-wide-paternal-uniparental-disomy-in-an-individual-without-features-of-beckwith-wiedemann-syndrome 2017-06-14T12:33:16-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/41/false-positive-results-reported-by-direct-to-consumer-genetic-tests-highlight-the-importance-of-clinical-confirmation-testing-for-appropriate-patient-care 2017-06-16T16:35:26-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/37/the-value-of-novel-candidate-gene-analysis-in-individuals-with-epilepsy-undergoing-exome-sequencing 2017-08-21T22:14:22-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/44/prospective-evaluation-of-a-facilitated-referral-pathway-to-improve-uptake-of-genetic-assessment-for-women-with-newly-diagnosed-ovarian-cancer 2017-08-21T22:14:49-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/46/frequency-of-germline-mutations-in-brip1-rad51c-and-rad51d-among-women-with-ovarian-primary-peritoneal-and-fallopian-tube-cancer 2017-06-14T13:00:35-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/47/in-laboratory-clinical-data-we-trust-accuracy-and-completeness-of-test-requisition-form-data-in-a-cohort-of-ovarian-and-uterine-cancer-patients-referred-for-clinical-genetic-testing 2017-06-16T16:36:32-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/48/multigene-panel-ordering-preferences-for-breast-cancer-patients-a-comparison-across-physician-specialties 2017-08-22T16:44:18-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/51/bap1-tumor-predisposition-syndrome-preliminary-data-from-a-laboratory-based-multi-gene-panel-testing-cohort 2017-06-16T16:34:30-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/49/gender-disparty-overlooking-hereditary-prostate-cancer 2017-06-14T13:10:40-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/45/common-attributes-in-mutation-carriers-identified-in-a-32-gene-hereditary-cancer-panel 2017-06-14T12:55:45-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/50/classifying-variants-in-the-chek2-gene-the-importance-of-collaboration 2017-10-04T18:18:17-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/34/what-about-the-guys-an-assessment-of-gender-differences-in-hereditary-colorectal-cancer-testing 2017-06-14T11:53:54-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/39/importance-of-genetic-testing-for-patients-with-multiple-colorectal-cancer-primaries 2017-06-14T12:28:02-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/100/unaffected-women-and-genetic-testing-for-hereditary-breast-cancer-to-test-or-not-to-test 2017-09-20T14:07:38-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/54/atm-mutations-contribution-to-hereditary-breast-pancreatic-cancer 2023-12-18T11:47:47-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/55/comparison-of-non-breast-and-ovarian-cancer-phenotypes-of-brca1-2-mutation-carriers-across-multi-gene-panels 2023-12-18T11:48:02-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/56/predicting-germline-mutations-in-brca1-2-and-beyond-a-comparison-of-women-with-single-and-multiple-breast-primaries 2023-12-18T11:48:53-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/58/a-novel-rpl35a-mutation-associated-with-diamond-blackfan-anemia 2023-12-04T15:19:36-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/57/identification-and-evaluation-of-rare-congenital-central-hypoventilation-syndrome-cchs-causing-phox2b-non-polyalanine-repeat-expansion-mutations-nparms-and-associated-phenotypes 2017-07-05T14:44:19-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/350/taming-concerns-regarding-the-accuracy-of-laboratory-clinical-data-a-detailed-comparative-analysis-1 2023-11-28T13:37:06-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/351/high-throughput-characterization-of-brca1-and-brca2-splicing-defects-1 2023-11-28T15:30:50-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/9/diagnostic-yield-for-chromosome-microarray-analysis-in-patients-with-autistic-features 2017-06-13T19:19:43-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/10/reclassifying-duplication-variants-in-high-risk-cancer-genes-by-identifying-tandem-duplication-breakpoints 2023-12-18T11:51:51-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/11/diagnostic-exome-sequencing-identifies-a-novel-homozygous-alteration-in-deaf1-further-delineating-the-phenotypic-spectrum 2023-12-04T09:16:08-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/12/high-throughput-characterization-of-brca1-and-brca2-splicing-defects 2017-06-17T10:59:07-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/13/taming-concerns-regarding-the-accuracy-of-laboratory-clinical-data-a-detailed-comparative-analysis 2023-12-18T11:52:23-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/16/conventional-cytogenetics-gold-standard-for-mapping-of-large-genomic-imbalances-on-chromosome 2017-06-14T10:22:17-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/17/de-novo-alterations-in-klf7-are-a-novel-cause-of-intellectual-disability-psychiatric-and-neuromuscular-issues 2023-12-04T09:18:09-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/18/inheritance-patterns-may-not-always-be-as-expected-diagnostic-exome-sequencing-des-uncovers-alterations-in-x-linked-genes-in-equal-amounts-in-males-and-females-with-intellectual-disability 2017-06-13T19:17:56-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/19/the-many-faces-of-scn1a 2023-12-18T11:52:39-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/61/the-pten-gene-clingen-expert-panel-a-model-for-creating-a-framework-for-gene-specific-criteria-using-acmg-guidelines 2023-12-18T11:52:54-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/15/the-pten-promoter-to-be-or-not-to-be-included-on-multigene-panel-tests 2023-12-18T11:53:20-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/60/cancer-risks-are-elevated-among-relatives-of-mre11a-rad50-and-nbn-mutation-carriers-but-similar-to-mutation-negative-families-in-a-laboratory-based-cohort 2023-12-18T11:50:47-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/62/a-novel-autosomal-recessive-alteration-in-the-ryr1-gene-in-a-patient-with-profound-hypotonia 2023-12-18T11:50:29-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/14/advances-in-the-diagnosis-of-hereditary-kidney-cancer-initial-results-of-a-multigene-panel-test 2017-06-13T15:59:24-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/63/types-and-frequencies-of-lynch-syndrome-mutations-identified-through-multigene-panel-testing 2023-12-04T09:41:54-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/65/phenotypes-of-patients-with-apc-gene-mutations-identified-via-multi-gene-cancer-panel-testing 2023-12-18T11:55:08-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/66/unknown-synergistic-effect-of-digenetic-inheritance-of-mmr-pathogenic-mutations-double-heterozygosity-in-lynch-syndrome-a-single-case-report-amp-family-study 2023-12-18T11:56:56-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/67/pold1-and-pole-an-update-on-phenotype-analysis 2023-12-18T11:55:51-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/64/revisiting-the-role-of-chek2-mutations-in-hereditary-breast-colorectal-cancer-probands 2023-12-18T11:56:03-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/105/types-and-frequencies-of-lynch-syndrome-mutations-identified-through-multigene-panel-testing-1 2023-12-04T10:29:02-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/81/a-retrospective-review-of-family-studies-in-reclassifying-variants-of-unknown-significance-detected-in-cardiomyopathy-multigene-panels 2023-12-18T12:01:38-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/68/facing-the-challenge-of-genetic-counselors-need-for-education-about-genomic-technologies-opportunities-for-improvement-in-training-for-genetic-counselors 2023-12-18T12:04:28-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/69/epigc-a-collaborative-approach-to-an-emerging-professional-and-clinical-need 2023-12-18T12:03:33-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/70/from-a-trio-to-a-duo-non-paternity-identified-through-diagnostic-exome-sequencing 2023-12-18T12:05:06-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/72/intermediate-fmr1-cgg-repeat-sizes-35-54-may-also-contribute-to-fertility-issues-in-women-with-potential-premature-ovarian-insufficiency 2023-12-18T12:06:15-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/83/all-in-the-family-a-first-look-at-outcomes-when-multiple-relatives-undergo-multi-gene-panel-testing 2023-12-18T12:01:55-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/84/continued-coverage-and-reimbursement-challenges-for-diagnostic-exome-sequencing-after-5-years-genetic-counselors-can-help-to-overturn-denied-cases 2023-12-18T12:02:40-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/85/secondary-findings-in-trio-family-members-of-probands-undergoing-diagnostic-exome-sequencing 2023-12-18T12:06:51-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/80/breast-and-colorectal-cancer-risk-in-monoallelic-mutyh-carriers-ascertained-via-multigene-panel-testing 2023-12-18T12:02:13-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/82/x-linked-mohr-tranebjaerg-syndrome-variable-phenotype-in-females 2023-12-18T12:07:26-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/87/ambryshare-a-new-model-to-fostering-a-global-effort-for-sharing-genomic-data-to-better-understand-human-disease 2017-06-20T18:20:57-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/86/exploring-trends-in-mutation-distribution-of-multi-gene-panel-testing-based-on-ethnicity 2017-06-15T12:29:50-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/89/clinical-validity-scoring-of-gene-disease-associations-in-diagnostic-exome-sequencing-effects-on-reporting-and-reanalysis 2017-06-15T12:35:21-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/52/impact-of-hereditary-multigene-panel-testing-for-cancer-survivors 2017-06-16T16:36:05-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/90/structural-quantification-discrimination-and-reclassification-surf-of-pathogenic-variants 2017-06-15T12:38:43-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/92/increased-risk-of-her2-positive-breast-cancer-among-germline-chek2-mutation-carriers-with-breast-cancer 2017-06-15T13:14:54-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/93/prospective-registry-of-multiplex-testing-prompt-a-web-based-platform-to-assess-cancer-risk-of-genetic-variants 2017-07-05T14:12:11-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/79/risks-of-triple-negative-breast-cancer-associated-with-cancer-predisposition-gene-mutations 2017-06-15T11:38:13-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/78/secondary-findings-on-diagnostic-exome-sequencing-patient-preferences-and-detection-rates-based-on-1500-des-samples-tested-at-a-single-clinical-laboratory-in-the-united-states 2017-06-15T11:07:10-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/91/increased-utilization-of-multi-gene-panel-testing-for-hereditary-cancer-overcoming-initial-barriers 2017-06-16T16:36:52-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/75/ashkenazi-jewish-descent-and-panel-testing-beyond-brca-founder-mutations 2023-12-18T11:59:09-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/76/multigene-panel-testing-for-arrhythmias-diagnostic-yield-and-phenotypic-spectrum 2023-12-04T15:12:48-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/77/hereditary-mutations-in-colorectal-cancer-more-than-meets-the-diagnostic-eye 2017-06-15T10:19:40-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/74/breast-and-ovarian-cancer-risks-associated-with-cancer-predisposition-gene-mutations-identified-by-multigene-panel-testing 2017-07-05T14:43:30-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/2/stat-reasons-and-ordering-outcomes-for-hereditary-breast-cancer-genetic-testing 2017-06-15T10:00:28-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/73/diagnostic-exome-sequencing-in-pediatric-patients-with-congenital-heart-disease 2017-06-15T09:52:23-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/71/positive-predictors-of-inherited-cancer-susceptibility-among-women-with-ovarian-and-endometrial-cancer 2017-06-16T16:38:19-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/59/clinical-laboratories-implement-the-acmg-amp-guidelines-to-resolve-differences-in-variant-interpretations-submitted-to-clinvar 2019-01-08T10:48:30-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/4/low-incidence-of-abnormal-cell-free-fetal-dna-testing-in-the-presence-of-isolated-sonographic-soft-markers-for-aneuploidy 2017-06-13T18:48:08-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/5/increasing-uptake-of-hereditary-cancer-multi-gene-panel-testing-overcoming-initial-barriers 2018-09-24T10:13:28-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/6/family-matters-how-segregation-studies-reclassify-variants-in-thoracic-aortic-aneurysm-and-dissection-multigene-panels 2017-06-13T18:54:26-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/7/clinical-utility-of-diagnostic-exome-sequencing-in-hereditary-cancer 2017-06-13T19:06:06-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/8/landscape-of-variants-of-unknown-significance-in-fbn1-identified-in-patients-with-taad-and-marfan-syndrome 2017-06-13T18:58:49-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/3/performance-of-acmg-amp-variant-interpretation-guidelines-among-nine-laboratories-in-the-clinical-sequencing-exploratory-research-consortium 2019-01-08T10:49:24-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/88/gender-bias-underdiagnosing-hereditary-cancer-in-men-with-prostate-cancer 2023-12-04T15:17:40-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/53/associations-between-breast-cancer-subtypes-and-mutations-in-cancer-predisposition-genes-identified-by-clinical-genetic-testing-of-breast-cancer-patients 2023-12-04T13:28:33-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/390/multi-gene-testing-in-a-male-breast-cancer-cohort-insights-and-unexpected-results 2023-12-07T11:51:32-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/391/multi-gene-panel-testing-and-the-cancers-identified-in-patients-at-risk-for-hereditary-breast-cancer 2023-12-07T11:57:02-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/358/mutations-in-huwe1-cause-intellectual-disability-speech-difficulties-and-epileptic-encephalopathies 2023-12-06T14:49:13-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/359/delineating-the-grin1-spectrum-a-distinct-genetic-nmda-receptor-encephalopathy 2023-12-06T14:55:16-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/360/delineation-of-the-eef1a2-epileptic-encephalopathy-phenotypic-spectrum 2023-12-06T14:59:54-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/361/the-phenotypic-and-genetic-spectrum-of-dnm1-encephalopathy 2023-12-06T15:15:21-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/374/diagnostic-exome-sequencing-with-inheritance-model-based-analysis-results-from-a-cohort-of-81-probands-referred-with-cardiac-indications-as-compared-to-the-group-of-500-unselected-families-with-undiagnosed-genetic-conditions 2023-12-18T12:10:52-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/376/germline-mosaicism-detection-with-family-centered-exome-sequencing-more-common-than-previously-recognized 2023-12-07T08:27:14-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/375/the-evaluation-of-the-molecular-basis-of-disease-embody-in-clinical-reporting-what-genetic-counselors-need-to-know-for-counseling-and-return-of-novel-genetic-etiology-results-identified-via-diagnostic-exome-sequencing 2023-12-07T08:25:11-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/377/11p13-microdeletion-involving-partial-deletion-of-elp4-in-a-newborn-patient-without-aniridia 2023-12-07T08:31:04-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/371/communication-strategies-utilized-by-people-with-nf2-and-hearing-loss 2023-12-07T08:22:39-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/378/novel-in-frame-deletion-in-gria3-a-case-report 2023-12-07T08:34:46-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/372/characteristics-of-li-fraumeni-syndrome-in-a-chek2-multi-gene-panel-cohort 2023-12-07T08:12:28-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/373/phenotype-comparison-between-founder-and-non-founder-chek2-mutation-carriers 2023-12-07T08:22:30-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/386/beyond-the-usual-suspects-features-of-hereditary-colorectal-cancer-in-a-chek2-cohort 2023-12-07T11:20:09-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/387/multiple-mutations-in-lynch-syndrome-case-report-and-experience-of-one-clinical-laboratory 2023-12-07T11:23:08-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/388/msh2-inversion-phenotype-is-similar-to-other-msh2-mutations 2023-12-07T11:26:05-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/389/pold1-and-pole-preliminary-data-from-a-laboratory-based-multi-gene-panel-testing-cohort 2023-12-07T11:28:58-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/385/a-case-of-de-novo-lynch-syndrome-with-germline-mosaicism 2023-12-07T11:16:18-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/370/novel-gene-discovery-in-the-epilepsies-using-diagnostic-exome-sequencing 2023-12-07T07:35:54-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/368/diagnostic-exome-sequencing-des-provides-a-diagnosis-for-23-of-adult-patients 2023-12-06T20:56:57-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/369/diagnostic-exome-sequencing-identifies-alterations-in-the-newly-characterized-gene-coq4-expanding-the-phenotypic-spectrum 2023-12-18T12:11:47-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/363/a-patient-with-beaulieu-boycott-innes-syndrome-illustrating-the-utility-of-whole-exome-sequencing 2023-12-06T20:21:07-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/365/cask-mutation-identified-by-whole-exome-sequencing-in-a-patient-that-expands-the-clinical-spectrum-for-micpch-syndrome 2023-12-06T20:37:19-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/367/variant-of-unknown-significance-rates-vary-by-ethnicity-and-genes-analyzed 2023-12-06T20:50:25-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/366/single-gene-sgt-vs-multi-gene-panel-testing-mgpt-for-tp53-germline-mutations-in-li-fraumeni-syndrome-lfs 2023-12-06T20:44:18-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/364/clinical-laboratories-collaborate-to-resolve-variant-interpretation-differences-in-clinvar 2023-12-06T20:29:12-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/384/benefits-and-safety-of-multigene-panel-testing-in-patients-at-risk-for-hereditary-breast-cancer 2023-12-07T11:02:11-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/362/overview-of-multi-gene-panels-for-hereditary-cancer 2023-12-06T19:23:53-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/383/germline-testing-in-hereditary-cancer-genes-subsequent-to-the-identification-of-mutations-in-tumor-specimens 2023-12-07T10:44:02-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/382/women-with-breast-and-uterine-cancer-have-increased-risk-for-genetic-mutations-a-case-control-analysis 2023-12-07T10:39:46-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/111/a-retrospective-analysis-of-multigene-panel-testing-for-marfan-syndrome-aneurysm-and-related-disorders-diagnostic-yield-and-cardiac-phenotypic-spectrum 2023-12-05T10:55:37-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/352/tgfbr2-novel-variant-p-y470d-likely-disease-causing-in-large-loeys-dietz-kindred 2023-12-05T10:45:48-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/110/a-novel-gene-not-so-novel-anymore-personalized-in-vitro-model-and-further-evidence-for-association-of-dnm1-with-early-infantile-epileptic-encephalopathy-through-clinical-exome-sequencing 2023-12-06T13:40:09-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/114/multigene-testing-for-primary-ciliary-dyskinesia-pcd-diagnostic-yield-and-phenotypic-summary 2023-12-06T14:16:23-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/354/diagnostic-exome-sequencing-des-of-a-female-patient-with-features-of-autism-spectrum-disorder-asd-identifies-a-novel-gene-ryr3-which-lies-at-the-human-15q14-schizophrenia-autism-susceptibility-locus 2023-12-06T13:56:19-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/355/clinical-diagnostic-exome-sequencing-identifies-a-maternally-inherited-89-base-pair-deletion-in-the-ube3a-gene-associated-with-angelman-syndrome 2023-12-06T14:00:51-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/356/diagnostic-exome-sequencing-identifies-alterations-in-gli2-and-ptch1-in-a-previously-undiagnosed-patient-with-holoprosencephaly-seizures-and-hypopituitarism 2023-12-06T14:14:04-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/108/diagnostic-whole-exome-sequencing-identifies-alterations-in-the-novel-gene-wars2-in-a-patient-with-severe-infantile-onset-leukoencephalopathy 2023-12-06T13:34:09-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/1/diagnostic-exome-sequencing-positively-identified-relevant-alterations-in-half-of-prenatal-samples-tested 2023-12-05T10:59:14-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/109/exome-sequencing-covers-gt-99-of-mutations-identified-on-targeted-next-generation-sequencing-panels 2023-12-06T13:38:34-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/112/the-likelihood-of-positive-results-from-diagnostic-exome-sequencing-is-not-predicted-by-ordering-physician-specialty 2023-12-06T14:02:26-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/113/multiple-molecular-diagnoses-identified-through-diagnostic-exome-sequencing 2023-12-06T14:04:44-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/116/diagnostic-exome-sequencing-diagnostic-yield-novel-gene-discovery-expected-and-unexpected-results 2023-12-06T14:07:31-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/353/diagnostic-exome-sequencing-detection-rates-in-patients-with-prior-uninformative-microarray-results 2023-12-06T13:48:20-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/357/comparison-of-clinical-features-in-pten-positive-patients-ascertained-by-single-gene-testing-versus-hereditary-cancer-multi-gene-panel-testing 2023-12-06T14:22:54-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/115/observation-of-cancers-other-than-breast-in-monoallelic-atm-gene-mutation-carriers-and-their-families 2023-12-05T10:51:46-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/380/transitioning-from-single-to-multi-gene-testing-for-hereditary-cancer-predisposition-an-advanced-practice-nurses-experience 2023-12-07T10:20:37-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/381/yield-of-multi-gene-testing-in-affected-and-unaffected-patients-meeting-nccn-brca1-2-testing-criteria 2023-12-07T10:26:22-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/379/characterizing-the-mutation-spectrum-in-brca1-2-negative-early-onset-breast-cancer-patients-undergoing-multigene-panel-testing 2023-12-07T10:07:21-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/421/teasing-out-the-palb2-phenotype 2023-12-09T17:24:46-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/420/results-of-next-generation-sequencing-panels-in-a-large-community-based-hereditary-cancer-risk-program 2023-12-09T17:20:36-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/392/navigating-the-benefits-and-limitations-of-current-molecular-testing-options-for-the-clinical-identification-of-disease-causing-pcdh19-mutations 2023-12-07T12:10:57-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/429/defining-allelic-heterogeneity-among-clinically-important-mutations-in-cftr 2023-12-09T18:20:59-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/416/diagnostic-exome-sequencing-as-the-foundation-of-building-pharmacogenomics-based-therapeutic-models-for-the-treatment-of-ion-channel-epilepsy 2023-12-09T16:29:42-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/419/enhanced-detection-of-large-indels-in-diagnostic-exome-sequencing 2023-12-09T16:54:07-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/415/diagnostic-exome-sequencing-provides-diagnoses-among-patients-with-abnormal-brain-mri-findings 2023-12-09T16:21:20-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/418/diagnostic-exome-sequencing-establishes-molecular-diagnoses-among-patients-with-gastrointestinal-disease 2023-12-09T16:48:04-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/417/clinical-exome-sequencing-identifies-a-novel-gene-lins-associated-with-intellectual-disability-failure-to-thrive-seizures-dysmorphology-and-language-regression 2023-12-09T16:41:09-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/414/majority-of-pten-mutations-identified-on-multi-gene-panel-tests-are-in-non-classic-patients-expanding-clinical-phenotype-or-incomplete-clinical-history 2023-12-09T16:13:39-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/411/novel-mutation-in-cltc-associated-with-anomalous-development-1 2023-12-09T15:41:52-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/412/mutations-in-stk11-identified-exclusively-in-individuals-with-clinical-histories-suggestive-of-peutz-jeghers-syndrome 2023-12-09T16:01:47-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/413/further-defining-the-polyposis-phenotype-associated-with-pten-mutations 2023-12-09T16:06:11-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/430/a-retrospective-analysis-of-diagnostic-exome-sequencing-results-among-neonatal-patients 2023-12-09T18:49:24-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/431/diagnostic-exome-sequencing-provides-a-diagnosis-for-half-of-neonatal-patients-a-retrospective-analysis-of-detection-rates-and-phenotypes-among-neonates 2023-12-09T20:42:09-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/410/diagnostic-exome-sequencing-for-patients-with-a-family-history-of-consanguinity-over-40-of-positive-results-do-not-follow-an-autosomal-recessive-pattern 2023-12-07T15:22:19-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/406/cost-should-not-be-a-barrier-to-genetic-testing-in-patients-with-paragangliomas-and-pheochromocytomas 2023-12-07T15:02:32-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/407/nf1-mutations-detected-on-multi-gene-cancer-panel-testing-in-probands-with-atypical-phenotypes 2023-12-07T15:07:36-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/409/multi-gene-testing-for-paragangliomas-and-pheochromocytomas-diagnostic-yield-and-phenotypic-spectrum 2023-12-07T15:18:40-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/408/patients-with-multiple-pathogenic-mutations-detected-by-multi-gene-panel-testing-in-a-lynch-syndrome-cohort 2023-12-07T15:17:10-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/422/unexpected-cdh1-mutations-identified-on-multigene-panels 2023-12-09T17:37:56-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/423/individuals-with-lynch-syndrome-and-colon-polyps-identified-by-multi-gene-panels 2023-12-09T17:41:57-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/424/hereditary-pancreatic-cancer-multi-gene-test-preliminary-results 2023-12-09T17:45:39-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/426/the-relationship-between-renal-cell-carcinoma-and-lynch-syndrome-more-investigation-is-needed 2023-12-09T17:51:22-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/427/patients-with-multiple-pathogenic-mutations-detected-by-multi-gene-panel-testing-in-a-lynch-syndrome-cohort-1 2023-12-09T17:54:35-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/428/discrepant-tumor-test-results-in-individuals-with-lynch-syndrome-identified-by-next-generation-sequencing-panels 2023-12-09T18:01:23-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/425/further-defining-the-polyposis-phenotype-associated-with-pten-mutations-1 2023-12-09T17:49:58-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/395/results-from-multigene-panel-testing-for-79-pan-cardio-genes 2023-12-07T12:38:57-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/400/roughly-half-of-patients-presenting-with-ataxia-and-or-spasticity-receive-a-definitive-diagnosis-with-diagnostic-exome-sequencing-des 2023-12-07T12:58:08-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/404/diagnostic-exome-sequencing-des-in-a-patient-with-syndromic-intellectual-disability-identifies-a-novel-gene-cdc42-which-lies-at-the-1p36-deletion-syndrome-locus 2023-12-18T12:14:38-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/402/the-ever-expanding-clinical-phenotype-associated-with-pten-gene-mutations-two-remarkably-different-cases-involving-the-pten-mutation-p-d24g-detected-by-sanger-sequencing-and-exome-sequencing-analyses 2023-12-07T13:21:53-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/396/diagnostic-exome-sequencing-identifies-a-de-novo-variant-in-a-consanguineous-family 2023-12-07T12:42:52-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/398/exome-sequencing-identifies-five-mutations-in-the-dync1h1-gene-associated-with-severe-neurological-phenotypes 2023-12-07T12:52:02-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/397/diagnostic-exome-sequencing-des-unmasks-two-discrete-genetic-etiologies-in-a-patient-with-ataxia-and-epilepsy-dual-molecular-diagnosis-in-a-patient-highlights-the-utility-of-diagnostic-exome-sequencing 2023-12-07T12:47:38-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/399/diagnostic-exome-sequencing-des-unravels-novel-gene-findings-in-a-significant-portion-of-previously-undiagnosed-patients 2023-12-07T12:55:00-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/401/negative-diagnostic-exome-sequencing-results-a-retrospective-analysis-of-the-phenotypic-spectrum-of-patients-with-negative-exome-sequencing-results 2023-12-07T13:01:28-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/403/mutations-in-newly-discovered-mendelian-disease-genes-represent-a-significant-portion-of-positive-findings-in-diagnostic-exome-sequencing-des 2023-12-07T13:11:00-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/405/reclassification-of-historical-mutations-in-the-cftr-gene-for-cystic-fibrosis-reveals-that-37-of-previously-classified-mutations-are-variants-of-unknown-significance-or-benign-alterations 2023-12-07T13:19:59-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/394/proband-with-msh2-and-pten-germline-alterations-identified-on-multi-gene-panel-testing 2023-12-07T12:39:51-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/393/beyond-brca1-2-expanding-phenotypes-for-probands-with-cdh1-pten-stk11-and-tp53-mutations 2023-12-07T12:29:20-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/107/novel-mutation-in-cltc-associated-with-anomalous-development 2023-12-18T11:51:16-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/439/des-is-uniquely-useful-in-the-identification-of-multi-gene-alterations-oligogenic-findings-make-up-a-significant-portion-of-previously-undiagnosed-patients 2023-12-09T21:53:54-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/441/diagnostic-exome-sequencing-beneficial-among-patients-with-a-prior-diagnosis 2023-12-12T08:03:27-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/440/clinical-exome-sequencing-identifies-two-novel-iqsec2-mutations-associated-with-x-linked-intellectual-disability-with-seizures-implications-for-genetic-counseling-and-clinical-diagnosis 2023-12-09T21:57:52-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/444/haploinsufficiency-of-gjb5-identified-via-exome-sequencing-causesa-novel-form-of-cutis-laxa 2023-12-12T08:02:24-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/443/case-report-of-a-17q21-31-microdeletion-associated-with-eftud2-mandibulofacial-dysostosis-with-microcephaly-identified-by-comparative-genomic-hybridization 2023-12-09T23:13:20-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/442/a-retrospective-analysis-of-discrepancies-between-genotypes-and-phenotypes-on-next-generation-sequencing-colon-cancer-panels-colonext-ngs-implications-for-clinical-diagnosis 2023-12-09T22:37:51-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/445/cancer-phenotypes-of-germline-monoallelic-atm-mutation-carriers-and-their-families 2023-12-12T08:10:24-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/446/mutation-detection-rate-of-exome-sequencing-using-next-generation-sequencing-panel-results-as-a-reference 2023-12-12T08:23:20-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/449/strategy-for-reporting-secondary-findings-for-diagnostic-exome-sequencing-des 2023-12-12T08:35:41-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/448/clinical-report-of-concurrent-trisomy-21-and-22q11-21-microdeletion-identified-through-array-based-comparative-genomic-hybridization 2023-12-12T08:32:30-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/447/clinical-report-of-a-17q12-microdeletion-with-additional-unreported-clinical-features-expansion-on-the-phenotype 2023-12-12T08:28:50-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/451/utilization-of-diagnostic-exome-sequencing-for-the-molecular-diagnosis-of-mitochondrial-disorders-and-therapeutic-implications 2023-12-12T08:51:58-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/450/clinical-exome-sequencing-leads-to-the-diagnosis-of-mitochondrial-complex-i-deficiency-in-a-family-with-global-developmental-delays-ataxia-and-cerebellar-and-pons-hypoplasia 2023-12-12T08:44:24-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/434/family-based-exome-sequencing-reveals-that-de-novo-alterations-make-up-a-significant-portion-of-previously-undiagnosed-patients 2023-12-09T21:06:17-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/435/clinical-exome-sequencing-identifies-a-novel-gene-snap25-associated-with-seizures 2023-12-09T21:17:45-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/437/clinical-diagnostic-exome-sequencing-identified-a-novel-mutation-in-actg2-possibly-due-to-germline-mosaicism-in-two-affected-children-with-megacystis-and-echogenic-bowel-in-a-chinese-family 2023-12-09T21:25:22-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/438/nonsense-mutations-identified-in-ube3b-in-a-patient-with-blepharophimosis-ptosis-intellectual-disability-syndrome-by-clinical-diagnostic-exome-sequencing 2023-12-09T21:33:12-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/436/apparent-digenic-triallelic-inheritance-in-early-onset-ataxia-through-whole-exome-sequencing 2023-12-09T21:19:41-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/432/exome-sequencing-in-a-patient-with-syndromic-intellectual-disability-identifies-znf238-a-novel-gene-which-lies-within-the-1q43q44-microdeletion-syndrome 2023-12-09T21:00:39-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-poster/433/diagnostic-exome-sequencing-suggests-digenic-inheritance-in-a-cobalamin-metabolism-disorder 2023-12-09T21:03:31-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publications 2026-04-02T12:29:43-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/497/identification-of-de-novo-variants-from-parent-proband-duos-via-long-read-sequencing 2026-03-20T08:30:47-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/498/sequencing-approaches-in-hereditary-cancer-testing-strengths-limitations-and-future-directions 2026-03-25T11:51:34-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/495/gata3-deletion-associated-with-juvenile-idiopathic-arthritis-expanding-the-phenotypic-spectrum-of-hypoparathyroidism-sensorineural-deafness-and-renal-dysplasia-hdr-syndrome 2025-11-12T08:39:12-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/492/10-years-of-exome-sequencing-and-reanalysis-among-racial-ethnic-and-ancestral-groups-the-importance-of-equitable-reanalysis-access 2025-11-12T08:13:10-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/494/brca1-brca2-and-palb2-related-fanconi-anemia-scope-to-expand-disease-phenotypic-features-and-predict-breast-cancer-risk-in-heterozygotes 2025-11-12T08:34:24-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/489/a-quantitative-bayesian-informed-approach-to-gene-specific-variant-classification-updated-expert-panel-recommendations-improve-classification-of-tp53-germline-variants-for-li-fraumeni-syndrome 2025-11-12T07:38:43-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/490/smarca4-pathogenic-variants-gynecological-cancer-histories-from-a-laboratory-tested-cohort 2025-11-12T07:43:25-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/474/specifications-of-the-acmg-amp-variant-curation-guidelines-for-the-analysis-of-germline-palb2-sequence-variants 2025-10-30T07:18:36-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/491/frequency-and-clinical-features-of-germline-pathogenic-variants-in-sarcoma-a-case-control-study 2025-11-12T07:46:55-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/493/paired-dna-rna-testing-uncovers-a-deep-intronic-pten-pathogenic-variant-associated-with-clinical-cowden-syndrome-a-case-report 2025-11-12T08:16:44-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/484/implementing-a-genetic-counselor-led-model-for-hereditary-myeloid-malignancies-a-real-world-study 2025-11-11T18:41:00-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/485/specifications-of-the-acmg-amp-variant-curation-guidelines-for-the-analysis-of-germline-palb2-sequence-variants 2025-11-11T18:48:24-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/475/rare-variants-in-prkci-cause-van-der-woude-syndrome-and-other-features-of-peridermopathy 2025-11-11T08:58:43-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/496/hereditary-diffuse-gastric-cancer-spectrum-associated-with-germline-ctnna1-loss-of-function-revealed-by-clinical-and-molecular-data-from-351-carrier-families-and-over-37-000-non-carrier-controls 2025-11-12T08:55:08-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/483/quantifying-evidence-for-phenotypic-specificity-pp4-for-syndromic-phenotypes-large-scale-integration-of-rare-germline-fh-variants-from-diagnostic-laboratory-testing-for-hlrcc-hereditary-leiomyomatosis-and-renal-cell-cancer-and-renal-cancer 2025-11-11T18:34:28-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/482/a-novel-insertion-deletion-in-apc-promotor-1b-is-associated-with-both-gastric-and-colon-polyposis 2025-11-11T18:13:23-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/480/association-of-rps20-loss-of-function-variants-with-colorectal-cancer-risk-in-a-cohort-of-over-950-000-individuals 2025-11-11T17:50:48-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/464/understanding-how-gene-disease-relationships-can-impact-clinical-utility-adaptations-and-challenges-in-hereditary-cancer-testing 2025-10-30T07:09:37-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/478/saturation-mapping-of-mutyh-variant-effects-using-dna-repair-reporters 2025-11-11T10:23:06-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/461/extracting-and-calibrating-evidence-of-variant-pathogenicity-from-population-biobank-data 2025-08-19T07:07:19-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/463/low-allele-frequency-variants-identified-on-germline-multi-gene-panel-testing-for-cancer-predisposition-can-suggest-the-presence-of-constitutional-mosaicism 2025-08-21T10:10:27-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/481/clinically-important-endpoints-in-individuals-with-leukodystrophy-a-multisite-study 2025-11-11T18:01:50-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/479/characteristics-predicting-reduced-penetrance-variants-in-the-high-risk-cancer-predisposition-gene-tp53 2025-11-11T15:31:29-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/465/acmg-sf-v3-3-list-for-reporting-of-secondary-findings-in-clinical-exome-and-genome-sequencing-a-policy-statement-of-the-american-college-of-medical-genetics-and-genomics-acmg 2025-11-11T15:15:55-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/473/distinct-rates-of-vus-reclassification-are-observed-when-subclassifying-vus-by-evidence-level 2025-09-08T11:41:57-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/454/benefits-limitations-and-impacts-of-reproductive-carrier-screening-and-telehealth-based-genetic-counseling-for-individuals-with-an-increased-chance-to-have-a-child-with-a-genetic-condition 2025-08-19T07:07:05-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/466/case-report-biallelic-brca1-pathogenic-alterations-in-a-fanconi-anemia-patient-and-clinical-implications-of-variant-location 2025-09-08T09:57:25-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/460/impact-of-laboratory-driven-proactive-reanalysis-reclassification-to-positive-in-5-of-initially-negative-or-uncertain-exome-sequencing-cases 2025-07-28T10:46:52-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/459/acmg-amp-interpretation-of-brca1-missense-variants-structure-informed-scores-add-evidence-strength-granularity-to-the-pp3-bp4-computational-evidence 2025-08-19T07:06:46-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/469/integration-of-protein-stability-and-alpha-missense-scores-improves-bioinformatic-impact-prediction-for-p53-missense-and-in-frame-amino-acid-deletion-variants 2025-09-08T10:21:47-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/462/clinical-validity-of-autosomal-dominant-alpk3-loss-of-function-variants-as-a-cause-of-hypertrophic-cardiomyopathy 2025-08-21T09:59:42-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/470/the-clingen-syndromic-disorders-gene-curation-expert-panel-assessing-the-clinical-validity-of-111-gene-disease-relationships 2025-09-08T10:56:03-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/467/updated-acmg-amp-specifications-for-variant-interpretation-and-gene-curations-from-the-clingen-rasopathy-expert-panels 2025-09-08T10:14:14-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/458/bi-allelic-med16-variants-cause-a-medopathy-with-intellectual-disability-motor-delay-and-craniofacial-cardiac-and-limb-malformations 2025-05-22T09:45:22-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/455/association-of-gene-variant-type-and-location-with-breast-cancer-risk-in-the-general-population 2025-05-15T10:33:44-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/468/structural-biology-in-variant-interpretation-perspectives-and-practices-from-two-studies 2025-09-08T10:17:10-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/471/autosomal-dominant-hk1-related-neurodevelopmental-disorder-with-visual-defects-and-brain-anomalies-nedviba-an-emerging-mitochondrial-disorder 2025-09-08T11:28:12-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/436/calibration-of-additional-computational-tools-expands-clingen-recommendation-options-for-variant-classification-with-pp3-bp4-criteria 2025-11-11T10:12:46-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/457/consensus-guidelines-for-assessing-eligibility-of-pathogenic-dna-variants-for-antisense-oligonucleotide-treatments 2025-05-15T10:46:22-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/456/strchive-a-dynamic-resource-detailing-population-level-and-locus-specific-insights-at-tandem-repeat-disease-loci 2025-05-15T10:32:34-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/472/heterozygous-missense-variants-in-the-atpase-phospholipid-transporting-9a-gene-atp9a-alter-dendritic-spine-maturation-and-cause-dominantly-inherited-nonsyndromic-intellectual-disability 2025-09-08T11:36:58-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/476/genes-associated-with-hypertrophic-cardiomyopathy-a-reappraisal-by-the-clingen-hereditary-cardiovascular-disease-gene-curation-expert-panel 2025-11-11T09:46:27-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/453/male-proband-with-intractable-seizures-and-a-de-novo-start-codon-disrupting-variant-in-glul 2025-05-14T12:12:28-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/429/rna-methyltransferase-spout1-cenp-32-links-mitotic-spindle-organization-with-the-neurodevelopmental-disorder-spadmiss 2025-11-11T09:22:50-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/439/functional-evaluation-and-clinical-classification-of-brca2-variants 2025-11-11T08:36:55-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/412/double-chek2-pathogenic-and-low-risk-variants-and-associated-cancer-phenotypes 2025-08-08T12:06:05-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/440/hereditary-transthyretin-amyloidosis-in-patients-referred-to-a-genetic-testing-program 2025-08-19T07:06:32-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/477/lessons-learned-in-migrating-from-one-commercial-genetics-clinical-decision-making-tool-to-another-assessment-of-data-integrity-and-utilization 2025-11-11T09:54:08-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/379/congenital-urinary-tract-anomalies-are-a-variable-finding-associated-with-nevoid-basal-cell-carcinoma-syndrome 2025-08-19T07:06:15-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/443/validation-of-the-nccn-yale-criteria-for-the-identification-of-cdh1-pathogenic-variant-carriers 2025-08-08T12:01:48-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/447/bap1-tumor-predisposition-syndrome 2025-02-19T06:46:50-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/441/variant-of-uncertain-significance-patterns-among-patients-with-early-onset-colorectal-cancer 2025-08-08T12:02:58-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/442/pathogenic-variants-in-cancer-susceptibility-genes-predispose-to-ductal-carcinoma-in-situ-of-the-breast 2025-11-11T08:17:14-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/437/reduced-penetrance-brca1-and-brca2-pathogenic-variants-in-clinical-germline-genetic-testing 2025-04-07T12:14:49-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/438/the-clinical-genome-resource-clingen-advancing-genomic-knowledge-through-global-curation 2025-04-08T11:44:27-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/427/evidence-based-recommendations-for-gene-specific-acmg-amp-variant-classification-from-the-clingen-enigma-brca1-and-brca2-variant-curation-expert-panel 2025-04-08T11:59:02-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/435/large-scale-application-of-clingen-insight-apc-specific-acmg-amp-variant-classification-criteria-leads-to-substantial-reduction-in-vus 2025-04-08T11:46:04-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/432/whole-genome-sequencing-based-analysis-of-inflammation-biomarkers-in-the-trans-omics-for-precision-medicine-topmed-consortium 2025-04-09T09:05:07-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/434/management-targeted-genetic-evaluation-of-an-idiopathic-neuropathy-cohort-through-attrv-amyloidosis-screening 2025-04-09T08:53:41-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/425/assessment-of-the-evidence-yield-for-the-calibrated-pp3-bp4-computational-recommendations 2025-04-08T11:55:22-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/423/clinical-features-and-genotype-phenotype-correlations-in-epilepsy-patients-with-de-novo-dync1h1-variants 2025-04-09T08:54:11-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/433/considerations-for-reporting-variants-in-novel-candidate-genes-identified-during-clinical-genomic-testing 2025-04-09T08:55:15-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/424/the-impact-of-clinical-genome-sequencing-in-a-global-population-with-suspected-rare-genetic-disease 2025-04-08T11:50:25-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/421/cask-pathogenic-variant-which-expands-the-clinical-spectrum-for-micpch-syndrome-in-an-adult-patient 2025-04-09T09:08:02-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/420/consideration-of-disease-penetrance-in-the-selection-of-secondary-findings-gene-disease-pairs-a-policy-statement-of-the-american-college-of-medical-genetics-and-genomics-acmg 2025-04-08T11:51:09-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/416/cachd1-interacts-with-wnt-receptors-and-regulates-neuronal-asymmetry-in-the-zebrafish-brain 2024-05-14T06:45:50-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/431/specifications-of-the-acmg-amp-variant-curation-guidelines-for-the-analysis-of-germline-atm-sequence-variants 2025-08-08T12:10:47-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/452/benefits-and-harms-of-interception-and-early-detection-of-cancer 2025-08-19T07:05:55-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/419/outcomes-of-a-universal-germline-screening-program-in-a-community-urology-practice 2025-04-08T11:52:08-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/422/genetic-counseling-for-the-dystrophinopathies-practice-resource-of-the-national-society-of-genetic-counselors 2025-04-08T11:52:37-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/415/challenges-and-approaches-to-calibrating-patient-phenotype-as-evidence-for-cancer-gene-variant-classification-under-acmg-amp-guidelines 2025-04-08T11:57:09-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/414/biallelic-variants-in-gtf3c5-a-regulator-of-rna-polymerase-iii-mediated-transcription-cause-a-multisystem-developmental-disorder 2025-04-08T12:00:07-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/410/recommendations-for-risk-allele-evidence-curation-classification-and-reporting-from-the-clingen-low-penetrance-risk-allele-working-group 2025-04-08T12:16:48-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/411/solving-missing-heritability-in-patients-with-familial-adenomatous-polyposis-with-dna-rna-paired-testing 2025-04-08T11:54:08-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/418/functional-analysis-and-clinical-classification-of-462-germline-brca2-missense-variants-affecting-the-dna-binding-domain 2025-04-08T11:56:18-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/284/gene-specific-acmg-amp-classification-criteria-for-germline-apc-variants-recommendations-from-the-clingen-insight-hereditary-colorectal-cancer-polyposis-variant-curation-expert-panel 2025-04-08T12:07:41-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/417/cancer-burden-in-individuals-with-single-versus-double-pathogenic-variants-in-cancer-susceptibility-genes 2025-04-08T11:55:43-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/293/diagnostic-outcomes-of-concurrent-dna-and-rna-sequencing-in-individuals-undergoing-hereditary-cancer-testing 2025-04-08T12:07:18-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/430/specifications-of-the-acmg-amp-variant-curation-guidelines-for-hereditary-hemorrhagic-telangiectasia-genes-eng-and-acvrl1 2025-04-23T13:14:17-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/408/clingen-guidance-for-use-of-the-pp1-bs4-co-segregation-and-pp4-phenotype-specificity-criteria-for-sequence-variant-pathogenicity-classification 2025-04-08T12:01:21-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/413/clinical-interpretation-of-kcnh2-variants-using-a-robust-ps3-bs3-functional-patch-clamp-assay 2025-04-08T11:59:34-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/445/a-novel-cysteine-rich-adaptor-protein-is-required-for-mucin-packaging-and-secretory-granule-stability-in-vivo 2025-04-08T11:56:37-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/409/spliceosome-malfunction-causes-neurodevelopmental-disorders-with-overlapping-features 2025-04-09T09:14:38-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/449/systematic-evidence-review-and-meta-analysis-of-outcomes-associated-with-cancer-genetic-counseling 2025-08-19T07:05:37-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/426/atypical-cancer-risk-profile-in-carriers-of-italian-founder-brca1-variant-p-his1673del-implications-for-classification-and-clinical-management 2025-04-08T11:58:11-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/407/effect-of-the-lsd1-inhibitor-rn-1-on-globin-and-global-gene-expression-during-erythroid-differentiation-in-baboons-papio-anubis 2025-04-08T12:00:46-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/405/pretest-video-education-versus-genetic-counseling-for-patients-with-prostate-cancer-progen-a-multisite-randomized-controlled-trial 2025-04-08T12:28:30-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/428/assigning-credit-where-it-is-due-an-information-content-score-to-capture-the-clinical-value-of-multiplexed-assays-of-variant-effect 2025-08-19T07:04:31-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/446/advanced-variant-classification-framework-reduces-the-false-positive-rate-of-predicted-loss-of-function-variants-in-population-sequencing-data 2025-02-19T06:43:13-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/406/brca1-frameshift-variants-leading-to-extended-incorrect-protein-c-termini 2025-04-08T12:09:26-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/403/genetic-counseling-in-diabetes-mellitus-a-practice-resource-of-the-national-society-of-genetic-counselors 2025-04-08T12:10:22-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/404/combining-clinical-and-molecular-characterization-of-cdh1-a-multidisciplinary-approach-to-reclassification-of-a-splicing-variant 2025-04-08T12:15:08-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/390/enigma-chek2gether-project-a-comprehensive-study-identifies-functionally-impaired-chek2-germline-missense-variants-associated-with-increased-breast-cancer-risk 2025-04-08T12:22:43-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/255/a-genotype-first-approach-identifies-high-incidence-of-nf1-pathogenic-variants-with-distinct-disease-associations 2025-08-08T12:15:09-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/384/chek2-is-not-a-li-fraumeni-syndrome-gene-time-to-update-public-resources 2025-04-08T12:13:28-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/169/the-landscape-of-reported-vus-in-multi-gene-panel-and-genomic-testing-time-for-a-change 2025-04-08T12:27:47-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/386/a-framework-for-individualized-splice-switching-oligonucleotide-therapy 2025-04-08T12:10:47-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/450/using-the-acmg-amp-framework-to-capture-evidence-related-to-predicted-and-observed-impact-on-splicing-recommendations-from-the-clingen-svi-splicing-subgroup 2025-02-19T07:27:28-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/392/characterization-of-pot1-tumor-predisposition-syndrome-tumor-prevalence-in-a-clinically-diverse-hereditary-cancer-cohort 2025-04-08T12:11:59-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/398/barriers-to-hormone-therapy-following-prophylactic-bilateral-salpingo-oophorectomy-in-brca1-2-mutation-carriers 2025-08-19T07:03:58-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/305/pathogenic-variants-among-females-with-breast-cancer-and-a-non-breast-cancer-reveal-opportunities-for-cancer-interception 2025-08-19T07:02:15-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/448/correction-to-pathogenic-variants-among-females-with-breast-cancer-and-a-non-breast-cancer-reveal-opportunities-for-cancer-interception 2025-04-08T15:03:59-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/380/germline-genetic-testing-after-cancer-diagnosis 2025-08-19T07:03:18-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/451/acmg-sf-v3-2-list-for-reporting-of-secondary-findings-in-clinical-exome-and-genome-sequencing-a-policy-statement-of-the-american-college-of-medical-genetics-and-genomics-acmg 2025-02-19T09:45:46-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/370/optimising-clinical-care-through-cdh1-specific-germline-variant-curation-improvement-of-clinical-assertions-and-updated-curation-guidelines 2025-04-08T12:29:17-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/283/is-appendiceal-cancer-a-lynch-syndrome-associated-cancer-reply 2025-08-19T06:58:44-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/381/clinical-multigene-panel-testing-identifies-racial-and-ethnic-differences-in-germline-pathogenic-variants-among-patients-with-early-onset-colorectal-cancer 2025-08-19T07:02:00-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/325/cascade-testing-after-exome-sequencing-retrospective-analysis-of-linked-family-data-at-2-us-laboratories 2025-08-19T07:01:35-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/281/points-to-consider-in-the-practice-of-postmortem-genetic-testing-a-statement-of-the-american-college-of-medical-genetics-and-genomics-acmg 2025-04-08T12:19:42-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/286/recommendations-for-next-generation-sequencing-germline-variant-confirmation-a-joint-report-of-the-association-for-molecular-pathology-and-national-society-of-genetic-counselors 2025-04-08T12:55:07-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/393/psmc3-proteasome-subunit-variants-are-associated-with-neurodevelopmental-delay-and-type-i-interferon-production 2025-04-09T09:10:21-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/285/how-parents-of-children-with-ataxia-telangiectasia-use-dynamic-coping-to-navigate-cyclical-uncertainty 2025-04-09T09:09:52-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/388/functional-and-clinical-characterization-of-variants-of-uncertain-significance-identifies-a-hotspot-for-inactivating-missense-variants-in-rad51c 2025-04-08T12:14:19-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/331/abrogation-of-map4k4-protein-function-causes-congenital-anomalies-in-humans-and-zebrafish 2025-08-19T06:58:19-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/254/specifications-of-the-acmg-amp-variant-classification-guidelines-for-germline-dicer1-variant-curation 2025-04-08T12:18:08-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/282/wnt-pathway-inhibitors-are-upregulated-in-xlh-dental-pulp-cells-in-response-to-odontogenic-differentiation 2025-04-08T12:18:40-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/387/functional-and-clinical-studies-reveal-pathophysiological-complexity-of-clcn4-related-neurodevelopmental-condition 2025-04-09T09:16:09-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/299/germline-pathogenic-smarca4-variants-in-neuroblastoma 2025-04-08T12:20:11-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/328/inherited-cancer-predisposing-mutations-in-patients-with-therapy-related-myeloid-neoplasms 2023-08-02T07:12:51-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/295/inherited-bone-marrow-failure-with-macrothrombocytopenia-due-to-germline-tubulin-beta-class-i-tubb-variant 2025-04-09T09:21:39-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/364/nbn-pathogenic-germline-variants-are-associated-with-pan-cancer-susceptibility-and-in-vitro-dna-damage-response-defects 2025-04-08T12:55:30-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/376/simplified-and-more-sensitive-criteria-for-identifying-individuals-with-pathogenic-cdh1-variants 2025-08-19T06:57:45-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/314/three-newly-recognized-likely-pathogenic-gene-variants-associated-with-hereditary-transthyretin-amyloidosis 2025-04-15T14:03:16-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/329/smad3-promotes-adverse-cardiovascular-remodeling-and-dysfunction-in-doxorubicin-treated-hearts 2023-07-25T05:29:54-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/320/calibration-of-computational-tools-for-missense-variant-pathogenicity-classification-and-clingen-recommendations-for-pp3-bp4-criteria 2025-04-08T12:53:33-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/294/case-report-and-review-of-the-literature-immune-dysregulation-in-a-large-familial-cohort-due-to-a-novel-pathogenic-rela-variant 2025-08-19T06:57:08-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/303/massive-macroglossia-a-rare-side-effect-of-covid-19-clinical-histologic-and-genomic-findings-in-covid-19-positive-versus-covid-19-negative-patients 2025-04-09T09:25:13-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/374/clinical-splicing-and-functional-analysis-to-classify-brca2-exon-3-variants-application-of-a-points-based-acmg-amp-approach 2025-04-09T07:37:40-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/292/development-and-validation-of-the-premmplus-model-for-multigene-hereditary-cancer-risk-assessment 2025-04-09T07:34:38-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/322/saturation-scale-functional-evidence-supports-clinical-variant-interpretation-in-lynch-syndrome 2025-04-08T12:56:34-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/366/the-development-of-an-infrastructure-to-facilitate-the-use-of-whole-genome-sequencing-for-population-health 2025-04-08T12:29:45-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/327/differences-in-cancer-phenotypes-among-frequent-chek2-variants-and-implications-for-clinical-care-checking-chek2 2025-04-08T12:54:26-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/378/inherited-cancer-susceptibility-gene-sequence-variations-among-patients-with-appendix-cancer 2025-08-08T12:18:02-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/385/de-novo-coding-variants-in-the-ago1-gene-cause-a-neurodevelopmental-disorder-with-intellectual-disability 2025-04-09T09:23:58-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/397/genotype-phenotype-correlations-in-scn8a-related-disorders-reveal-prognostic-and-therapeutic-implications 2025-04-09T09:33:03-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/324/identification-of-genes-regulating-hepatocyte-injury-by-a-genome-wide-crispr-cas9-screen 2025-04-08T12:55:50-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/400/the-gene-curation-coalition-a-global-effort-to-harmonize-gene-disease-evidence-resources 2025-04-09T07:36:17-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/290/a-novel-social-contract-an-attempt-to-harmonize-a-sponsor-s-exploratory-research-with-a-clinical-study-participant-s-data-rights 2025-04-08T12:58:02-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/326/phenotypic-and-genetic-spectrum-of-atp6v1a-encephalopathy-a-disorder-of-lysosomal-homeostasis 2025-04-09T09:23:09-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/323/mutational-and-splicing-landscape-in-a-cohort-of-43-000-patients-tested-for-hereditary-cancer 2025-04-08T12:56:11-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/291/a-calibrated-functional-patch-clamp-assay-to-enhance-clinical-variant-interpretation-in-kcnh2-related-long-qt-syndrome 2025-04-09T09:23:29-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/296/human-kcnq5-de-novo-mutations-underlie-epilepsy-and-intellectual-disability 2025-04-22T11:39:22-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/360/acmg-sf-v3-1-list-for-reporting-of-secondary-findings-in-clinical-exome-and-genome-sequencing-a-policy-statement-of-the-american-college-of-medical-genetics-and-genomics-acmg 2025-04-08T12:57:37-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/369/recommendations-for-clinical-interpretation-of-variants-found-in-non-coding-regions-of-the-genome 2025-04-08T12:57:04-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/358/diagnostic-testing-laboratories-are-valuable-partners-for-disease-gene-discovery-5-year-experience-with-genematcher 2025-04-24T12:43:08-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/401/misattributed-parentage-identified-through-diagnostic-exome-sequencing-frequency-of-detection-and-reporting-practices 2025-04-24T12:54:14-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/308/risk-assessment-and-genetic-counseling-for-lynch-syndrome-practice-resource-of-the-national-society-of-genetic-counselors-and-the-collaborative-group-of-the-americas-on-inherited-gastrointestinal-cancer 2025-04-09T08:22:48-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/375/an-integrative-model-for-the-comprehensive-classification-of-brca1-and-brca2-variants-of-uncertain-clinical-significance 2025-04-09T08:03:28-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/289/an-algorithm-for-optimal-testing-in-co-segregation-analysis 2025-04-08T13:27:32-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/287/germline-variant-spectrum-among-african-american-men-undergoing-prostate-cancer-germline-testing-need-for-equity-in-genetic-testing 2023-08-01T07:35:44-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/318/recurrent-de-novo-missense-variants-across-multiple-histone-h4-genes-underlie-a-neurodevelopmental-syndrome 2025-04-09T09:15:29-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/330/germline-pathogenic-variants-in-cancer-risk-genes-among-patients-with-thyroid-cancer-and-suspected-predisposition 2025-04-08T12:30:07-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/346/diagnostic-criteria-for-constitutional-mismatch-repair-deficiency-cmmrd-recommendations-from-the-international-consensus-working-group 2025-04-24T12:51:34-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/357/rna-sequencing-uncovers-clinically-actionable-germline-intronic-msh2-variants-in-previously-unresolved-lynch-syndrome-families 2025-04-24T12:42:41-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/302/a-founder-chek2-pathogenic-variant-in-association-with-kidney-cancer 2025-04-23T13:25:13-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/311/universal-germline-panel-testing-for-individuals-with-pheochromocytoma-and-paraganglioma-produces-high-diagnostic-yield 2025-04-23T13:25:37-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/307/response-to-mcgurk-et-al 2025-04-09T08:08:34-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/377/multi-ethnic-gwas-and-fine-mapping-of-glycaemic-traits-identify-novel-loci-in-the-page-study 2025-04-09T08:35:07-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/317/prevalence-and-spectrum-of-pathogenic-variants-among-patients-with-multiple-primary-cancers-evaluated-by-clinical-characteristics 2025-04-24T12:48:13-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/288/serial-changes-in-liquid-biopsy-derived-variant-allele-frequency-predict-immune-checkpoint-inhibitor-responsiveness-in-the-pan-cancer-setting 2025-04-09T07:33:34-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/315/suspected-clonal-hematopoiesis-as-a-natural-functional-assay-of-tp53-germline-variant-pathogenicity 2025-04-24T12:47:50-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/356/vhl-mosaicism-the-added-value-of-multi-tissue-analysis 2025-04-23T13:26:58-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/335/clinician-reported-impact-of-germline-multigene-panel-testing-on-cancer-risk-management-recommendations 2023-08-14T08:46:43-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/355/the-clinical-genome-resource-clingen-familial-hypercholesterolemia-variant-curation-expert-panel-consensus-guidelines-for-ldlr-variant-classification 2025-04-09T09:24:20-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/319/quantifying-evidence-toward-pathogenicity-for-rare-phenotypes-the-case-of-succinate-dehydrogenase-genes-sdhb-and-sdhd 2025-04-09T09:33:37-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/280/classification-of-the-canonical-splice-alteration-mutyh-c-934-2a-g-is-likely-benign-based-on-rna-and-clinical-data 2025-08-08T11:16:05-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/382/germline-pathogenic-variants-in-cancer-predisposition-genes-among-women-with-invasive-lobular-carcinoma-of-the-breast 2025-04-24T12:49:29-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/312/closing-the-gap-systematic-integration-of-multiplexed-functional-data-resolves-variants-of-uncertain-significance-in-brca1-tp53-and-pten 2025-04-23T13:27:45-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/334/association-of-family-cancer-history-with-pathogenic-variants-in-specific-breast-cancer-susceptibility-genes 2025-04-23T13:27:18-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/399/pura-related-developmental-and-epileptic-encephalopathy-phenotypic-and-genotypic-spectrum 2025-04-15T14:04:50-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/389/risk-of-late-onset-breast-cancer-in-genetically-predisposed-women 2025-04-24T12:50:12-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/341/different-fumarate-hydratase-gene-variants-are-associated-with-distinct-cancer-phenotypes 2025-04-24T12:44:00-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/371/novel-variants-in-kat6b-spectrum-of-disorders-expand-our-knowledge-of-clinical-manifestations-and-molecular-mechanisms 2025-04-15T14:06:35-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/310/rethinking-genetic-counseling-clinical-skills-training-in-the-time-of-covid-19 2025-04-09T08:37:49-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/336/a-durable-response-to-pembrolizumab-in-a-patient-with-uterine-serous-carcinoma-and-lynch-syndrome-due-to-the-msh6-germline-mutation 2023-07-24T10:54:45-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/276/racial-and-ethnic-differences-in-multigene-hereditary-cancer-panel-test-results-for-women-with-breast-cancer 2023-07-31T07:20:53-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/343/an-updated-quantitative-model-to-classify-missense-variants-in-the-tp53-gene-a-novel-multifactorial-strategy 2025-04-24T12:50:54-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/309/case-case-analysis-addressing-ascertainment-bias-for-multigene-panel-testing-implicates-brca1-and-palb2-in-endometrial-cancer 2025-04-24T12:48:43-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/338/paired-like-homeobox-gene-phox2b-nonpolyalanine-repeat-expansion-mutations-nparms-genotype-phenotype-correlation-in-congenital-central-hypoventilation-syndrome-cchs 2023-07-31T07:22:08-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/316/high-density-blood-transcriptomics-reveals-precision-immune-signatures-of-sars-cov-2-infection-in-hospitalized-individuals 2023-08-14T09:06:57-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/313/incidental-detection-of-acquired-variants-in-germline-genetic-and-genomic-testing-a-points-to-consider-statement-of-the-american-college-of-medical-genetics-and-genomics-acmg 2025-04-24T12:46:41-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/359/somatic-tumor-profile-analysis-in-a-patient-with-germline-pms2-mutation-and-synchronous-ovarian-and-uterine-carcinomas 2025-04-24T12:47:25-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/383/disruption-of-rfx-family-transcription-factors-causes-autism-attention-deficit-hyperactivity-disorder-intellectual-disability-and-dysregulated-behavior 2025-04-15T14:05:58-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/373/atp1a2-and-atp1a3-associated-early-profound-epileptic-encephalopathy-and-polymicrogyria 2025-04-15T14:02:57-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/368/harmonizing-the-collection-of-clinical-data-on-genetic-testing-requisition-forms-to-enhance-variant-interpretation-in-hypertrophic-cardiomyopathy-hcm-a-study-from-the-clingen-cardiomyopathy-variant-curation-expert-panel 2025-04-15T14:02:11-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/353/nubpl-mitochondrial-disease-new-patients-and-review-of-the-genetic-and-clinical-spectrum 2025-04-11T13:36:40-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/367/phenotypic-expansion-of-the-bptf-related-neurodevelopmental-disorder-with-dysmorphic-facies-and-distal-limb-anomalies 2025-04-18T13:14:43-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/352/pediatric-myelodysplastic-syndrome-with-germline-rras-mutation-expanding-the-phenotype-of-rasopathies 2025-04-24T13:00:30-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/342/real-world-integration-of-genomic-data-into-the-electronic-health-record-the-pennchart-genomics-initiative 2023-07-31T07:42:17-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/332/taok1-is-associated-with-neurodevelopmental-disorder-and-essential-for-neuronal-maturation-and-cortical-development 2025-04-15T14:03:48-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/298/breast-cancer-polygenic-risk-scores-in-the-clinical-cancer-genetic-counseling-setting-current-practices-and-impact-on-patient-management 2023-08-01T06:24:38-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/396/spen-haploinsufficiency-causes-a-neurodevelopmental-disorder-overlapping-proximal-1p36-deletion-syndrome-with-an-episignature-of-x-chromosomes-in-females 2025-04-15T14:07:13-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/340/backpack-health-reduces-data-sharing-barriers-between-the-medical-community-and-individuals-with-rare-diseases 2025-04-18T13:12:26-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/351/specifications-of-the-acmg-amp-variant-interpretation-guidelines-for-germline-tp53-variants 2025-04-24T13:00:56-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/395/mutation-specific-pathophysiological-mechanisms-define-different-neurodevelopmental-disorders-associated-with-satb1-dysfunction 2025-04-15T14:04:20-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/350/integration-of-functional-assay-data-results-provides-strong-evidence-for-classification-of-hundreds-of-brca1-variants-of-uncertain-significance 2025-04-24T12:59:14-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/252/strong-functional-data-for-pathogenicity-or-neutrality-classify-brca2-dna-binding-domain-variants-of-uncertain-significance 2025-04-24T12:54:37-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/348/echs1-disease-in-two-unrelated-families-of-samoan-descent-common-variant-rare-disorder 2025-04-18T13:10:58-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/301/discovery-of-a-neuromuscular-syndrome-caused-by-biallelic-variants-in-ascc3 2025-04-09T09:24:47-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/372/variants-in-the-sk2-channel-gene-kcnn2-lead-to-dominant-neurodevelopmental-movement-disorders 2025-04-11T13:41:32-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/277/histone-h3-3-beyond-cancer-germline-mutations-in-histone-3-family-3a-and-3b-cause-a-previously-unidentified-neurodegenerative-disorder-in-46-patients 2025-04-15T14:07:39-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/391/ovarian-and-breast-cancer-risks-associated-with-pathogenic-variants-in-rad51c-and-rad51d 2025-04-24T13:02:28-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/349/rna-seq-analysis-is-a-useful-tool-in-variant-classification 2025-04-24T12:57:36-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/354/validation-of-a-prostate-cancer-polygenic-risk-score 2025-04-24T12:57:56-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/274/facing-the-challenge-of-genetic-counselors-need-for-rapid-continuing-education-about-genomic-technologies 2023-07-06T05:22:36-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/362/a-second-cohort-of-chd3-patients-expands-the-molecular-mechanisms-known-to-cause-snijders-blok-campeau-syndrome 2025-04-23T13:16:16-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/251/genotype-phenotype-correlations-among-tp53-carriers-literature-review-and-analysis-of-probands-undergoing-multi-gene-panel-testing-and-single-gene-testing 2025-04-24T12:55:28-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/306/prevalence-of-germline-pathogenic-and-likely-pathogenic-variants-in-patients-with-second-breast-cancers 2023-07-31T07:09:38-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/394/genotype-phenotype-correlation-at-codon-1740-of-setd2 2025-04-18T13:11:30-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/347/tsc1-variant-associated-with-mild-or-absent-clinical-features-of-tuberous-sclerosis-complex-in-a-three-generation-family 2025-04-18T13:10:19-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/300/suggested-application-of-her2-breast-tumor-phenotype-for-germline-tp53-variant-classification-within-acmg-amp-guidelines 2025-04-24T13:01:22-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/304/a-rare-tp53-mutation-predominant-in-ashkenazi-jews-confers-risk-of-multiple-cancers 2025-04-24T12:58:47-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/250/paired-tumor-sequencing-and-germline-testing-in-breast-cancer-management-an-experience-of-a-single-academic-center 2025-02-19T09:20:27-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/344/clinical-validity-of-expanded-carrier-screening-evaluating-the-gene-disease-relationship-in-more-than-200-conditions 2025-04-24T12:53:30-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/339/points-to-consider-when-assessing-relationships-or-suspecting-misattributed-relationships-during-family-based-clinical-genomic-testing-a-statement-of-the-american-college-of-medical-genetics-and-genomics-acmg 2025-04-24T12:51:58-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/321/estimating-the-relative-frequency-of-leukodystrophies-and-recommendations-for-carrier-screening-in-the-era-of-next-generation-sequencing 2023-07-25T05:42:20-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/333/prevalence-of-pathogenic-variants-in-dna-damage-response-and-repair-genes-in-patients-undergoing-cancer-risk-assessment-and-reporting-a-personal-history-of-early-onset-renal-cancer 2025-04-24T13:02:05-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/273/curated-multiple-sequence-alignment-for-the-adenomatous-polyposis-coli-apc-gene-and-accuracy-of-in-silico-pathogenicity-predictions 2025-04-24T13:03:25-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/365/damaging-de-novo-missense-variants-in-eef1a2-lead-to-a-developmental-and-degenerative-epileptic-dyskinetic-encephalopathy 2025-04-18T13:11:58-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/337/reticular-dysgenesis-caused-by-an-intronic-pathogenic-variant-in-ak2 2025-04-18T13:15:24-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/279/the-evolution-of-constitutional-sequence-variant-interpretation 2025-08-08T11:16:25-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/248/mutation-prevalence-tables-for-hereditary-cancer-derived-from-multi-gene-panel-testing 2020-11-23T11:21:28-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/249/diagnosing-hereditary-cancer-predisposition-in-men-with-prostate-cancer 2020-11-23T11:20:14-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/247/the-contribution-of-germline-predisposition-gene-mutations-to-clinical-subtypes-of-invasive-breast-cancer-from-a-clinical-genetic-testing-cohort 2025-04-25T09:45:44-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/361/de-novo-and-inherited-variants-in-znf292-underlie-a-neurodevelopmental-disorder-with-features-of-autism-spectrum-disorder 2025-04-23T13:15:45-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/272/gene-family-information-facilitates-variant-interpretation-and-identification-of-disease-associated-genes-in-neurodevelopmental-disorders 2023-07-25T05:42:39-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/278/widening-of-the-genetic-and-clinical-spectrum-of-lamb-shaffer-syndrome-a-neurodevelopmental-disorder-due-to-sox5-haploinsufficiency 2025-04-09T09:39:22-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/297/differences-in-patient-ascertainment-affect-the-use-of-gene-specified-acmg-amp-phenotype-related-variant-classification-criteria-evidence-for-tp53 2023-07-31T07:30:37-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/244/splicing-profile-by-capture-rna-seq-identifies-pathogenic-germline-variants-in-tumor-suppressor-genes 2025-04-25T09:37:23-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/246/rare-brip1-missense-alleles-confer-risk-for-ovarian-and-breast-cancer 2025-04-25T09:46:53-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/245/rare-germline-pathogenic-mutations-of-dna-repair-genes-are-most-strongly-asssociated-with-grade-group-5-prostate-cancer 2020-11-23T11:13:35-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/275/facilitated-referral-pathway-for-genetic-testing-at-the-time-of-ovarian-cancer-diagnosis-uptake-of-genetic-counseling-and-testing-and-impact-on-patient-reported-stress-anxiety-and-depression 2023-07-31T07:29:23-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/363/mn1-c-terminal-truncation-syndrome-is-a-novel-neurodevelopmental-and-craniofacial-disorder-with-partial-rhombencephalosynapsis 2025-04-18T13:15:58-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/271/loss-of-function-mutations-in-udp-glucose-6-dehydrogenase-cause-recessive-developmental-epileptic-encephalopathy 2025-05-21T07:10:12-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/107/when-moments-matters-finding-answers-with-rapid-exome-sequencing 2020-11-23T11:05:47-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/488/identification-of-genetic-heterogeneity-of-alzheimer-s-disease-across-age 2025-11-12T07:28:47-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/130/cancer-risks-associated-with-germline-palb2-pathogenic-variants-an-international-study-of-524-families 2025-04-25T09:44:02-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/345/targeting-cellular-heterogeneity-with-cxcr2-blockade-for-the-treatment-of-therapy-resistant-prostate-cancer 2023-07-31T07:31:47-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/101/classification-of-variants-of-uncertain-significance-in-brca1-and-brca2-using-personal-and-family-history-of-cancer-from-individuals-in-a-large-hereditary-cancer-multigene-panel-testing-cohort 2025-04-25T09:36:25-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/35/germline-variants-in-cancer-genes-in-high-risk-non-brca-patients-from-puerto-rico 2020-11-23T10:57:38-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/139/clinical-diagnostic-exome-sequencing-in-dystonia-genetic-testing-challenges-for-complex-conditions 2025-04-23T13:24:24-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/241/assessment-of-diagnostic-outcomes-of-rna-genetic-testing-for-hereditary-cancer 2025-04-25T09:46:02-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/93/comparison-of-somatic-and-germline-variant-interpretation-in-hereditary-cancer-genes 2025-04-24T13:03:43-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/239/revel-and-bayesdel-outperform-other-in-silico-meta-predictors-for-clinical-variant-classification 2025-04-25T09:43:36-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/237/de-novo-missense-variants-in-fbxw11-cause-diverse-developmental-phenotypes-including-brain-eye-and-digit-anomalies 2025-04-23T13:16:43-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/238/de-novo-variants-in-slc12a6-cause-sporadic-early-onset-progressive-sensorimotor-neuropathy 2025-04-22T11:38:52-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/75/magel2-related-disorders-a-study-and-case-series 2025-04-23T13:22:19-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/236/tumour-characteristics-provide-evidence-for-germline-mismatch-repair-variant-pathogenicity 2025-04-25T09:43:07-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/235/a-clinical-guide-to-hereditary-cancer-panel-testing-evaluation-of-gene-specific-cancer-associations-and-sensitivity-of-genetic-testing-criteria-in-a-cohort-of-165-000-high-risk-patients 2024-08-06T12:30:36-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/230/de-novo-variants-disturbing-the-transactivation-capacity-of-pou3f3-cause-a-characteristic-neurodevelopmental-disorder 2025-04-23T13:22:45-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/240/genetics-of-gastric-cancer-what-do-we-know-about-the-genetic-risks 2020-11-18T13:47:38-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/231/clinical-features-and-cancer-risk-in-families-with-pathogenic-cdh1-variants-irrespective-of-clinical-criteria 2025-04-25T09:40:04-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/228/son-haploinsufficiency-causes-impaired-pre-mrna-splicing-of-cakut-genes-and-heterogeneous-renal-phenotypes 2025-04-23T13:23:46-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/232/p53-major-hotspot-variants-are-associated-with-poorer-prognostic-features-in-hereditary-cancer-patients 2025-04-25T09:41:59-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/233/an-alternative-approach-to-establishing-unbiased-colorectal-cancer-risk-estimation-in-lynch-syndrome 2025-04-25T09:46:25-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/234/impact-of-rna-testing-on-cardiac-variant-interpretation-and-patient-management 2025-04-09T09:35:40-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/227/a-recurrent-missense-variant-in-ap2m1-impairs-clathrin-mediated-endocytosis-and-causes-developmental-and-epileptic-encephalopathy 2025-04-23T13:23:17-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/225/recontact-practices-of-cancer-genetic-counselors-and-an-exploration-of-professional-legal-and-ethical-duty 2020-11-05T09:30:08-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/226/genotype-phenotype-associations-among-panel-based-tp53-subjects 2025-04-25T09:45:21-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/229/mouse-screen-reveals-multiple-new-genes-underlying-mouse-and-human-hearing-loss 2025-04-23T13:17:24-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/224/family-communication-and-patient-distress-after-germline-genetic-testing-in-individuals-with-pancreatic-ductal-adenocarcinoma 2020-11-05T09:10:38-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/223/prevalence-of-germline-variants-in-inflammatory-breast-cancer 2020-11-05T09:06:16-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/219/clinical-validity-assessment-of-genes-for-inclusion-in-multi-gene-panel-testing-a-systematic-approach 2020-10-28T10:44:30-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/220/a-retrospective-review-of-multiple-findings-in-diagnostic-exome-sequencing-half-are-distinct-and-half-are-overlapping-diagnoses 2025-04-25T09:41:31-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/222/alternative-splicing-and-acmg-amp-2015-based-classification-of-palb2-genetic-variants-an-enigma-report 2025-04-25T09:39:23-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/216/clinical-spectrum-of-stx1b-related-epileptic-disorders 2025-04-11T13:35:22-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/218/slc35a2-cdg-functional-characterization-expanded-molecular-clinical-and-biochemical-phenotypes-of-30-unreported-individuals 2025-04-23T13:21:03-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/214/the-spectrum-of-genetic-testing 2019-03-06T10:20:42-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/211/comprehensive-paired-tumor-germline-testing-for-lynch-syndrome-bringing-resolution-to-the-diagnostic-process 2020-10-28T09:36:06-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/212/rna-genetic-testing-identifies-germline-pathogenic-msh2-tandem-duplications-in-lynch-syndrome-patients 2025-04-25T09:42:33-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/217/spatially-clustering-de-novo-variants-in-cyfip2-encoding-the-cytoplasmic-fmrp-interacting-protein-2-cause-intellectual-disability-and-seizures 2025-04-23T13:17:50-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/209/mutations-in-map3k1-that-cause-46-xy-disorders-of-sex-development-disrupt-distinct-structural-domains-in-the-protein 2025-04-23T13:21:53-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/203/novel-mutations-in-the-mitochondrial-complex-i-assembly-gene-ndufaf5-reveal-heterogeneous-phenotypes 2025-08-19T06:50:06-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/210/de-novo-variants-in-mapk8ip3-cause-intellectual-disability-with-variable-brain-anomalies 2025-05-21T07:09:37-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/486/association-between-invasive-lobular-breast-cancer-and-mutations-in-the-mismatch-repair-gene-msh6-reply 2025-11-12T07:16:21-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/208/women-with-breast-and-uterine-cancer-are-more-likely-to-harbor-germline-mutations-than-women-with-breast-or-uterine-cancer-alone-a-case-for-expanded-gene-testing 2020-10-22T10:07:36-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/215/biallelic-vars-variants-cause-developmental-encephalopathy-with-microcephaly-that-is-recapitulated-in-vars-knockout-zebrafish 2025-04-23T13:18:21-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/201/detection-of-structural-variation-using-target-captured-next-generation-sequencing-data-for-genetic-diagnostic-testing 2025-05-21T06:53:23-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/207/an-additional-case-of-hennekam-lymphagiectasia-lymphedema-syndrome-caused-by-loss-of-function-mutation-in-adamts3 2025-08-19T06:49:23-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/200/monoallelic-mutyh-carrier-status-is-not-associated-with-increased-breast-cancer-risk-in-a-multigene-panel-cohort 2025-05-21T07:29:58-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/202/prevalence-of-germline-mutations-in-polyposis-and-colorectal-cancer-associated-genes-in-patients-with-multiple-colorectal-polyps 2023-07-31T07:08:53-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/205/biallelic-disruption-of-pkdcc-causes-a-skeletal-disorder-characterized-by-rhizomelic-shortening-of-extremities-and-dysmorphic-features 2025-08-19T06:45:37-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/213/hcn1-mutation-spectrum-from-neonatal-epileptic-encephalopathy-to-benign-generalized-epilepsy-and-beyond 2025-05-21T07:08:54-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/204/de-novo-mutations-in-the-gtp-gdp-binding-region-of-rala-a-ras-like-small-gtpase-cause-intellectual-disability-and-developmental-delay 2025-05-21T07:07:13-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/191/specifications-of-the-acmg-amp-variant-curation-guidelines-for-the-analysis-of-germline-cdh1-sequence-variants 2025-06-18T05:50:30-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/190/clinical-whole-exome-sequencing-results-impact-medical-management 2025-05-21T06:49:01-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/206/a-recurrent-de-novo-heterozygous-cog4-substitution-leads-to-saul-wilson-syndrome-disrupted-vesicular-trafficking-and-altered-proteoglycan-glycosylation 2025-08-19T06:48:50-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/194/scaling-resolution-of-variant-classification-differences-in-clinvar-between-41-clinical-laboratories-through-an-outlier-approach 2025-05-21T06:52:34-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/192/the-current-genetic-landscape-of-triple-negative-breast-cancer 2020-10-22T09:28:56-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/197/two-missense-variants-detected-in-breast-cancer-probands-preventing-brca2-palb2-protein-interaction 2020-10-22T09:29:49-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/242/breast-cancer-risk-in-neurofibromatosis-type-1-is-a-function-of-the-type-of-nf1-gene-mutation-a-new-genotype-phenotype-correlation 2020-10-22T09:37:45-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/196/gene-specific-criteria-for-pten-variant-curation-recommendations-from-the-clingen-pten-expert-panel 2025-05-08T07:59:46-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/199/misattributed-parentage-as-an-unanticipated-finding-during-exome-genome-sequencing-current-clinical-laboratory-practices-and-an-opportunity-for-standardization 2025-05-21T06:50:13-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/187/a-bayesian-framework-for-efficient-and-accurate-variant-prediction 2025-05-08T07:57:51-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/180/syt1-associated-neurodevelopmental-disorder-a-case-series 2025-05-21T07:05:50-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/188/iqsec2-related-encephalopathy-in-males-and-females-a-comparative-study-including-37-novel-patients 2025-05-21T07:06:35-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/189/recommendations-for-interpreting-the-loss-of-function-pvs1-acmg-amp-variant-criterion 2025-05-08T07:59:03-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/159/clinical-germline-diagnostic-exome-sequencing-for-hereditary-cancer-findings-within-novel-candidate-genes-are-prevalent-human-molecular-genetics 2025-04-25T09:47:55-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/186/de-novo-mutations-of-ccnk-cause-a-syndromic-neurodevelopmental-disorder-with-distinctive-facial-dysmorphism 2025-04-25T09:48:41-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/178/association-of-breast-and-ovarian-cancers-with-predisposition-genes-identified-by-large-scale-sequencing 2025-05-21T07:21:03-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/177/triple-negative-breast-cancer-risk-genes-identified-by-multigene-hereditary-cancer-panel-testing 2025-05-21T07:28:00-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/176/prospective-study-of-germline-genetic-testing-in-incident-cases-of-pancreatic-adenocarcinom 2024-08-06T12:27:01-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/167/dna-breakpoint-assay-reveals-a-majority-of-gross-duplications-occur-in-tandem-reducing-vus-classifications-in-breast-cancer-predisposition-genes 2025-05-21T07:28:44-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/170/multigene-hereditary-cancer-panels-reveal-high-risk-pancreatic-cancer-susceptibility-genes 2025-05-21T07:26:44-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/166/quantitative-analysis-of-brca1-and-brca2-germline-splicing-variants-using-a-novel-rna-massively-parallel-sequencing-assay 2025-06-18T05:49:29-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/175/mylk-pathogenic-variants-aortic-disease-presentation-pregnancy-risk-and-characterization-of-pathogenic-missense-variants 2020-10-09T09:46:22-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/181/de-novo-itpr1-variants-are-a-recurrent-cause-of-early-onset-ataxia-acting-via-loss-of-channel-function 2025-04-25T09:48:19-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/182/de-novo-variants-in-neurodevelopmental-disorders-with-epilepsy 2025-05-21T07:02:31-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/185/expanding-the-phenotypic-spectrum-associated-with-ophn1-variants 2025-05-21T07:07:58-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/183/de-novo-and-inherited-loss-of-function-variants-in-tlk2-clinical-and-genotype-phenotype-evaluation-of-a-distinct-neurodevelopmental-disorder 2025-05-21T07:04:47-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/171/advocating-for-the-consumer-clinical-confirmation-of-all-direct-to-consumer-raw-data-alterations-remains-critical 2025-05-21T06:51:44-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/253/clinical-and-molecular-characteristics-of-nf1-pathogenic-variants-identified-on-hereditary-cancer-multi-gene-panels 2021-02-22T10:22:27-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/174/hereditary-lobular-breast-cancer-with-an-emphasis-on-e-cadherin-genetic-defect 2025-06-18T05:51:57-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/160/functional-variants-in-tbx2-are-associated-with-a-syndromic-cardiovascular-and-skeletal-developmental-disorder 2025-04-22T11:40:45-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/198/de-novo-variants-in-klf7-are-a-potential-novel-cause-of-developmental-delay-intellectual-disability-neuromuscular-and-psychiatric-symptoms 2025-05-21T07:11:39-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/173/a-novel-de-novo-cdh1-germline-variant-aids-in-the-classification-of-c-terminal-e-cadherin-alterations-predicted-to-escape-nonsense-mediated-mrna-decay 2025-02-19T08:41:30-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/164/improved-acmg-compliant-in-silico-prediction-of-pathogenicity-for-missense-substitutions-encoded-by-tp53-variants 2025-05-21T07:29:24-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/165/efficient-detection-of-copy-number-mutations-in-pms2-exons-with-close-homologs-detection-of-copy-number-variants-in-3-pms2-exons 2018-07-06T13:54:03-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/172/delineating-a-new-feature-of-constitutional-mismatch-repair-deficiency-cmmrd-syndrome-breast-cancer 2020-10-08T13:22:46-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/184/genetic-disorders-and-mortality-in-infancy-and-early-childhood-delayed-diagnoses-and-missed-opportunities 2025-05-21T06:50:58-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/162/whole-exome-sequencing-uncovers-oxidoreductases-dhtkd1-and-ogdhl-as-linkers-between-mitochondrial-dysfunction-and-eosinophilic-esophagitis 2020-10-08T13:01:09-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/158/biallelic-mutations-in-pmpcb-encoding-the-catalytic-subunit-of-the-mitochondrial-presequence-protease-cause-neurodegeneration-with-cerebellar-atrophy-in-early-childhood 2025-05-21T07:03:25-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/161/mutations-in-scn3a-cause-early-infantile-epileptic-encephalopathy 2025-05-21T07:04:05-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/154/tumornext-lynch-mmr-a-comprehensive-next-generation-sequencing-assay-for-the-detection-of-germline-and-somatic-mutations-in-genes-associated-with-mismatch-repair-deficiency-and-lynch-syndrome 2024-08-06T12:22:43-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/163/diagnostic-exome-sequencing-identifies-gli2-haploinsufficiency-and-chromosome-20-uniparental-disomy-in-a-patient-with-developmental-anomalies 2025-08-19T06:45:00-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/147/exome-sequencing-in-neonates-diagnostic-rates-characteristics-and-time-to-diagnosis 2025-05-08T07:54:02-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/146/false-positive-results-released-by-direct-to-consumer-genetic-tests-highlight-the-importance-of-clinical-confirmation-testing-for-appropriate-patient-care 2024-08-06T12:23:02-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/155/the-acmg-amp-reputable-source-criteria-for-the-interpretation-of-sequence-variants 2025-05-08T07:56:47-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/152/defining-the-phenotypic-spectrum-of-slc6a1-mutations 2025-04-22T11:39:57-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/157/clinical-and-genetic-spectrum-of-ampd2-related-pontocerebellar-hypoplasia-type-9 2025-04-25T09:49:28-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/156/differences-in-tp53-mutation-carrier-phenotypes-emerge-from-panel-based-testing 2025-04-25T09:47:25-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/142/missense-variants-in-rhobtb2-cause-a-developmental-and-epileptic-encephalopathy-in-humans-and-altered-levels-cause-neurological-defects-in-drosophila 2025-04-23T13:11:13-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/140/biallelic-mutations-in-fut8-cause-a-congenital-disorder-of-glycosylation-with-defective-fucosylation 2025-08-08T12:25:13-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/153/functional-dysregulation-of-cdc42-causes-diverse-developmental-phenotypes 2025-04-25T09:49:05-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/127/biallelic-mutations-in-the-ferredoxin-reductase-gene-cause-novel-mitochondriopathy-with-optic-atrophy 2025-04-11T13:40:00-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/141/de-novo-variants-in-gria4-lead-to-intellectual-disability-with-or-without-seizures-and-gait-abnormalities 2025-04-11T13:39:14-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/105/cancer-genetic-counseling-and-testing-in-an-era-of-rapid-change 2020-10-08T10:58:08-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/144/de-novo-mutations-in-protein-kinase-genes-camk2a-and-camk2b-cause-intellectual-disability 2025-04-23T13:10:10-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/179/kufor-rakeb-syndrome-due-to-a-novel-atp13a2-mutation-in-2-chinese-american-brothers 2025-04-23T13:09:16-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/124/de-novo-missense-mutations-in-dhx30-impair-global-translation-and-cause-a-neurodevelopmental-disorder 2025-05-21T07:18:29-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/143/somatic-tp53-variants-frequently-confound-germline-testing-results 2020-10-08T11:30:40-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/121/frequency-of-mutations-in-a-large-series-of-clinically-ascertained-ovarian-cancer-cases-tested-on-multi-gene-panels-compared-to-reference-controls 2020-10-08T10:28:28-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/126/de-novo-variants-in-the-alternative-exon-5-of-scn8a-cause-epileptic-encephalopathy 2025-04-23T13:09:45-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/128/de-novo-mutations-in-ppp3ca-cause-severe-neurodevelopmental-disease-with-seizures 2025-04-23T13:07:59-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/129/haploinsufficiency-of-the-chromatin-remodeler-bptf-causes-syndromic-developmental-and-speech-delay-postnatal-microcephaly-and-dysmorphic-features 2025-04-23T13:08:40-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/110/clinical-laboratories-collaborate-to-resolve-differences-in-variant-interpretations-submitted-to-clinvar 2025-05-21T06:55:08-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/104/biallelic-loss-of-function-variants-in-dock3-cause-muscle-hypotonia-ataxia-and-intellectual-disability 2025-05-21T07:14:31-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/102/pten-promoter-variants-are-not-associated-with-common-cancers-implications-for-multigene-panel-testing 2017-11-07T19:23:11-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/120/next-generation-deep-sequencing-corrects-diagnostic-pitfalls-of-traditional-molecular-approach-in-a-patient-with-prenatal-onset-of-pompe-disease 2025-08-19T06:54:40-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/125/delineating-sptan1-associated-phenotypes-from-isolated-epilepsy-to-encephalopathy-with-progressive-brain-atrophy 2025-04-23T13:10:46-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/114/expansion-and-further-delineation-of-the-setd5-phenotype-leading-to-global-developmental-delay-variable-dysmorphic-features-and-reduced-penetrance 2025-04-22T11:43:14-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/131/the-role-of-iqsec2-in-syndromic-intellectual-disability-narrowing-the-diagnostic-odyssey 2025-04-22T11:42:41-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/132/heterozygous-de-novo-ubtf-gain-of-function-variant-is-associated-with-neurodegeneration-in-childhood 2025-04-22T11:42:14-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/133/post-mortem-diagnostic-exome-sequencing-identifies-a-de-novo-tubb3-alteration-in-a-newborn-with-prenatally-diagnosed-hydrocephalus-and-suspected-walker-warburg-syndrome 2025-04-22T11:41:09-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/122/the-role-of-genetic-testing-in-epilepsy-diagnosis-and-management 2025-05-21T07:13:49-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/117/kinetic-and-structural-changes-in-hsmtphers-induced-by-pathogenic-mutations-in-human-fars2 2025-08-19T06:50:35-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/99/advances-in-the-diagnosis-of-hereditary-kidney-cancer-initial-results-of-a-multigene-panel-test 2025-05-21T07:24:24-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/111/dnm1-encephalopathy-a-new-disease-of-vesicle-fission 2025-05-21T07:12:33-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/118/male-patients-affected-by-mosaic-pcdh19-mutations-5-new-cases 2025-05-21T07:10:52-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/136/grin2b-encephalopathy-novel-findings-on-phenotype-variant-clustering-functional-consequences-and-treatment-aspects 2025-05-21T07:17:51-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/106/clinical-diagnostic-exome-evaluation-for-an-infant-with-a-lethal-disorder-genetic-diagnosis-of-tarp-syndrome-and-expansion-of-the-phenotype-in-a-patient-with-a-newly-reported-rbm10-alteration 2025-04-09T09:38:07-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/115/foxg1-syndrome-genotype-phenotype-association-in-83-patients-with-foxg1-variants 2025-04-22T11:43:45-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/134/yy1-haploinsufficiency-causes-an-intellectual-disability-syndrome-featuring-transcriptional-and-chromatin-dysfunction 2025-04-22T11:41:51-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/109/deficiency-of-wars2-encoding-mitochondrial-tryptophanyl-trna-synthetase-causes-severe-infantile-onset-leukoencephalopathy 2025-08-19T06:55:12-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/108/colon-pathology-characteristics-in-li-fraumeni-syndrome 2017-11-28T17:17:22-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/7/classification-of-genes-standardized-clinical-validity-assessment-of-gene-disease-associations-aids-diagnostic-exome-analysis-and-reclassifications 2025-05-21T06:57:06-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/135/choices-for-return-of-primary-and-secondary-genomic-research-results-of-790-members-of-families-with-mendelian-disease 2025-05-21T06:57:55-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/151/a-survey-of-current-practices-for-genomic-sequencing-test-interpretation-and-reporting-processes-in-us-laboratories 2025-07-24T13:50:46-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/119/mild-orotic-aciduria-in-umps-heterozygotes-a-metabolic-finding-without-clinical-consequences 2025-08-19T06:50:55-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/137/genetic-and-phenotypic-heterogeneity-suggest-therapeutic-implications-in-scn2a-related-disorders 2025-05-21T07:15:11-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/270/further-evidence-that-de-novo-missense-and-truncating-variants-in-zbtb18-cause-intellectual-disability-with-variable-features 2025-07-24T13:49:25-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/100/multigene-panel-testing-provides-a-new-perspective-on-lynch-syndrome 2019-01-18T13:24:00-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/2/associations-between-cancer-predisposition-testing-panel-genes-and-breast-cancer 2020-10-07T13:08:30-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/112/efforts-toward-consensus-variant-interpretation-by-commercial-laboratories 2025-05-21T06:54:06-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/123/unexpected-cdh1-mutations-identified-on-multi-gene-panels-pose-clinical-management-challenges 2020-10-07T13:03:35-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/113/exome-sequencing-covers-98-of-mutations-identified-on-targeted-next-generation-sequencing-panels 2025-05-21T06:59:43-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/138/reply-to-gan-or-and-colleagues-and-manole-and-colleagues 2025-05-21T07:15:59-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/264/the-clinical-utility-of-next-generation-sequencing-results-in-a-community-based-hereditary-cancer-risk-program 2023-07-31T07:05:20-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/267/male-breast-cancer-in-a-multi-gene-panel-testing-cohort-insights-and-unexpected-results 2025-07-24T13:22:38-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/6/outcomes-of-diagnostic-exome-sequencing-in-patients-with-diagnosed-or-suspected-autism-spectrum-disorders 2025-05-21T07:17:16-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/8/characterization-of-a-caveolin-1-mutation-associated-with-both-pah-and-congenital-generalized-lipodystrophy 2025-07-24T12:56:20-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/90/sanger-confirmation-is-required-to-achieve-optimal-sensitivity-and-specificity-in-next-generation-sequencing-panel-testing 2025-05-21T07:01:35-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/258/development-implementation-and-assessment-of-a-genetics-curriculum-across-institutions 2023-06-01T06:42:41-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/261/a-recurrent-mutation-in-kcna2-as-a-novel-cause-of-hereditary-spastic-paraplegia-and-ataxia 2025-06-18T06:07:08-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/43/beyond-dna-an-integrated-and-functional-approach-for-classifying-germline-variants-in-breast-cancer-genes 2025-07-24T13:24:16-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/256/tumornext-a-comprehensive-tumor-profiling-assay-that-incorporates-high-resolution-copy-number-analysis-and-germline-status-to-improve-testing-accuracy 2023-05-31T13:01:03-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/263/patient-and-genetic-counselor-perceptions-of-in-person-versus-telephone-genetic-counseling-for-hereditary-breast-ovarian-cancer 2023-06-01T13:02:54-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/259/the-dynamics-of-a-genetic-counseling-peer-supervision-group 2023-06-01T07:14:42-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/269/de-novo-missense-variants-in-ppp1cb-are-associated-with-intellectual-disability-and-congenital-heart-disease 2025-07-24T13:34:15-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/10/diagnostic-exome-sequencing-provides-a-molecular-diagnosis-for-a-significant-proportion-of-patients-with-epilepsy 2025-05-21T07:19:49-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/268/de-novo-mutations-in-son-disrupt-rna-splicing-of-genes-essential-for-brain-development-and-metabolism-causing-an-intellectual-disability-syndrome 2025-07-24T13:30:55-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/260/loss-of-synj1-dual-phosphatase-activity-leads-to-early-onset-refractory-seizures-and-progressive-neurological-decline 2025-06-18T06:03:03-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/262/phenotypic-spectrum-of-gabra1-from-generalized-epilepsies-to-severe-epileptic-encephalopathies 2025-07-24T13:06:25-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/265/breast-cancer-risk-is-similar-for-chek2-founder-and-non-founder-mutation-carriers 2025-07-24T13:17:19-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/9/candidate-gene-criteria-for-clinical-reporting-diagnostic-exome-sequencing-identifies-altered-candidate-genes-among-8-of-patients-with-undiagnosed-diseases 2025-06-18T06:00:02-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/487/current-state-of-theoretical-and-experimental-studies-of-the-voltage-dependent-anion-channel-vdac 2025-11-12T07:21:59-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/266/genetic-basis-of-cowden-syndrome-and-its-implications-for-clinical-practice-and-risk-management 2025-07-24T13:18:09-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/257/performance-of-acmg-amp-variant-interpretation-guidelines-among-nine-laboratories-in-the-clinical-sequencing-exploratory-research-consortium 2025-05-21T07:00:44-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/86/de-novo-mutations-of-kiaa2022-in-females-cause-intellectual-disability-and-intractable-epilepsy 2025-05-21T07:19:07-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/27/combined-genetic-and-splicing-analysis-of-brca1-c-594-2a-c-641a-g-highlights-the-relevance-of-naturally-occurring-in-frame-transcripts-for-developing-disease-gene-variant-classification-algorithms 2025-07-24T13:13:56-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/77/identification-of-a-syndrome-comprising-microcephaly-and-intellectual-disability-but-not-white-matter-disease-associated-with-a-homozygous-c-676c-t-p-r226w-deaf1-mutation 2023-08-02T07:24:25-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/76/stxbp1-encephalopathy-a-neurodevelopmental-disorder-including-epilepsy 2025-06-18T06:01:08-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/81/improving-the-molecular-diagnosis-and-treatment-of-epilepsy-with-complex-genetic-testing 2023-08-02T07:23:17-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/67/cltc-as-a-clinically-novel-gene-associated-with-multiple-malformations-and-developmental-delay 2025-07-24T13:28:44-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/71/pogz-truncating-alleles-cause-syndromic-intellectual-disability 2025-06-18T05:58:53-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/82/delineating-the-grin1-phenotypic-spectrum-a-distinct-genetic-nmda-receptor-encephalopathy 2025-06-18T06:02:02-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/83/three-cases-of-troyer-syndrome-in-two-families-of-filipino-descent 2025-07-24T12:24:34-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/87/loss-of-function-of-the-retinoid-related-nuclear-receptor-rorb-gene-and-epilepsy 2025-07-24T13:33:19-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/84/autosomal-recessive-mutations-in-thoc6-cause-intellectual-disability-syndrome-delineation-requiring-forward-and-reverse-phenotyping 2025-07-24T12:43:41-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/85/brat1-mutations-present-with-a-spectrum-of-clinical-severity 2025-06-18T06:03:50-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/28/next-generation-sequencing-and-applications-to-the-diagnosis-and-treatment-of-lung-cancer 2020-10-05T13:54:06-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/5/mutations-in-rasa1-and-gdf2-identified-in-patients-with-clinical-features-of-hereditary-hemorrhagic-telangiectasia 2025-08-08T10:43:26-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/14/exome-sequencing-positively-identified-relevant-alterations-in-more-than-half-of-cases-with-an-indication-of-prenatal-ultrasound-anomalies 2025-08-08T10:46:43-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/12/diagnostic-exome-sequencing-for-patients-with-a-family-history-of-consanguinity-over-38-of-positive-results-are-not-autosomal-recessive-pattern 2020-10-05T13:48:41-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/13/clingen-and-genetic-testing 2025-08-08T10:50:01-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/11/diagnostic-exome-sequencing-identifies-a-novel-gene-emilin1-associated-with-autosomal-dominant-hereditary-connective-tissue-disease 2025-07-24T13:26:43-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/148/multi-gene-panel-testing-detects-equal-rates-of-pathogenic-brca1-2-mutations-and-has-a-higher-diagnostic-yield-compared-to-limited-brca1-2-analysis-alone-in-patients-at-risk-for-hereditary-breast-cancer 2019-01-16T14:20:34-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/34/processed-pseudogene-confounding-deletion-duplication-assays-for-smad4 2025-08-08T10:48:52-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/79/wac-loss-of-function-mutations-cause-a-recognisable-syndrome-characterised-by-dysmorphic-features-developmental-delay-and-hypotonia-and-recapitulate-10p11-23-microdeletion-syndrome 2025-08-08T10:44:46-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/150/the-escherichia-coli-narl-receiver-domain-regulates-transcription-through-promoter-specific-functions 2025-07-24T13:52:33-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/18/elp2-is-a-novel-gene-implicated-in-neurodevelopmental-disabilities 2023-08-02T07:19:36-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/17/new-insights-into-the-genetics-of-fetal-megacystis-actg2-mutations-encoding-2-smooth-muscle-actin-in-megacystis-microcolon-intestinal-hypoperistalsis-syndrome-berdon-syndrome 2025-08-08T10:50:53-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/94/not-all-next-generation-sequencing-diagnostics-are-created-equal-understanding-the-nuances-of-solid-tumor-assay-design-for-somatic-mutation-detection 2025-07-24T13:53:16-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/16/progressive-movement-disorder-in-brothers-carrying-a-gnao1-mutation-responsive-to-deep-brain-stimulation 2025-08-08T10:44:03-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/30/rescreening-for-genetic-mutations-using-multi-gene-panel-testing-in-patients-who-previously-underwent-non-informative-genetic-screening 2020-10-05T12:50:39-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/15/whole-exome-sequencing-as-a-diagnostic-tool-in-a-family-with-episodic-ataxia-type-1 2025-08-08T10:44:23-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/32/the-importance-of-proper-bioinformatics-analysis-and-clinical-interpretation-of-tumor-genomic-profiling-a-case-study-of-undifferentiated-sarcoma-and-a-constitutional-pathogenic-brca2-mutation-and-an-mlh1-variant-of-uncertain-significance 2025-08-08T10:49:09-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/63/array-cgh-is-an-effective-first-tier-diagnostic-test-for-eftud2-associated-congenital-mandibulofacial-dysostosis-with-microcephaly-mfdm 2025-08-08T10:51:22-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/78/germline-activating-mtor-mutation-arising-through-gonadal-mosaicism-in-two-brothers-with-megalencephaly-and-neurodevelopmental-abnormalities 2025-08-08T10:50:20-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/36/hereditary-predisposition-to-ovarian-cancer-looking-beyond-brca1-brca2 2025-08-08T10:48:36-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/29/response-to-cragun-et-al 2025-08-08T10:49:27-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/31/patient-experiences-living-with-pancreatic-cancer-risk 2020-10-02T09:19:56-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/40/panel-based-testing-for-inherited-colorectal-cancer-a-descriptive-study-of-clinical-testing-performed-by-a-u-s-laboratory 2020-10-02T09:21:32-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/21/enhanced-utility-of-family-centered-diagnostic-exome-sequencing-with-inheritance-model-based-analysis-results-from-500-unselected-families-with-undiagnosed-genetic-conditions 2025-08-08T10:53:37-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/42/factors-which-impact-the-delivery-of-genetic-risk-assessment-services-focused-on-inherited-cancer-genomics-expanding-the-role-and-reach-of-certified-genetics-professionals 2020-10-02T09:50:47-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/73/rodriguez-syndrome-with-sf3b4-mutation-a-severe-form-of-nager-syndrome 2020-10-01T11:36:42-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/20/expanding-the-clinical-and-mutational-spectrum-of-kaufman-oculocerebrofacial-syndrome-with-biallelic-ube3b-mutations 2025-08-08T10:54:05-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/23/diagnostic-exome-sequencing-identifies-two-novel-iqsec2-mutations-associated-with-x-linked-intellectual-disability-with-seizures-implications-for-genetic-counseling-and-clinical-diagnosis 2025-08-08T10:54:33-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/19/congenital-lethal-motor-neuron-disease-with-a-novel-defect-in-ribosome-biogenesis 2025-08-08T11:00:51-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/22/diagnostic-exome-sequencing-and-tailored-bioinformatics-of-the-parents-of-a-deceased-child-with-cobalamin-deficiency-suggests-digenic-inheritance-of-the-mtr-and-lmbrd1-genes 2025-08-08T10:48:18-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/80/development-of-a-genomic-dna-reference-material-panel-for-rett-syndrome-mecp2-related-disorders-genetic-testing 2025-08-08T10:53:00-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/41/genetic-and-clinical-determinants-of-constitutional-mismatch-repair-deficiency-syndrome-report-from-the-constitutional-mismatch-repair-deficiency-consortium 2025-08-08T10:54:56-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/45/molecular-testing-for-cystic-fibrosis-carrier-status-practice-guidelines-recommendations-of-the-national-society-of-genetic-counselors 2025-08-08T10:52:23-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/38/the-validation-and-clinical-implementation-of-brcaplus-a-comprehensive-high-risk-breast-cancer-diagnostic-assay 2025-08-08T10:55:35-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/65/clinical-report-of-a-17q12-microdeletion-with-additionally-unreported-clinical-features 2025-08-08T10:53:16-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/33/isolated-trisomy-2-in-bone-marrows-of-patients-with-suspected-hematopoietic-malignancies 2020-09-30T14:26:11-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/39/utilization-of-multigene-panels-in-hereditary-cancer-predisposition-testing-analysis-of-more-than-2-000-patients 2025-08-08T10:52:40-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/88/comprehensive-functional-analysis-of-chymotrypsin-c-ctrc-variants-reveals-distinct-loss-of-function-mechanisms-associated-with-pancreatitis-risk 2025-08-08T11:01:23-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/24/patient-decisions-for-disclosure-of-secondary-findings-among-the-first-200-individuals-undergoing-clinical-diagnostic-exome-sequencing 2020-09-30T14:09:21-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/25/a-human-de-novo-mutation-in-myh10-phenocopies-the-loss-of-function-mutation-in-mice 2025-08-08T11:02:28-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/26/mutation-in-snap25-as-a-novel-genetic-cause-of-epilepsy-and-intellectual-disability 2025-08-08T11:02:49-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/47/novel-cftr-variants-identified-during-the-first-3-years-of-cystic-fibrosis-newborn-screening-in-california 2025-08-08T11:01:44-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/48/impact-of-ivs8-tg-m-t-n-on-irt-and-sweat-chloride-levels-in-newborns-identified-by-california-cf-newborn-screening 2025-08-08T11:04:31-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/95/high-resolution-genomic-profiling-of-chromosomal-abnormalities-in-human-stem-cells-using-the-135-k-stemarray 2025-08-08T11:03:31-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/97/rapid-detection-of-the-acmg-acog-recommended-23-cftr-disease-causing-mutations-using-ion-torrent-semiconductor-sequencing 2025-08-08T11:03:11-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/91/functional-analysis-of-eight-missense-mutations-in-the-spink1-gene 2025-08-08T11:04:11-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/96/array-comparative-genomic-hybridization-characterization-of-human-pluripotent-stem-cells 2025-08-08T11:03:48-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/98/high-resolution-array-cgh-characterization-of-human-stem-cells-using-a-stem-cell-focused-microarray 2025-08-08T11:08:53-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/53/the-role-of-the-f508c-mutation-in-congenital-bilateral-absence-of-the-vas-deferens 2025-08-08T11:10:40-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/92/identification-of-cftr-prss1-and-spink1-mutations-in-381-patients-with-pancreatitis 2025-08-08T11:11:18-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/56/comprehensive-genetic-analysis-of-the-cystic-fibrosis-transmembrane-conductance-regulator-from-dried-blood-specimens-implications-for-newborn-screening 2025-08-08T11:15:33-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/57/diagnostic-testing-by-cftr-gene-mutation-analysis-in-a-large-group-of-hispanics-novel-mutations-and-assessment-of-a-population-specific-mutation-spectrum 2026-02-23T12:36:40-08:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/59/improved-detection-of-cystic-fibrosis-mutations-in-infertility-patients-with-dna-sequence-analysis 2025-04-09T09:35:15-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/103/apc-associated-polyposis-conditions 2025-08-19T06:51:16-07:00 daily 0.8 https://www.ambrygen.com/science/peer-reviewed-publication/168/quality-of-clinician-reported-cancer-history-when-ordering-genetic-testing 2025-05-21T07:27:16-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentations 2026-04-02T12:29:44-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/147/symposium-lunch-talk 2026-03-31T15:01:47-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/150/mave-progress-report-how-ambry-genetics-validates-and-deploys-high-throughput-functional-assays 2026-02-21T13:07:45-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/149/clinical-translation-of-a-mutyh-mave-into-a-diagnostic-laboratory-workflow-enables-largescale-vus-resolution 2026-02-21T12:58:43-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/151/clinical-utility-of-multiplexed-assays-of-variant-effects-maves-in-a-pediatric-cohort 2026-02-21T13:18:27-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/146/laboratory-led-initiatives-to-improve-equity-in-genomic-testing 2026-01-13T16:57:01-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/148/fractional-clues-decoding-nf1-variant-pathogenicity-through-low-vaf 2026-02-18T08:49:47-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/152/a-multiplex-assay-of-variant-effect-mave-of-msh6-enables-accurate-prospective-lynch-syndrome-clinical-variant-interpretation-1 2026-03-05T06:04:47-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/144/trends-of-variant-reclassification-in-a-large-cardiogenetic-testing-cohort 2025-11-07T06:18:19-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/142/a-multiplex-assay-of-variant-effect-mave-of-msh6-enables-accurate-prospective-lynch-syndrome-clinical-variant-interpretation 2025-10-14T11:58:47-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/141/identification-of-de-novo-variants-from-parent-proband-duos-via-long-read-sequencing 2025-10-14T12:02:03-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/143/the-guardian-expanded-newborn-screening-study-short-and-medium-term-follow-up-with-the-first-15-000-participants-enrolled 2025-10-14T12:14:08-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/145/cancer-specific-risks-associated-with-germline-palb2-pathogenic-variants-from-a-large-clinical-genetic-testing-cohort 2025-12-10T10:38:34-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/140/beyond-familial-adenomatous-polyposis-using-genotype-phenotype-correlations-to-discern-germline-versus-somatic-status-for-apc-whole-gene-deletions-among-860-000-tests 2025-10-09T09:57:07-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/139/analysis-of-missense-variants-in-rps20-and-an-association-with-colorectal-cancer-predisposition 2025-10-09T09:53:03-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/135/structural-and-functional-components-of-variant-assessment-in-hereditary-breast-and-ovarian-cancer-susceptibility 2025-05-06T06:32:58-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/136/functional-validation-and-clinical-classification-of-all-missense-variants-characterized-by-saturation-genome-editing-of-rad51c 2025-05-06T06:29:04-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/134/maximizing-clinical-utility-of-exomes-greater-than-the-sum-of-its-parts 2025-03-07T12:46:25-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/133/impact-of-rna-sequencing-on-variant-classification-experience-at-a-high-volume-cancer-genetics-center 2024-11-14T05:16:44-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/131/gastric-and-lobular-breast-cancer-prevalence-in-ctnna1-heterozygotes-identified-via-multigene-panel-testing-1 2024-11-14T05:11:56-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/132/finding-more-answers-with-genetic-testing-maximizing-the-diagnostic-yield-of-exome-sequencing 2024-11-12T11:26:49-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/129/expanding-the-reach-of-paired-dna-and-rna-sequencing-results-from-450-000-consecutive-individuals-from-a-hereditary-cancer-cohort 2024-08-29T11:26:06-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/130/when-clinical-meets-molecular-why-when-and-how-do-ctnna1-germline-variants-cause-hereditary-diffuse-gastric-cancer-development 2024-08-29T11:44:43-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/128/innovations-in-genetic-testing-designing-and-selecting-effective-panels-for-maximized-clinical-utility 2024-08-05T14:03:04-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/125/racial-and-ethnic-patterns-of-variants-of-uncertain-significance-vus-among-patients-with-early-onset-colorectal-cancer 2024-06-17T09:12:26-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/126/long-read-sequencing-elucidates-complex-germline-variants-in-individuals-undergoing-hereditary-gastrointestinal-cancer-testing 2024-06-20T06:19:50-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/127/pancreatic-cancer-is-more-common-than-melanoma-in-non-white-cdkn2a-positive-individuals 2024-06-17T09:32:35-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/123/gastric-and-lobular-breast-cancer-prevalence-in-ctnna1-heterozygotes-identified-via-multigene-panel-testing 2024-06-03T08:39:34-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/124/variant-classification-and-clinical-actionability 2024-06-03T08:43:27-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/122/systematic-application-of-clingen-insight-apc-specific-acmg-amp-variant-classification-criteria-alleviates-the-burden-of-variants-of-uncertain-significance-in-clinvar-and-lovd-databases 2024-06-03T07:53:32-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/121/saturation-genome-editing-based-functional-evaluation-and-clinical-classification-of-brca2-single-nucleotide-variants 2024-06-03T07:17:06-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/120/yale-criteria-for-genetic-testing-in-cases-of-suspected-hereditary-diffuse-gastric-cancer-hdgc-are-more-sensitive-than-igclc-and-ern-genturis-criteria-in-a-large-american-cohort 2024-05-20T07:30:27-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/119/current-work-of-the-apc-subcommittee-of-the-insight-clingen-hereditary-crc-polyposis-variant-curation-expert-panel-interpretation-of-selected-apc-variants-based-on-the-apc-specific-acmg-amp-variant-classification-criteria 2024-05-08T12:22:00-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/118/reduced-penetrance-brca1-and-brca2-pathogenic-variants-in-clinical-germline-genetic-testing 2024-03-22T09:18:32-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/116/testing-with-intention-leveraging-a-standardized-gene-disease-validity-framework-in-the-face-of-evolving-evidence 2024-02-09T13:04:25-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/115/utility-of-targeted-rna-analysis-in-neurological-disorders 2024-05-31T10:27:13-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/117/acmg-amp-cap-clingen-standards-for-sequence-and-copy-number-variant-classification 2024-03-05T06:36:00-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/92/expanding-the-clinical-reach-of-rna-sequencing-evaluating-testing-outcomes-of-concurrent-germline-dna-and-rna-genetic-testing-in-a-cohort-of-43-000-individuals-undergoing-hereditary-cancer-testing 2023-09-01T16:12:18-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/93/implementation-of-a-digital-cancer-risk-assessment-tool-and-genetic-testing-program-in-gastroenterology-practices-throughout-the-u-s-identifies-inherited-cancer-susceptibility-syndromes-in-15-6-of-patients-tested 2023-11-01T14:40:19-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/88/reassessed-and-revealed-patient-and-genetic-counselor-experience-with-proactive-reanalysis 2023-10-08T13:45:20-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/90/addressing-equity-in-exome-sequencing-proactive-reanalysis-helps-to-reduce-racial-ethnic-and-ancestral-disparities 2023-10-08T13:40:35-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/91/identification-of-high-risk-hereditary-cancer-syndrome-patients-in-a-primary-care-cohort-using-a-patient-facing-risk-stratification-tool 2023-12-18T09:25:01-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/89/not-all-actionable-variants-in-brca1-and-brca2-are-created-equal-challenges-of-classifying-and-interpreting-reduced-penetrance-variants 2023-12-18T09:26:16-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/87/democratizing-cancer-risk-stratification-hca-healthcares-scalable-approach-using-a-patient-facing-digital-platform 2023-12-18T09:28:22-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/94/breast-cancer-risk-associated-with-missense-variants-in-brca2 2023-12-18T09:30:19-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/95/germline-genetic-testing-use-and-results-after-a-cancer-diagnosis 2023-10-13T10:28:16-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/85/multiplexed-assays-of-variant-effect-for-all-possible-missense-alterations-located-in-the-dna-binding-domain-of-brca2 2023-12-18T09:37:28-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/84/brca1-frameshift-variants-leading-to-extended-incorrect-protein-termini 2023-12-18T09:35:37-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/86/functional-and-clinical-characterization-of-brca2-hypomorphic-missense-variants 2023-12-18T09:36:17-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/80/variant-reclassification-in-a-large-cardiogenetic-testing-cohort-the-importance-of-disease-specific-variant-classification-criteria 2024-01-10T14:05:03-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/82/classification-of-sequence-variants-in-cancer-susceptibility-genes-today-and-tomorrow 2023-12-18T09:53:10-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/83/acmg-clingen-amp-cap-standards-for-classifying-sequence-variants-1 2023-12-18T10:05:26-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/71/working-9-5-youve-got-passion-and-a-vision-new-ways-to-provide-genetic-counseling 2023-12-18T10:07:25-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/70/when-opportunity-knocks-build-a-door-an-interactive-session-to-build-successful-business-cases-to-solve-everyday-challenges 2023-12-18T10:07:54-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/75/a-deep-dive-into-apc-introns-paired-dna-rna-testing-identifies-novel-fap-and-afap-alleles-in-the-deep-intronic-regions-of-apc 2023-12-18T10:11:38-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/72/from-bench-to-clinical-report-application-of-rna-and-functional-maves-to-reduce-vus-and-improve-positive-yield-of-genetic-testing 2023-12-18T10:10:10-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/78/inherited-cancer-susceptibility-gene-mutations-among-patients-with-appendix-cancer 2022-09-09T11:48:22-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/79/ctnna1-germline-variants-associate-with-a-disease-spectrum-extending-beyond-hereditary-diffuse-gastric-cancer 2023-12-18T10:12:23-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/76/utility-of-rna-testing-in-individuals-at-increased-risk-for-hereditary-or-familial-pancreatic-cancer 2023-12-18T10:09:32-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/77/disparities-in-the-uptake-of-cascade-genetic-testing-among-family-members-of-mutation-positive-lynch-and-hboc-syndrome-patients 2022-09-09T11:46:10-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/74/bringing-genetics-into-your-practice-talk-to-your-office-admin 2023-12-18T10:15:37-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/96/mutation-spectrum-and-rates-of-variants-of-uncertain-significance-among-african-american-males-undergoing-prostate-cancer-germline-testing-need-for-equity-in-genetic-testing 2023-11-13T11:20:39-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/114/application-of-rna-sequencing-evidence-improves-equity-in-variant-interpretation 2024-01-10T18:14:23-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/100/expanding-access-to-genetic-services-at-community-clinics-using-a-virtual-assistant 2023-11-26T13:11:41-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/101/impact-of-concurrent-dna-and-rna-genetic-testing-on-variant-classification-and-medical-management-in-a-cohort-of-40-000-patients-undergoing-hereditary-cancer-testing 2023-11-26T13:13:55-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/97/implementation-of-routine-genetic-screening-in-a-rural-gastrointestinal-clinic-leads-to-the-identification-of-inherited-gastrointestinal-disorders-and-other-cancer-risks-in-20-of-patients-tested 2023-12-18T10:16:43-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/98/pathogenic-duplications-in-tumor-suppressor-genes-cause-aberrant-mrna-splicing 2023-11-20T12:03:38-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/99/the-uniform-application-of-protein-functional-data-has-an-impressive-potential-to-resolve-vus-rates-in-brca2 2023-11-20T14:15:43-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/102/development-and-validation-of-the-premmplus-clinical-prediction-model-for-multigene-hereditary-cancer-risk-assessment 2023-11-26T15:49:08-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/103/de-novo-recurrent-variants-in-u2af2-rna-binding-domains-in-an-intellectual-disability-syndrome 2023-11-26T16:12:17-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/105/paired-like-homeobox-gene-phox2b-non-polyalanine-repeat-expansion-mutations-genotype-phenotype-correlation-in-congenital-central-hypoventilation-syndrome-and-later-onset-cchs 2023-11-26T19:05:11-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/104/a-randomized-controlled-trial-of-video-education-or-in-person-genetic-counseling-for-men-with-prostate-cancer-progen 2023-11-26T17:56:50-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/69/predicted-truncating-variants-in-smarca4-may-be-innocent-the-importance-of-multi-institutional-collaboration 2023-12-18T10:23:03-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/66/the-new-gc-in-town-demystifying-the-role-of-gene-curation-in-variant-interpretation-clinical-reporting-and-case-reanalysis 2023-12-18T10:29:28-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/67/clarity-in-chaos-using-somatic-genetic-testing-to-inform-germline-interpretation 2023-12-18T10:29:44-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/68/the-r659q-and-k618a-mlh1-variants-of-uncertain-significance-and-benign-independently-are-pathogenic-when-inherited-in-cis 2023-12-18T10:32:36-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/64/reclassification-of-splicing-vus-in-neurological-disease-genes-via-rna-seq 2019-10-07T15:51:46-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/65/high-throughput-rna-splicing-profile-increases-detection-of-clinically-actionable-variants-while-reducing-inconclusive-results-in-patients-with-hereditary-cancer-predisposition 2019-10-07T15:52:19-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/60/germline-genetic-associations-with-high-risk-prostate-cancer-and-age-at-diagnosis 2023-12-18T11:09:47-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/61/genetic-risk-score-predicts-early-age-of-onset-of-prostate-cancer 2023-12-18T11:09:09-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/63/genetic-testing-updates-for-surgeons-presentation 2023-12-18T11:12:07-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/59/three-quarters-of-upgraded-negative-reports-due-to-reclassification-are-due-to-lab-initiated-proactive-reanalysis 2023-12-18T11:28:11-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/57/in-a-class-all-by-itself-the-importance-of-reclassifying-genes-and-variants-to-better-guide-patient-care 2023-12-18T11:32:43-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/58/a-collaborative-view-of-genomic-variant-interpretation-clinical-genetic-counselors-laboratories-and-patients 2023-12-18T11:33:44-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/56/explaining-an-atypical-immunohistochemical-pattern-using-paired-tumor-germline-testing-for-lynch-syndrome 2018-10-11T06:42:25-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/53/phenotypic-expression-of-cdh1-germline-mutations-unselected-for-hereditary-diffuse-gastric-cancer 2018-02-27T07:16:31-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/55/polygenic-risk-score-for-breast-cancer-in-high-risk-women 2023-12-18T11:43:15-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/50/are-gleason-score-and-metastatic-disease-status-important-for-men-with-prostate-cancer-undergoing-multigene-panel-testing 2023-12-18T11:45:20-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/51/functional-assays-identify-clinically-actionable-variants-in-hereditary-breast-and-ovarian-cancer-predisposition-genes 2023-12-18T11:46:11-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/54/multi-gene-panels-vs-diagnostic-exome-sequencing-a-comparison-of-genetic-testing-options-for-neurodevelopmental-disorders 2018-03-20T12:10:20-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/52/biallelic-mutations-in-the-ferredoxin-reductase-gene-cause-novel-mitochondriopathy-with-optic-atrophy 2018-02-09T13:21:07-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/49/sanger-confirmation-of-ngs-data 2018-04-02T10:28:40-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/46/multiple-findings-in-diagnostic-exome-sequencing-separate-or-intertwined-diagnoses 2020-12-04T09:16:00-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/47/an-inside-look-at-mosaic-findings-in-cancer-susceptibility-genes-during-one-year-at-a-clinical-diagnostic-laboratory 2020-12-04T09:11:01-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/48/defining-value-based-practices-for-clinical-laboratories-quality-flexibility-and-collaboration 2020-12-04T09:02:19-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/37/de-novo-germline-variants-in-histone-3-family-3a-h3f3a-and-histone-3-family-3b-h3f3b-associated-with-a-severe-neurodegenerative-disorder-and-functional-effect-unique-from-their-somatic-mutations 2020-12-04T08:58:06-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/44/germline-mutation-prevalence-in-consecutive-unselected-individuals-with-pancreatic-adenocarcinoma 2017-10-16T21:55:19-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/45/prevalence-of-mutations-in-adenomatous-polyposis-and-colorectal-cancer-associated-genes-in-patients-with-multiple-colon-polyps-stratified-by-age-1 2020-12-03T09:19:21-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/38/resolving-variant-interpretation-differences-in-clinvar-between-43-clinical-laboratories-1 2020-12-03T09:15:19-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/41/gene-specific-allele-frequency-thresholds-for-benign-evidence-to-empower-variant-interpretation 2020-12-03T09:14:13-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/39/de-novo-mutations-in-protein-kinase-genes-camk2a-and-camk2b-cause-intellectual-disability 2017-09-26T17:47:40-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/40/prevalence-of-mutations-in-a-large-series-of-clinically-ascertained-ovarian-cancer-cases-tested-on-multi-gene-panels-compared-to-reference-controls 2017-09-26T17:47:56-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/42/coverage-matters-high-rate-of-promoter-1b-deletions-in-a-large-apc-testing-cohort 2020-12-03T09:12:25-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/43/prevalence-of-mutations-in-adenomatous-polyposis-and-colorectal-cancer-associated-genes-in-patients-with-multiple-colon-polyps-stratified-by-age 2017-09-11T15:28:04-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/32/up-front-vs-post-reporting-parental-co-segregation-analysis-is-one-approach-superior 2017-08-21T22:15:55-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/31/phenotype-and-colorectal-cancer-risk-in-apc-i1307k-homozygotes 2017-09-20T13:50:55-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/36/inside-pandora-s-box-implications-of-acmg-secondary-findings-for-cardiology-amp-oncology-clinical-practice-inside-scoop-from-the-laboratory-a-review-of-lab-based-outcomes-research 2017-09-11T13:48:07-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/34/navigating-variant-interpretation-differences-in-cardiovascular-genetics-emerging-data-amp-perspectives-from-clinicians-amp-laboratories 2017-08-30T16:44:08-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/33/what-s-loss-got-to-do-with-it-working-with-grief-as-a-genetic-counselor 2017-08-30T16:44:51-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/35/the-expanding-genetic-counseling-landscape-for-cancers-of-childhood-blood-and-brain 2017-08-30T16:48:06-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/29/the-importance-of-data-sharing-in-classification-of-variants-in-mismatch-repair-genes 2017-07-27T20:44:47-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/30/resolving-variant-interpretation-differences-in-clinvar-between-43-clinical-laboratories 2020-12-03T09:09:38-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/2/germline-genetic-testing-in-unselected-pancreatic-ductal-adenocarcinoma-pdac-patients 2021-10-04T10:46:39-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/3/is-this-brain-tumor-genetic-assessment-and-evaluation-for-hereditary-causes-of-primary-brain-tumors 2020-12-03T09:05:40-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/5/genetic-testing-in-the-epilepsies-testing-options-diagnostic-yield-and-unique-challenges-in-variant-interpretation 2017-06-19T15:32:28-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/4/knocking-out-a-titan-assessing-the-effect-of-truncating-ttn-alterations-in-a-large-clinical-cohort 2017-06-19T13:59:05-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/6/breast-cancer-risks-associated-with-mutations-in-cancer-predisposition-genes-identified-by-clinical-genetic-testing-of-50-000-breast-cancer-patients 2023-12-18T11:49:14-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/8/germline-mutations-in-individuals-with-meningioma-and-breast-cancer 2017-06-20T16:18:43-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/7/tumor-predisposition-and-genetic-risk-assessment-in-a-neuro-oncology-practice 2017-06-19T15:30:42-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/9/reframing-what-we-already-know-sales-and-marketing-101-for-genetic-counselors 2023-12-18T11:49:56-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/1/data-double-take-three-examples-of-atypical-pathogenic-alterations-detected-in-exome-sequencing-data 2023-12-18T11:54:06-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/10/cancer-risks-associated-with-predisposition-gene-mutations-identified-by-hereditary-cancer-panel-testing-of-85-000-patients 2023-12-18T11:53:42-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/12/msh6-and-pms2-carriers-identified-by-multi-gene-testing-may-have-a-breast-ovarian-cancer-phenotype 2023-12-18T11:58:17-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/11/breast-and-colorectal-cancer-risk-in-monoallelic-mutyh-carriers-ascertained-via-multi-gene-panel-testing 2023-12-18T11:57:21-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/15/to-disclose-or-not-to-disclose-an-investigation-of-counselor-self-disclosure-in-the-field-of-genetic-counseling 2023-12-18T12:09:30-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/14/prenatal-exome-sequencing-issues-of-clinical-utility-and-beyond 2023-12-18T12:08:53-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/13/brca2-mutation-carriers-may-present-with-primary-brain-tumors-a-review-of-a-multigene-panel-testing-cohort 2023-12-18T12:08:19-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/16/whole-exome-sequencing-in-the-epilepsies-the-developing-diagnostic-exome-signature-of-epilepsy-genes-over-a-five-year-period 2020-11-24T10:50:56-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/17/ambryshare-a-model-for-sharing-genomic-data-to-understand-all-human-disease 2017-06-20T11:12:49-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/18/clinical-laboratories-implement-the-acmg-amp-guidelines-to-resolve-differences-in-variant-interpretations-submitted-to-clinvar 2020-11-24T10:29:12-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/19/msh6-and-pms2-mutation-carriers-ascertained-through-multi-gene-panel-testing-may-present-with-a-hereditary-breast-and-ovarian-cancer-phenotype 2020-11-24T10:26:16-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/20/a-journey-into-the-unknown-exploring-the-clinical-diagnostic-path-from-targeted-panel-to-whole-exome-sequencing 2017-06-20T11:47:51-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/21/breast-and-ovarian-cancer-risks-beyond-brca1-2-from-a-cohort-of-15-000-women-undergoing-multigene-panel-testing 2023-12-04T10:02:09-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/22/diagnostic-exome-sequencing-is-successful-in-providing-diagnoses-among-patients-with-intellectual-disability-and-developmental-delay-strong-family-history-correlates-with-an-increased-novel-genetic-etiology-detection-rate 2020-11-24T10:21:47-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/23/bevacizumab-impact-on-hearing-loss-due-to-neurofibromatosis-type-2-associated-vestibular-schwannomas-and-associated-biomarkers 2023-12-04T13:34:47-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/106/diagnostic-exome-sequencing-is-successful-in-providing-diagnoses-among-patients-with-intellectual-disability-and-developmental-delay-strong-family-history-correlates-with-an-increased-novel-genetic-etiology-detection-rate-1 2023-12-18T11:59:48-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/24/evaluation-of-a-multi-gene-panel-test-for-inherited-paragangliomas-and-pheochromocytomas-is-it-time-to-re-assess-guidelines-for-genetic-testing 2020-11-24T10:10:34-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/25/clinical-diagnostic-exome-sequencing-identified-compound-heterozygous-aspm-gene-alterations-in-a-fetus-with-marked-microcephaly 2020-11-24T10:04:22-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/26/rising-to-the-level-of-clinical-importance-challenges-to-adjudicating-and-reporting-variants-discovered-with-genomic-analysis 2020-11-24T10:01:50-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/27/de-novo-mutations-of-kiaa2022-in-females-cause-epileptic-encephalopathy 2020-11-24T09:54:19-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/28/diagnostic-exome-sequencing-in-a-prenatal-setting 2017-06-21T12:26:03-07:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/110/diagnostic-exome-sequencing-as-the-standard-of-care 2023-12-07T08:46:58-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/109/practice-guidelines-2-0-developing-high-quality-clinically-relevant-practice-guidelines 2023-12-07T08:40:43-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/108/a-recurrent-mutation-in-kcna2-in-complicated-autosomal-dominant-spastic-paraplegia-an-expansion-of-the-channelopathy-spectrum-and-a-novel-disease-mechanism 2023-12-06T21:12:03-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/107/somatic-tp53-mutations-detected-in-germline-testing-the-importance-of-phenotypic-correlation-in-cancer-predisposition-testing 2023-12-06T21:05:27-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/112/bringing-elsi-issues-to-life-the-drama-of-dna 2023-12-18T12:13:48-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/111/the-clinical-and-psychosocial-complexities-of-obtaining-a-diagnosis-for-rare-genetic-disorders-navigating-the-diagnostic-odyssey 2023-12-07T14:36:31-08:00 daily 0.8 https://www.ambrygen.com/science/scientific-presentation/113/the-panel-results-came-back-now-what-do-i-do-cancer-panel-case-presentations-with-your-peers 2023-12-18T12:14:01-08:00 daily 0.8 https://www.ambrygen.com/science/delivering-accuracy 2026-04-02T12:29:44-07:00 daily 0.8 https://www.ambrygen.com/science/gene-classification 2026-04-02T12:29:44-07:00 daily 0.8 https://www.ambrygen.com/science/classifi 2026-04-02T12:29:44-07:00 daily 0.8 https://www.ambrygen.com/science/candidate-disease-gene-discovery 2026-04-02T12:29:44-07:00 daily 0.8 https://www.ambrygen.com/science/variant-classification 2026-04-02T12:29:44-07:00 daily 0.8 https://www.ambrygen.com/science/sanger-sequencing-confirmation 2026-04-02T12:29:44-07:00 daily 0.8 https://www.ambrygen.com/science/family-studies 2026-04-02T12:29:44-07:00 daily 0.8 https://www.ambrygen.com/science/our-scientific-excellence 2026-04-02T12:29:44-07:00 daily 0.8 https://www.ambrygen.com/science/ambrys-translational-genomics-atg-lab 2026-04-02T12:29:44-07:00 daily 0.8 https://www.ambrygen.com/providers/oncology/test-menu 2026-04-03T12:29:44-07:00 daily 0.8 https://www.ambrygen.com/providers/cardiology/test-menu 2026-04-03T12:29:44-07:00 daily 0.8 https://www.ambrygen.com/providers/exome-and-general-genetics/test-menu 2026-04-03T12:29:44-07:00 daily 0.8 https://www.ambrygen.com/providers/neurology/test-menu 2026-04-03T12:29:44-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/149/neurology/neurodevelopmentnext 2020-08-30T19:10:50-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/148/neurology/epilepsynext-expanded 2020-08-30T19:10:50-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/147/Not-Available 2024-02-13T14:26:33-08:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/146/oncology/brcanext 2024-02-13T14:26:33-08:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/144/cardiology/other-lipid-disorders 2019-05-02T12:32:21-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/142/neurology/customnext-neuro 2020-08-20T18:55:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/141/neurology/schwannomatosis 2017-07-12T20:08:54-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/139/cardiology/transthyretin-amyloidosis 2020-09-09T15:35:59-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/138/oncology/hereditary-retinoblastoma 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/137/oncology/pleuropulmonary-blastoma-and-dicer1-related-disorders 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/136/oncology/birt-hogg-dube-syndrome-bhds 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/135/oncology/pold1-and-pole-related-cancer 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/134/oncology/mutyh-associated-polyposis-map 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/133/oncology/hereditary-mixed-polyposis-syndrome 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/132/oncology/hereditary-diffuse-gastric-cancer-hdgc 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/131/oncology/familial-adenomatous-polyposis-fap 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/130/oncology/pten-related-disorders 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/129/oncology/palb2-associated-cancer 2017-07-10T19:33:45-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/128/oncology/chek2-related-cancer 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/127/neurology/neurofibromatosis-2 2017-07-13T21:06:01-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/124/oncology/multiple-endocrine-neoplasia-type-4 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/115/exome-and-general-genetics/telomere-related-pulmonary-fibrosis 2017-08-03T01:02:06-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/110/exome-and-general-genetics/surfactant-dysfunction 2018-01-31T15:56:34-08:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/107/exome-and-general-genetics/primary-ciliary-dyskinesia-pcd 2017-08-03T01:02:28-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/101/exome-and-general-genetics/congenital-central-hypoventilation-syndrome-cchs 2017-08-03T01:01:17-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/99/exome-and-general-genetics/shwachman-diamond-syndrome 2017-06-23T16:48:06-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/91/neurology/nevoid-basal-cell-carcinoma-syndrome-gorlin-syndrome 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/85/neurology/tuberous-sclerosis-complex 2018-02-01T16:27:04-08:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/83/exome-and-general-genetics/noonannext 2020-02-27T08:31:55-08:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/81/neurology/li-fraumeni-syndrome 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/77/neurology/ataxia-telangiectasia 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/73/neurology/legius-syndrome 2018-02-01T14:25:28-08:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/70/oncology/peutz-jeghers-syndrome 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/69/exome-and-general-genetics/pancreatitis-panel 2018-02-28T09:56:19-08:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/67/exome-and-general-genetics/hhtnext 2020-09-09T14:43:12-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/65/exome-and-general-genetics/juvenile-polyposis-syndrome 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/64/exome-and-general-genetics/ret-related-hirschsprung-disease 2017-06-23T15:59:47-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/62/neurology/autismnext 2020-08-30T19:31:11-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/61/exome-and-general-genetics/cystic-fibrosis 2025-05-12T15:20:54-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/56/exome-and-general-genetics/von-hippel-lindau-disease 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/55/neurology/fragile-x-associated-disorders 2017-08-03T15:42:24-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/54/neurology/neurofibromatosis-1 2017-07-13T21:12:21-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/53/exome-and-general-genetics/multiple-endocrine-neoplasia-type-2-men2-and-familial-medullary-thyroid-cancer-fmtc 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/52/exome-and-general-genetics/multiple-endocrine-neoplasia-type-1-men1 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/48/oncology/hereditary-leiomyomatosis-and-renal-cell-carcinoma 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/46/oncology/adenomatous-polyposis 2020-05-29T15:46:48-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/43/oncology/lynch-syndrome 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/38/cardiology/dcmnext 2020-09-01T14:31:43-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/35/cardiology/cmnext 2020-09-01T14:32:34-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/32/cardiology/customnext-cardio 2019-05-02T12:32:21-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/29/cardiology/cardionext 2020-06-17T15:57:02-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/28/oncology/cancernext-expanded 2025-12-18T12:17:56-08:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/27/cardiology/arvcnexttm 2020-09-01T14:27:59-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/25/oncology/brcaplus 2024-02-13T14:26:33-08:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/23/oncology/brca1-and-brca2 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/22/cardiology/cpvtnext 2018-08-07T09:59:31-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/15/cardiology/hcmnext 2020-09-01T14:30:51-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/14/cardiology/longqtnext-rhythmnext 2020-09-01T14:36:05-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/13/cardiology/fhnext 2020-09-09T15:20:51-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/12/cardiology/taadnext 2018-12-03T16:18:59-08:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/9/exome-and-general-genetics/snp-array 2020-04-02T13:07:48-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/8/neurology/epilepsynext 2020-08-30T19:32:40-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/7/exome-and-general-genetics/exomenext-and-exomereveal 2024-11-05T15:39:53-08:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/6/oncology/colonext 2018-07-05T13:23:49-07:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/2/oncology/customnext-cancer 2024-11-08T16:09:09-08:00 daily 0.8 https://www.ambrygen.com/providers/genetic-testing/1/oncology/cancernext 2025-12-18T12:17:22-08:00 daily 0.8 https://www.ambrygen.com/videos/ 2026-04-02T12:29:44-07:00 daily 0.8 https://www.ambrygen.com/video/index/videos/patients/cancer/english 2026-01-22T16:07:34-08:00 daily 0.8 https://www.ambrygen.com/video/index/videos/patients/cancer/spanish 2026-01-22T16:07:49-08:00 daily 0.8 https://www.ambrygen.com/video/index/videos 2024-11-08T12:27:42-08:00 daily 0.8 https://www.ambrygen.com/video/index/videos/patients/how-to-videos 2025-07-07T18:52:35-07:00 daily 0.8 https://www.ambrygen.com/video/index/videos/patients/patient-care 2025-07-07T18:46:15-07:00 daily 0.8 https://www.ambrygen.com/video/index/videos/patients/patient-hattr-compass 2024-11-08T12:27:42-08:00 daily 0.8 https://www.ambrygen.com/video/index/videos/patients/pre-test-genetic-education 2024-11-08T12:27:42-08:00 daily 0.8 https://www.ambrygen.com/video/index/videos/patients/cancer 2024-11-08T12:27:42-08:00 daily 0.8 https://www.ambrygen.com/video/index/videos/patients/spanish 2024-11-08T12:27:42-08:00 daily 0.8 https://www.ambrygen.com/video/index/videos/providers 2024-11-26T13:31:14-08:00 daily 0.8 https://www.ambrygen.com/video/index/videos/providers/gene-spotlight 2024-11-08T12:27:42-08:00 daily 0.8 https://www.ambrygen.com/video/index/videos/providers/provider-care-video 2025-02-11T12:01:11-08:00 daily 0.8 https://www.ambrygen.com/video/index/videos/research-and-collaborations/ambry-science 2025-07-28T16:59:24-07:00 daily 0.8 https://www.ambrygen.com/video/index/videos/research-and-collaborations/rnainsight 2025-07-28T17:14:49-07:00 daily 0.8 https://www.ambrygen.com/video/index/videos/the-care-program 2024-11-08T12:27:42-08:00 daily 0.8 https://www.ambrygen.com/video/index/videos/the-care-program/the-care-experience 2024-11-08T12:27:42-08:00 daily 0.8 https://www.ambrygen.com/video/view/8255/will-rna-testing-be-the-next-del-dup-for-clinical-genetics 2025-07-28T17:14:49-07:00 daily 0.8 https://www.ambrygen.com/video/view/8254/see-the-difference-with-ambrys-variant-assessment-team 2025-07-28T16:59:24-07:00 daily 0.8 https://www.ambrygen.com/video/view/8218/genetics-101 2025-07-07T18:46:15-07:00 daily 0.8 https://www.ambrygen.com/video/view/8217/setting-the-standard-for-genetic-testing 2025-07-07T18:40:02-07:00 daily 0.8 https://www.ambrygen.com/video/view/7784/ambry-genetics-care-providers-quotes 2025-02-11T12:01:11-08:00 daily 0.8 https://www.ambrygen.com/video/view/7493/ambry-classifi-our-commitment-to-finding-answers-for-your-patients 2024-11-26T13:31:14-08:00 daily 0.8 https://www.ambrygen.com/video/view/7379/finding-answers-kcnh5-related-epileptic-encephalopathy 2024-07-22T17:08:13-07:00 daily 0.8 https://www.ambrygen.com/video/view/7378/leading-with-science-brad-power 2024-07-22T17:06:25-07:00 daily 0.8 https://www.ambrygen.com/video/view/7377/alpk1-new-gene-disease-characterization-ends-the-diagnostic-odyssey 2024-07-24T11:26:45-07:00 daily 0.8 https://www.ambrygen.com/video/view/7376/casestudy-neurogenetics-victoria-suslovitch 2024-07-24T11:23:09-07:00 daily 0.8 https://www.ambrygen.com/video/view/7375/identifying-a-dual-diagnosis-with-margo-gallegos 2024-07-24T11:24:49-07:00 daily 0.8 https://www.ambrygen.com/video/view/7374/finding-an-answer-with-patient-for-life-an-interesting-case 2024-07-24T11:20:13-07:00 daily 0.8 https://www.ambrygen.com/video/view/7362/proactive-exome-reanalysis-a-mothers-perspective 2024-07-22T10:45:03-07:00 daily 0.8 https://www.ambrygen.com/video/view/7351/what-is-hereditary-cancer-with-spanish-sub-titles 2024-07-15T15:08:13-07:00 daily 0.8 https://www.ambrygen.com/video/view/7350/what-kind-of-results-can-i-expect-que-tipo-de-resultados-puedo-esperar-de-las-pruebas-geneticas 2024-07-15T15:07:17-07:00 daily 0.8 https://www.ambrygen.com/video/view/7349/what-is-hereditary-cancer-que-es-el-cancer-hereditario 2024-07-15T15:06:54-07:00 daily 0.8 https://www.ambrygen.com/video/view/7348/what-is-genetic-testing-que-son-las-pruebas-geneticas-y-como-pueden-ser-de-ayuda 2024-07-15T15:06:28-07:00 daily 0.8 https://www.ambrygen.com/video/view/7347/what-are-some-common-questions-que-preguntas-suele-hacer-la-gente 2024-07-15T15:06:10-07:00 daily 0.8 https://www.ambrygen.com/video/view/7346/how-do-i-know-if-i-need-genetic-testing-como-se-si-necesito-hacerme-pruebas-geneticas 2024-07-15T15:05:35-07:00 daily 0.8 https://www.ambrygen.com/video/view/7288/proactive-variant-reclassification-in-hereditary-cancer-genes 2024-06-25T16:01:16-07:00 daily 0.8 https://www.ambrygen.com/video/view/7205/meet-the-gene-team-amybeth-weaver 2024-06-03T19:09:07-07:00 daily 0.8 https://www.ambrygen.com/video/view/7153/why-ambry-2024 2024-05-10T09:13:14-07:00 daily 0.8 https://www.ambrygen.com/video/view/6950/meet-the-gene-team-bess-wayburn 2024-03-12T23:11:22-07:00 daily 0.8 https://www.ambrygen.com/video/view/6949/gene-of-the-month-may-2023-part-1-jennifer-huang 2024-03-13T08:47:44-07:00 daily 0.8 https://www.ambrygen.com/video/view/6948/ambry-gene-of-the-month-msh3 2024-03-12T23:05:37-07:00 daily 0.8 https://www.ambrygen.com/video/view/6942/leading-the-way-in-gene-classification 2024-03-11T10:53:18-07:00 daily 0.8 https://www.ambrygen.com/video/view/6941/innovation-in-variant-classification 2024-03-11T10:53:29-07:00 daily 0.8 https://www.ambrygen.com/video/view/6116/clinical-validity-scoring-at-ambry-genetics 2024-03-11T11:48:27-07:00 daily 0.8 https://www.ambrygen.com/video/view/6115/keeping-score-of-mutations-to-link-genes-to-disease 2024-03-11T11:48:39-07:00 daily 0.8 https://www.ambrygen.com/video/view/5947/ambry-genetics-care-providers-2022 2023-11-27T21:00:19-08:00 daily 0.8 https://www.ambrygen.com/video/view/5946/the-provider-experience-with-the-care-program-for-cancer 2023-11-27T20:12:38-08:00 daily 0.8 https://www.ambrygen.com/video/view/5724/care-patient-experience-with-jennifer-bentley-lake-medical-imaging 2023-11-28T17:31:42-08:00 daily 0.8 https://www.ambrygen.com/video/view/5723/dr-cathrine-keller-lake-medical-imaging 2023-10-25T18:15:27-07:00 daily 0.8 https://www.ambrygen.com/video/view/5578/the-patient-experience-with-the-care-program-for-cancer 2023-11-27T20:14:52-08:00 daily 0.8 https://www.ambrygen.com/video/view/4428/patient-for-life-morgan-turpin 2023-11-28T17:38:21-08:00 daily 0.8 https://www.ambrygen.com/video/view/4427/patient-for-life 2023-05-16T12:55:39-07:00 daily 0.8 https://www.ambrygen.com/video/view/3643/what-is-a-genetic-counselor 2021-11-08T15:50:09-08:00 daily 0.8 https://www.ambrygen.com/video/view/3639/ambryport-exome-demo 2021-11-08T10:55:02-08:00 daily 0.8 https://www.ambrygen.com/video/view/3638/ambryport-oncology-demo 2021-11-08T10:53:54-08:00 daily 0.8 https://www.ambrygen.com/video/view/3636/pre-test-genetics-education-imaging-centers-spanish 2021-11-08T10:50:27-08:00 daily 0.8 https://www.ambrygen.com/video/view/3635/pre-test-genetics-education-spanish 2021-11-08T10:49:28-08:00 daily 0.8 https://www.ambrygen.com/video/view/3634/pre-test-genetics-education-for-imaging-centers 2021-11-08T10:47:14-08:00 daily 0.8 https://www.ambrygen.com/video/view/3633/pre-test-genetics-education 2023-11-27T22:33:22-08:00 daily 0.8 https://www.ambrygen.com/video/view/3596/the-care-patient-experience 2023-11-27T20:47:57-08:00 daily 0.8 https://www.ambrygen.com/video/view/3595/how-does-genetic-testing-work 2025-07-07T18:52:35-07:00 daily 0.8 https://www.ambrygen.com/video/view/3594/how-to-submit-a-saliva-sample-of-genetic-testing 2025-04-16T15:41:31-07:00 daily 0.8 https://www.ambrygen.com/providers/resources/webinars 2026-04-02T12:29:44-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/294/counseling-about-changes-and-consent-in-direct-to-consumer-testing-with-scott-m-weissman-ms-cgc 2026-03-31T15:50:47-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/293/incorporating-patient-voices-and-priorities-in-genomic-testing-research-and-treatment-development-with-nan-doyle-ms-ms-lcgc 2026-03-31T14:44:56-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/290/from-clinic-visit-to-genetic-insight-how-pediatric-nps-can-implement-genetic-testing-in-neurodevelopmental-care-with-lexi-vierling-cpnp-pmhs-amp-aubrey-rose-ms-cgc 2026-02-19T11:46:19-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/292/a-scalable-approach-to-resolving-variants-of-uncertain-significance-with-lea-starita-phd 2026-03-26T10:08:45-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/291/public-genomic-literacy-current-status-and-paths-to-improvement-with-karmen-trzupek-ms-cgc 2026-02-23T12:34:43-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/289/consideration-of-inherited-cancer-risk-on-a-continuum-with-tuya-pal-md-facmg 2026-02-17T12:50:23-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/288/genetic-clinicians-and-rare-sibling-support-with-abby-turnwald-ms-cgc-and-sarah-jurgensmeyer-ms-cgc 2026-02-03T11:53:22-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/287/policy-efforts-to-increase-access-to-genetic-testing-with-jennifer-leib 2026-01-23T15:48:06-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/284/3rd-annual-research-round-up-with-laura-amendola-ms-cgc-carrie-horton-ms-cgc-and-holly-laduca-ms-cgc 2026-01-20T11:36:03-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/286/implicit-bias-in-genetics-education-the-impact-of-photographs-on-student-learning-and-perception-with-christina-falugi-ms-cgc 2026-01-02T16:15:52-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/285/securing-a-more-stable-economic-future-for-genetic-counselors-with-samantha-baxter-ms-cgc 2025-12-31T08:23:02-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/283/30-years-of-hereditary-breast-and-ovarian-cancer-genetic-testing-with-elizabeth-chao-md-facmg 2025-11-21T23:48:21-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/282/innovation-in-every-strand-maximizing-clinical-utility-with-strategic-test-design-with-tina-pesaran-ma-ms-cgc-and-tara-namey-ms-lcgc 2025-11-13T17:08:48-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/281/brca-and-beyond-hereditary-risk-for-cancers-of-the-breast-ovary-prostate-and-pancreas-with-julie-mak-ms-msc-cgc 2025-10-22T16:26:50-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/279/gene-therapy-in-neuromuscular-disease-real-world-experience-with-elicia-estrella-ms-cgc 2025-10-21T15:59:23-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/280/the-current-landscape-of-insurance-reimbursement-for-genetic-testing-with-rob-pilarski-ms-lgc 2025-09-30T12:50:43-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/278/genes-to-meds-how-genetic-testing-supports-drug-development-with-susan-toomey-ms 2025-08-20T06:58:02-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/275/unlocking-diagnoses-sooner-the-power-of-proactive-exome-reanalysis-with-patient-for-lifetm-with-kelly-hagman-ms-cgc-lgc-amp-meghan-towne-ms-cgc-lgc 2025-07-16T12:07:18-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/277/guidance-on-germline-testing-based-on-somatic-test-results-with-jessica-stoll-ms-cgc 2025-08-06T11:49:08-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/276/patient-for-life-when-new-evidence-changes-everything-with-meghan-towne-ms-cgc-lgc 2025-07-21T16:17:16-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/274/psychiatric-genomics-risks-methods-and-convergence-with-rare-disorders-with-rebecca-signer-ms-cgc 2025-07-22T14:21:48-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/273/long-read-sequencing-to-help-bridge-the-diagnostic-gap-in-rare-mendelian-conditions-with-emmanuele-c-delot-phd 2025-07-07T13:04:48-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/272/data-issues-in-genetic-medicine-with-donavan-cheng-phd 2025-05-29T13:39:03-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/271/equity-in-genetics-challenging-the-legacy-of-marginalization-in-research-and-clinic-with-kimberly-zayhowski-ms-cgc-amp-andrew-giles-ms-cgc 2025-05-28T12:50:07-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/270/genetics-knowledge-and-skills-among-non-genetics-professionals-with-lindsey-alico-ecker-ms-cgc 2025-05-15T12:42:44-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/269/genetic-testing-for-hematologic-cancers-with-julia-cooper-ms-cgc 2025-04-22T14:54:16-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/268/optimizing-the-ehr-for-genetic-counselor-workflows-risk-assessments-orders-results-and-care-pathways-with-chelsea-menke-ms-lcgc-and-karen-wernke-ms-cgc 2025-04-10T10:38:41-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/267/understanding-the-development-of-nccn-guidelines-for-high-risk-breast-ovarian-pancreatic-amp-prostate-cancer-with-leigha-senter-ms-cgc 2025-03-26T12:50:41-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/266/how-to-handle-a-variant-of-uncertain-significance-vus-with-caitlin-reid-ms-cgc 2025-03-17T10:22:05-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/265/the-use-of-maves-in-genetic-testing-with-fergus-j-couch-phd 2025-03-03T08:02:55-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/264/clinical-neurogenetic-testing-past-present-and-future-with-laina-lusk-mmsc-lcgc 2025-02-18T08:15:55-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/262/top-reads-of-2024-webinar-with-grace-vannoy-ms-cgc-carrie-horton-ms-cgc-and-marcy-richardson-phd 2025-02-13T09:48:26-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/263/double-helix-double-standards-recognizing-bias-in-published-literature-with-carrie-horton-ms-cgc 2025-02-04T08:28:13-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/261/like-share-care-social-media-and-patient-engagement-for-genetics-professionals-with-dena-goldberg-ms-cgc 2025-01-21T13:55:21-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/260/how-laboratories-play-a-role-in-member-benefits-by-forming-a-bridge-between-the-ordering-provider-and-the-health-plan-with-robert-pilarski-ms-lgc-marissa-russell-ms-lgc-gregory-nogle-1 2024-12-26T07:02:40-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/257/exomereveal-adding-the-power-of-rna-analysis-to-exome-testing-with-dana-mittag-ms-cgc-and-brian-schoenfeld-ms-lgc 2024-11-15T08:24:01-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/258/beyond-seizures-genetic-journeys-from-infancy-onward-with-beth-sheidley-sonal-mahida-and-rozalia-valentine 2024-12-02T07:28:49-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/256/the-clinical-genome-resource-clingen-overview-and-development-of-expert-panels-with-dr-deborah-ritter 2024-11-07T09:09:21-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/253/how-ordering-providers-can-avoid-unnecessary-detours-when-navigating-the-genetic-testing-billing-process-with-robert-pilarski-ms-lgc-marissa-russell-ms-lgc-gregory-nogle 2024-09-16T13:48:37-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/255/genetic-test-design-developing-and-curating-for-maximized-clinical-utility-with-devon-thrush-ms-cgc 2024-10-03T15:28:16-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/254/acmg-secondary-findings-cardiology-getting-to-the-heart-of-the-matter-with-kelly-radtke-phd 2024-09-18T12:04:47-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/252/gender-inclusive-counseling-for-hereditary-cancer-risk-with-danielle-mckenna-ms-lcgc 2024-09-03T08:32:37-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/251/long-read-sequencing-applications-to-elucidate-the-genetic-basis-of-human-disease-with-sami-belhadj-phd 2024-08-13T14:36:50-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/250/developing-individualized-therapies-for-rare-diseases-with-margaret-meserve-ms-cgc 2024-07-31T13:50:29-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/249/counseling-low-level-pathogenic-results-with-elizabeth-chao-m-d-facmg 2024-07-16T11:27:16-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/248/genetic-ataxias-clinical-overview-research-and-the-future-of-diagnosis-and-treatment-with-victoria-suslovitch-ms-cgc 2024-07-09T10:42:57-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/247/utility-of-rna-sequencing-in-rare-disease-with-rachid-karam-md-phd 2024-06-20T10:42:55-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/246/whats-in-a-number-breast-cancer-risk-assessment-models-and-clinical-applications-with-jill-e-stopfer-ms-lgc 2024-06-06T12:00:57-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/245/solving-missing-heritability-in-familial-adenomatous-polyposis-patients-using-paired-dna-rna-testing-with-colin-young-phd 2024-05-21T13:17:37-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/244/histories-and-futures-of-genetic-essentialism-on-bias-its-origins-and-its-harms-with-shoumita-dasgupta-phd 2024-05-13T12:50:03-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/243/the-evolving-landscape-of-gene-disease-validity-curation-and-its-impact-on-clinical-utility-with-jeni-herrera-mullar-mgc-cgc-dma 2024-04-26T05:08:48-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/242/there-and-back-again-a-cases-journey-through-the-undiagnosed-diseases-program-with-ellen-macnamara-scm-cgc 2024-04-09T11:01:49-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/241/using-the-acmg-amp-framework-to-capture-evidence-related-to-predicted-and-observed-impact-on-splicing-recommendations-from-the-clingen-svi-splicing-subgroup-with-steven-harrison 2024-03-28T11:39:50-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/238/gene-disease-validity-developing-and-applying-a-rigorous-framework-in-a-diagnostic-laboratory-with-meghan-towne-ms-cgc-lcgc-amp-devon-thrush-ms-cgc 2024-03-28T11:45:14-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/240/when-panel-testing-misses-the-mark-navigating-whole-exome-sequencing-for-cardiovascular-genomic-disorders-with-megan-betts-ms-lgc 2024-03-13T12:49:11-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/239/public-health-genomics-reaching-the-summit-with-jan-lowery-phd-mph 2024-02-28T09:11:02-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/237/the-power-of-cardiovascular-genetic-testing-from-implementation-to-targeted-therapies-with-sharlene-m-day-md 2024-02-21T12:00:06-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/236/current-state-of-prenatal-wes-clinical-updates-with-akila-subramaniam-md-mph 2024-01-29T08:13:23-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/235/update-on-the-genetics-neuroendocrine-neoplasms-with-pamela-brock-ms-cgc 2024-01-17T07:09:46-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/233/clinical-genomics-research-round-up-expert-snapshots-of-10-impactful-publications-of-2023 2024-01-24T14:50:36-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/234/evolving-applications-of-paired-dna-and-rna-sequencing-in-clinical-germline-genetic-testing-with-carrie-horton-ms-cgc 2024-01-03T06:57:40-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/232/gender-inclusivity-incorporation-into-clinical-and-lab-practices-with-andy-cantor-ms-lcgc-she-they-he-and-jehannine-austin-phd-fcahs-cgc 2023-11-07T13:02:01-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/231/making-numbers-meaningful-to-patients-and-the-public-with-jessica-s-ancker-mph-phd-facmi 2023-10-17T09:40:33-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/230/a-hope-story-prenatal-patient-advocacy-with-ashley-zink-md-and-rick-smith 2023-10-10T08:31:23-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/229/diagnosis-detecting-pathogenic-variants-beyond-standard-multigene-panel-sequencing-with-elizabeth-chao-m-d-facmg 2024-03-12T22:29:35-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/228/partnering-for-success-an-ob-gyn-perspective-on-high-risk-assessment-and-genetic-testing-with-liese-vito-md 2023-08-30T13:47:23-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/227/considerations-of-disease-specific-criteria-for-variant-classification-on-cardiogenetic-panels-with-meghan-towne-ms-cgc-lcgc 2024-03-12T22:29:15-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/225/newborn-screening-and-genomics-with-robert-c-green-md-mph 2024-02-13T23:18:08-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/226/factors-influencing-the-utility-of-rna-studies-with-heather-zimmermann-phd 2023-08-10T10:34:11-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/224/recommendations-for-next-generation-sequencing-germline-variant-confirmation-with-kristy-r-crooks-ph-d-facmg 2024-03-12T22:28:58-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/223/incorporating-genetic-risk-evaluation-into-management-of-cancer-after-diagnosis-methods-and-outcomes-of-the-georgia-california-genetic-testing-linkage-initiative-with-steven-katz-m-d-m-p-h 2023-07-05T08:45:36-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/220/genomic-newborn-screening-what-we-know-and-how-far-we-have-to-go-with-nina-b-gold-md 2023-05-16T11:01:23-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/222/a-landmark-ruling-celebrating-10-years-of-freedom-from-gene-patenting-moderated-by-elizabeth-chao-md-facmg 2023-07-12T11:33:48-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/221/what-we-owe-to-each-other-the-next-frontiers-of-deij-with-lila-aiyar-msc-cgc-ccgc 2023-05-24T10:08:44-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/219/addressing-the-challenges-of-vus-in-genetic-and-genomic-testing-with-heidi-rehm-phd-facmg 2023-04-28T10:50:01-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/218/field-guidance-for-genetic-screening-in-patients-with-cardiomyopathies-with-amy-kontorovich-md-phd 2023-05-05T08:40:00-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/216/the-whole-is-greater-than-the-sum-of-its-parts-understanding-gene-disease-validity-for-breast-cancer-genes-with-jennifer-herrera-mullar-mgc-cgc-dma 2024-03-27T11:04:54-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/217/apc-new-takes-on-an-old-gene-with-marcy-richardson-phd 2023-04-04T16:31:16-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/215/dont-eat-the-marshmallow-insurance-issues-that-impact-patient-access-to-care-with-stephanie-gandomi-ms-mba-cgc-cpc-cpco 2023-03-20T09:26:11-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/214/checking-chek2-cancer-phenotypes-among-frequent-chek2-variants-and-implications-for-clinical-care-with-huma-rana-md-mph 2023-03-09T12:38:53-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/213/the-finances-of-genetic-testing-perspectives-of-patients-payers-providers-and-clinical-labs-with-michael-astion-md-phd 2023-02-10T15:26:57-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/212/defining-the-breakpoints-to-fill-the-gap-the-evolving-role-of-chromosomal-microarray-with-catherine-schultz-ms-cgc 2023-02-16T12:44:44-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/211/carriers-and-bridges-a-comparison-of-big-datasets-with-fergus-couch-phd 2023-01-18T15:52:39-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/210/but-wait-theres-more-autosomal-dominant-genes-that-also-have-autosomal-recessive-phenotypes-with-kelly-radtke-phd 2023-01-04T09:05:30-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/208/proactive-patient-centric-care-in-reproductive-health-insights-to-optimize-provider-and-patient-experiences-with-elizabeth-chao-md-facmg-and-heather-fecteau-ms-cgc 2022-10-19T12:41:08-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/209/the-pancreatic-cancer-early-detection-precede-consortium-a-research-platform-to-study-risk-genetics-and-early-detection-of-pancreatic-cancer-with-jessica-everett-ms-cgc 2022-11-03T15:03:18-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/207/falling-between-the-cracks-the-challenge-of-classifying-hypomorphic-variants-with-marcy-richardson-phd 2022-10-20T12:51:15-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/206/expanding-the-reach-of-genetic-testing-why-the-role-of-the-genetic-counselor-remains-critical-with-jill-stopfer-ms-cgc 2022-09-28T15:54:57-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/205/genematcher-harnesses-the-power-of-genomic-data-to-further-disease-gene-discovery-and-improve-diagnostic-rates-with-meghan-towne-ms-cgc-lgc 2022-09-26T08:50:36-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/203/rna-genetic-sequencing-identifies-people-who-are-high-risk-for-cancer-but-would-have-been-missed-by-dna-testing-alone-with-carrie-horton-ms-cgc 2022-09-15T17:55:42-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/204/population-genomic-screening-toward-a-future-standard-of-care-with-miranda-hallquist-cgc-m-sc 2022-08-30T14:01:43-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/202/update-on-genetic-testing-for-prostate-cancer-challenges-and-opportunities-with-dr-kathleen-cooney-md-macp 2022-08-22T13:05:44-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/201/a-practical-approach-to-hereditary-risk-assessment-in-gastroenterology-practices-with-swati-patel-md-ms 2022-07-13T14:52:57-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/200/variant-nomenclature-standard-practice-and-common-glitches-with-george-riley-phd 2022-06-27T16:52:43-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/199/using-software-to-increase-patient-access-to-cancer-genetics-services-with-shannon-kieran-ms-mba-cgc-and-kelly-burgess-ms-cgc 2022-06-23T14:41:38-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/198/from-bench-to-clinical-report-translation-of-crispr-maves-to-improve-positive-yield-of-genetic-testing-with-carrie-horton-ms-cgc 2022-05-27T10:51:03-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/197/improving-hereditary-cancer-diagnostics-using-rna-sequencing-lessons-from-cdh1-with-rachid-karam-md-phd 2022-05-16T10:11:34-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/196/brugada-syndrome-with-arthur-a-m-wilde-md-phd 2022-04-13T15:17:51-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/194/oncology-genetic-testing-in-a-canadian-setting-challenges-and-opportunities-with-angela-bedard-ms-cgc-and-zoe-lohn-msc-ccgc-cgc 2022-03-31T09:44:06-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/195/assessing-hereditary-gi-cancer-risk-earlier-insights-from-a-gi-practice 2022-04-08T14:31:37-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/193/nips-successes-blunders-and-where-we-go-from-here-with-ellen-matloff-ms-cgc-and-rachael-bradshaw-ms-cgc 2022-03-22T15:35:25-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/192/the-evolution-of-whole-exome-medical-policy-payer-coverage-and-what-clinicians-need-to-know-with-stephanie-gandomi-ms-mba-cgc-cpc 2022-03-04T14:40:33-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/191/submitting-good-clinical-data-why-it-matters-with-jessica-grzybowski-ms-cgc-tina-pesaran-ma-ms-cgc-and-rob-pilarski-ms-lgc-msw 2022-02-23T16:59:03-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/190/screening-for-genetic-mutations-in-lipids-genetic-testing-in-clinical-lipidology-with-james-underberg-md-ms-facpm-facp-fash-faspc-fnyam-fnla 2022-02-16T09:31:25-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/189/clingen-expert-panel-curation-with-steven-harrison-phd-facmg 2022-01-26T15:57:47-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/188/gc-burnout-and-use-of-genetic-counseling-assistants-to-turn-that-frown-upside-down-with-carolyn-applegate-mgc-cgc 2022-01-19T14:35:48-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/187/the-intricacies-of-splicing-and-rna-data-in-germline-variant-classification-with-heather-zimmermann-phd-and-tina-pesaran-ma-ms-cgc 2022-01-11T10:00:46-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/185/misattributed-relationships-identified-through-exome-sequencing-with-kelly-hagman-ms-cgc-and-julie-stefka 2021-11-18T13:28:37-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/184/the-latest-updates-in-pediatric-cancer-predisposition-with-jaclyn-schienda-scm-cgc 2021-11-09T12:04:40-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/186/improved-identification-of-high-risk-cancer-patients-using-rna-analysis-supporting-patients-with-better-variant-classification 2021-11-17T10:24:27-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/183/examining-the-impact-of-pediatric-cancer-predisposition-for-adults-with-adrienne-wakeling-ms-lcgc-and-nicola-cadenas-ms-lcgc 2021-11-09T09:44:32-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/182/influencing-a-culture-of-quality-with-tammy-schepp-moncur 2021-10-29T04:58:39-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/180/introduction-to-machine-learning-concepts-nomenclature-and-applications-in-imaging-amp-genomics-with-jacob-hesterman-phd 2021-09-22T10:47:18-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/181/improving-hereditary-cancer-diagnostics-using-rna-sequencing-lessons-from-a-43k-patient-study-with-rachid-karam-m-d-ph-d 2021-10-07T17:11:30-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/179/genetic-testing-is-not-just-about-the-science-why-ethics-matters-too-with-kelly-ormond-ms-cgc 2021-09-30T08:58:58-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/177/medical-management-for-hereditary-cardiomyopathies-with-john-l-jeffries-md-mph-facc-faha-faap-fhfsa-frcpe 2021-08-26T13:29:37-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/178/psychiatric-genomics-evidence-based-genetic-counseling-for-psychiatric-disorders-with-emily-morris-msc-ccgc 2021-09-07T11:07:25-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/176/the-benefits-of-adding-rna-seq-in-clinical-genetic-testing-with-rachid-karam-md-phd-and-carrie-horton-ms-cgc 2021-09-07T15:41:23-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/175/experience-and-outcomes-of-utilizing-a-high-risk-identification-program-with-liese-vito-md 2021-08-18T14:26:14-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/174/dissecting-genetic-disorders-with-kelly-radtke-phd 2024-03-27T11:18:42-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/173/65-improving-access-to-hereditary-cancer-testing-and-medical-management-in-people-over-65-with-fergus-j-couch-phd-and-lisa-schlager 2021-08-04T14:20:07-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/172/streamlining-genetic-test-ordering-and-resulting-through-the-electronic-health-record-with-katherine-l-nathanson-md-stephanie-asher-ms-cgc-and-jordan-trivison 2021-07-22T09:47:45-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/171/secondary-findings-take-a-second-look-with-kathryn-singh-mph-ms-cgc 2021-07-06T16:16:49-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/170/somatic-interference-incidental-detection-of-somatic-variants-in-germline-testing-with-elizabeth-chao-md-facmg 2021-06-30T10:19:14-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/169/identification-and-hereditary-management-of-pheochromocytoma-and-paraganglioma 2021-06-24T11:05:34-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/168/the-utility-of-clinical-validity-with-bess-wayburn-phd-cgc 2024-03-27T11:18:20-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/167/the-bap1-tumor-predisposition-syndrome-with-robert-pilarski-ms-lgc-msw 2021-05-19T08:34:58-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/166/how-its-made-lab-edition-an-overview-of-the-test-development-process-at-a-commercial-lab-with-jessica-profato-ms-cgc-and-melissa-parra-ms-cgc 2021-05-11T16:00:39-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/165/arrhythmogenic-disorders-current-testing-and-management-strategies-with-marina-cerrone-md 2021-04-28T17:59:49-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/164/the-somatic-testing-landscape-optimizing-the-latest-technologies-for-better-precision-medicine-with-danielle-m-hernandez-phd 2021-04-05T12:52:45-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/163/a-path-towards-health-equity-the-pitfalls-progress-and-possibilities-with-chazeman-s-jackson-phd-ma 2021-03-24T14:59:51-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/160/evaluation-risk-stratification-and-management-of-arrhythmogenic-cardiomyopathy-with-arthur-a-m-wilde-md-phd-and-cynthia-a-james-scm-phd-cgc 2021-02-23T11:30:06-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/162/a-new-paradigm-patients-data-powering-progress-with-nicole-boice 2021-03-09T11:03:51-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/161/identification-of-individuals-at-high-risk-for-pancreatic-cancer-and-the-role-of-genetic-testing-to-guide-screening-with-fay-kastrinos-md-mph 2021-02-25T09:23:05-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/159/use-of-co-segregation-evidence-in-vus-resolution-for-oncology-focused-genes-with-jennifer-herrera-mullar-mgc-cgc-dma-and-marcy-richardson-phd 2021-01-20T08:29:07-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/158/genodermatoses-and-cancer-susceptibility-considerations-for-the-genetic-counselor-with-katherine-l-nathanson-md 2021-02-03T16:54:12-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/157/current-strategies-for-breast-cancer-risk-management-in-women-with-hereditary-predisposition-with-allison-kurian-md-msc 2021-01-14T16:44:51-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/156/understanding-covid-testing-and-prevention-view-from-a-pcp-with-danny-sands-md-mph 2021-01-13T16:35:52-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/154/exome-sequencing-for-prenatal-indications-with-meghan-towne-ms-cgc-lgc 2021-01-04T14:36:10-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/153/dont-take-negative-for-an-answer-with-kelly-radtke-phd-and-kelly-hagman-ms-cgc-lgc 2024-03-27T11:19:01-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/152/fostering-change-acmgs-new-diversity-equity-and-inclusion-committee-with-katy-phelan-phd-facmg 2020-11-20T08:30:16-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/155/leveraging-innovation-to-improve-the-identification-of-patients-with-hereditary-cancer-with-rachid-karam-md-phd-kory-jasperson-cgc-karen-powell-ms-cgc 2021-01-06T14:16:35-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/151/evaluating-the-family-after-sudden-death-in-the-young 2020-11-09T08:39:49-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/150/race-ethnicity-and-clinical-utility-in-cancer-genetics-with-holly-laduca-ms-cgc 2020-11-04T07:50:48-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/149/genetic-testing-for-prostate-cancer-advances-and-considerations-with-veda-giri-md 2020-10-20T14:15:10-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/148/quality-in-genetic-testing-laboratories-opening-the-black-box-with-carrie-horton-ms-cgc-and-elizabeth-chao-md-facmg 2020-09-29T10:50:24-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/147/diagnosis-management-and-genetics-of-hattr-amyloidosis-with-morie-gertz-md-macp-and-katie-agre-ms-lcgc 2020-09-08T11:44:28-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/146/challenges-and-improvements-in-clinical-interpretation-of-copy-number-variants-cnvs-with-mari-rossi-ms-phl 2020-08-25T09:48:20-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/145/homologous-recombination-deficient-diagnosis-and-parp-inhibitor-therapy-with-brady-culver-phd 2020-08-11T16:05:32-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/144/genetic-testing-in-adult-neurology-patients-with-catherine-schultz-ms-cgc 2020-07-21T09:06:20-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/143/integrating-functional-studies-into-variant-interpretation-with-marcy-richardson-phd 2020-07-14T16:46:00-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/142/exome-sequencing-as-a-first-tier-test-for-congenital-anomalies-or-neurodevelopmental-disorders-with-david-miller-md-phd 2020-07-13T08:56:28-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/141/opportunistic-screening-for-medically-actionable-secondary-genomic-findings-with-julie-sapp-scm-cgc 2020-06-10T08:47:20-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/140/navigating-transitions-between-telehealth-and-in-person-clinic 2020-06-02T09:27:29-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/136/effects-of-genetic-testing-results-on-clinical-management-for-lipid-patients-with-alan-brown-md 2020-05-26T10:15:06-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/139/rebroadcast-validation-of-rna-genetic-testing-for-routine-use-in-a-clinical-diagnostic-setting-with-tyler-landrith-phd 2020-04-16T12:54:27-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/135/foundations-in-compliance-for-molecular-genetic-testing-laboratories-with-thomas-gnielinski-jd 2020-05-04T16:16:01-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/138/rebroadcast-reanalysis-and-reclassification-of-diagnostic-exome-sequencing-with-kelly-radtke-phd 2020-04-16T12:54:42-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/137/rebroadcast-new-directions-in-access-to-genetic-counseling-information-notifications-and-engagement-for-precision-medicine 2020-04-16T12:57:23-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/134/illumina-sequencing-overview-library-prep-to-data-analysis-with-scott-westenberger-phd 2020-04-14T08:42:05-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/133/virtually-there-transitioning-your-genetics-clinic-to-telehealth-quickly 2020-04-09T15:29:52-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/132/using-structural-biology-to-support-variant-assessment-with-adam-chamberlin-phd 2020-03-23T16:29:07-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/131/how-can-clinical-validity-assessment-of-gene-disease-associations-aid-in-variant-classification-with-deepali-shinde-phd 2020-03-17T11:44:15-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/130/prostate-cancer-genetic-risk-assessment-it-actually-takes-three-to-tango-with-brian-t-helfand-md-phd 2020-03-13T16:14:40-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/129/new-directions-in-access-to-genetic-counseling-information-notifications-and-engagement-for-precision-medicine-with-ellen-matloff-ms-cgc 2020-03-02T15:35:08-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/128/parp-inhibitors-in-2020-where-are-we-now-and-where-are-we-going-with-payal-d-shah-md 2020-02-21T13:34:44-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/127/validation-of-rna-genetic-testing-for-routine-use-in-a-clinical-diagnostic-setting-with-tyler-landrith-phd 2020-01-22T08:46:08-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/126/gene-specific-cancer-associations-and-sensitivity-of-genetic-testing-criteria-with-holly-laduca-ms-cgc 2020-01-03T13:04:51-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/114/misattributed-parentage-as-an-unanticipated-finding-during-clinical-genomic-sequencing-with-josh-deignan-phd-facmg-cgmb-mb-ascp-cm 2019-11-15T11:32:14-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/124/genetics-101-basics-of-exome-sequencing-with-meghan-towne-ms-cgc-lgc 2019-09-19T13:46:22-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/122/5q-spinal-muscular-atrophy-sma-the-bench-to-the-bedside-with-elicia-estrella-ms-lcgc 2019-10-25T13:32:35-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/99/bioinformatics-amp-computational-terminology-for-the-clinic-how-to-talk-shop-with-a-lab-with-rishona-lavy-ms-cgc-amp-brice-sarver-phd 2019-02-26T10:42:18-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/119/increasing-the-positive-yield-of-hereditary-cancer-testing-with-concurrent-dna-and-rna-sequencing-with-rachid-karam-md-phd 2019-07-10T14:48:23-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/101/breast-cancer-risk-assessment-using-the-tyrer-cuzick-model-with-jack-cuzick-phd-frs-cbe 2019-08-16T07:42:27-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/103/reanalysis-and-reclassification-of-diagnostic-exome-sequencing-with-kelly-radtke-phd 2019-08-15T14:13:33-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/113/genetics-101-i-have-my-patient-s-genetic-testing-results-what-do-i-do-now-with-ginger-haynes-ms-cgc-mba 2019-07-12T14:24:59-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/125/will-rna-testing-be-the-next-del-dup-for-clinical-genetics-with-rachid-karam-md-phd 2019-07-31T15:55:27-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/117/genetics-101-genomic-technologies-and-bioinformatics-101-with-brice-sarver-phd 2019-07-12T10:27:24-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/116/all-ways-in-the-family-genetic-testing-for-hereditary-neurological-disorders-with-amanda-bergner-ms-cgc 2019-05-30T14:24:16-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/115/qualitative-vs-quantitative-approaches-to-classification-of-variants-in-tp53-and-other-hereditary-cancer-genes-with-amanda-spurdle-phd 2019-05-07T13:24:28-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/107/genetics-101-assessing-patients-for-hereditary-cancer-risk-with-emily-dalton-ms-cgc 2019-05-31T09:49:26-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/120/cost-and-coverage-in-genomic-medicine-economic-perspectives-with-scott-grosse-phd 2019-05-15T13:50:40-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/112/an-approach-to-inherited-neuropathies-with-michael-e-shy-md 2019-05-16T15:20:48-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/111/associations-between-hereditary-cancer-panel-predisposition-genes-and-breast-cancer-subtypes-with-fergus-couch-phd 2019-04-08T12:36:02-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/102/population-screening-for-lynch-syndrome-with-heather-hampel-ms-lgc 2019-05-16T15:22:37-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/110/selecting-a-test-for-your-patient-dtc-vs-single-gene-vs-panel-vs-exome-with-stephany-connor-ms-amp-johanna-schmidt-mph-mgc-lcgc 2019-03-19T15:12:04-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/100/a-systematic-framework-for-the-interpretation-of-copy-number-variants-cnvs-with-erin-riggs-ms-cgc 2019-03-15T13:44:12-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/109/talking-to-patients-about-genetic-testing-and-the-potential-psychosocial-implications-of-that-discussion-with-karen-hurley-phd 2019-02-11T16:30:24-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/123/integrating-polygenic-and-monogenic-germline-testing-results-into-prostate-cancer-risk-assessment-with-jianfeng-xu-md-dr-ph 2019-02-12T12:56:51-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/108/the-clinical-impact-of-tp53-inclusion-in-multi-gene-panels-with-huma-q-rana-md 2019-02-05T11:06:29-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/121/clinical-and-genetic-determinants-of-contralateral-breast-cancer-in-newly-diagnosed-breast-cancer-patients-with-katharine-yao-md 2019-01-17T10:17:00-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/106/the-importance-of-perinatal-postmortem-evaluation-with-rachael-bradshaw-ms-cgc 2019-01-16T13:43:29-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/98/variant-assessment-for-reduced-penetrance-diseases-with-elizabeth-chao-md-facmg 2019-01-11T14:38:12-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/80/rna-seq-as-a-complement-to-dna-genetic-testing-with-rachid-karam-md-phd 2018-10-08T11:53:33-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/82/bioinformatics-basics-variant-calling-using-high-throughput-sequencing-data-with-brice-sarver-phd 2018-09-18T14:24:58-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/97/advances-in-family-history-amp-clinical-data-management-tools-and-their-impact-on-precision-medicine-with-jamie-l-heureux-ms-cgc 2018-09-04T08:09:59-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/93/current-landscape-of-education-for-genetic-counselors-with-maryann-w-campion-edd-ms-lcgc 2018-06-20T12:03:16-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/95/predicting-the-functional-impact-of-missense-mutations-in-brca1-and-brca2-with-steven-hart-phd 2018-08-27T14:25:52-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/96/triple-negative-breast-cancer-risk-genes-identified-by-multigene-hereditary-cancer-panel-testing-with-fergus-couch-phd 2018-08-14T08:08:18-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/77/sample-tracking-at-a-large-scale-genetics-laboratory-from-sample-receipt-through-reporting-with-sharon-mexal-phd-mb-ascp-cgmbs 2018-08-13T15:37:54-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/76/the-impact-of-social-media-and-family-networking-on-diagnosing-patients-with-rare-diseases-with-matthew-might-phd 2018-08-06T17:48:22-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/75/study-designs-and-statistical-methods-for-assessing-the-genetic-architecture-of-disease-with-mary-helen-black-phd-ms 2018-07-12T09:10:48-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/74/genome-sequencing-in-healthy-individuals-updates-from-the-medseq-babyseq-and-peopleseq-with-robert-c-green-md-mph 2018-07-13T09:23:25-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/73/genomics-and-the-future-of-human-reproduction-with-henry-t-greely 2018-07-06T08:17:52-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/71/diagnostic-exome-sequencing-cost-effectiveness-and-exome-health-plan-coverage-with-nancy-niguidula-dph 2018-06-15T11:41:31-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/70/paired-tumor-germline-testing-for-lynch-syndrome-with-monalyn-umali-salvador-ms-cgc 2018-06-05T12:58:13-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/94/exome-sequencing-leads-to-a-diagnosis-in-up-to-40-of-critically-ill-neonates 2018-06-04T12:48:11-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/92/genetic-counseling-without-clinical-guidelines-perspectives-from-the-pediatric-oncology-experience-with-kami-wolfe-schneider-ms-cgc 2018-05-09T09:22:14-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/67/living-with-familial-hemiplegic-migraine-with-paralysis-the-patient-s-experience-with-kirsten-blanco 2018-05-03T13:38:27-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/91/data-sharing-through-national-efforts-the-canadian-open-genetics-repository-with-jordan-lerner-ellis-phd-facmg 2018-04-27T10:19:56-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/66/successes-in-characterizing-genes-through-genematcher-with-nara-l-m-sobreira-md-phd 2018-04-23T15:16:17-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/65/understanding-polygenic-risk-scores-the-next-step-in-individualizing-breast-cancer-risk-assessment-with-ora-karp-gordon-md-ms 2018-04-18T08:31:31-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/64/translational-therapies-for-epilepsy-with-orrin-devinsky-md 2018-04-13T14:03:49-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/89/novel-strategies-for-treatment-of-genetic-disorders-with-elizabeth-chao-md-facmg 2018-04-06T16:21:17-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/90/dtc-testing-the-good-the-bad-and-the-raw-data 2019-02-28T09:35:29-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/57/how-to-interpret-unclear-genetic-data-in-familial-gi-cancer-syndromes-with-richard-boland-md 2018-03-23T10:22:34-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/60/evidence-based-approach-to-variant-assessment-with-marcy-e-richardson-phd 2018-03-23T14:12:31-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/62/managing-carriers-of-moderate-cancer-predisposition-genes-in-2018-with-judy-garber-md-mph 2018-03-23T14:11:55-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/87/experiences-with-gene-discovery-in-a-research-setting-and-the-transition-into-clinical-care-with-casie-genetti-ms-cgc-and-jessica-douglas-ms-lgc 2018-03-23T14:14:18-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/88/rare-disease-day-webinar-learn-how-we-identified-novel-mutations-for-mitochondriopathy-with-sha-tang-ph-d-dagmg-and-taosheng-huang-md-ph-d 2018-03-23T14:26:38-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/86/heritable-thoracic-aortic-disease-genes-from-vuss-to-gene-specific-management-with-dianna-m-milewicz-md-phd 2019-02-28T10:52:27-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/85/drugging-undruggable-targets-for-cancer-where-we-stand-today-using-the-example-of-kras-with-garth-powis-d-phil 2018-03-23T14:07:48-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/84/discovering-candidate-genes-for-rare-diseases-with-david-dyment-md 2018-03-23T14:06:47-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/55/advocacy-in-the-rare-disease-community-with-ashley-yee-msw 2018-03-23T14:02:38-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/53/beyond-dna-how-functional-assays-enable-precision-diagnosis 2017-10-26T20:36:36-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/52/precisely-paired-applying-somatic-germline-testing-for-lynch-syndrome 2017-10-24T22:08:18-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/49/evaluating-zebrafish-assays 2017-07-18T18:53:18-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/48/insights-from-the-test-utilization-subcommittee-the-economic-and-clinical-impact-of-genetic-test-reviews 2017-07-18T18:55:48-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/47/review-tools-of-ucsc-genome-browser-from-basic-to-advanced 2020-12-10T09:42:07-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/46/the-impact-of-model-systems-on-the-characterization-of-disease-genes 2017-07-18T19:12:28-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/50/exomenext-an-evidence-based-approach-to-the-right-diagnosis 2017-10-16T18:30:35-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/45/variant-assessment-workshop-x-linked-from-simple-to-challenging 2017-07-18T20:34:47-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/44/evidence-based-methods-for-gene-disease-associations 2017-07-18T19:16:48-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/43/multiple-mutations-in-cardiogenetics 2017-07-18T20:34:24-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/51/genetic-counseling-and-testing-your-questions-answered 2017-07-03T11:30:02-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/42/what-does-one-do-about-those-pesky-vuss-ambry-s-translational-genomics-lab-brings-new-understanding-to-variants-of-uncertain-significance-vus 2017-07-18T19:19:06-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/2/the-truth-about-next-generation-sequencing 2017-07-18T19:19:25-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/39/inherited-arrhythmias-webinar-part-3 2017-04-07T17:58:27-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/38/inherited-arrhythmias-webinar-part-2 2017-04-07T17:58:55-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/37/inherited-arrhythmias-webinar-part-1 2017-04-07T17:40:51-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/36/a-journey-into-the-unknown-exploring-the-clinical-diagnostic-path-from-targeted-panel-to-whole-exome-sequencing 2017-07-18T18:35:42-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/35/the-microarray-and-beyond-genetic-testing-for-neurodevelopmental-disorders 2017-07-18T18:37:56-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/34/the-power-of-a-patient-driven-approach-to-cf-research 2017-04-12T15:29:21-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/33/seeing-the-forest-for-the-trees-epilepsy-as-a-presenting-feature-of-batten-disease 2017-07-18T18:37:14-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/32/ambry-shares-what-s-next-in-epilepsy-genetic-testing 2017-07-18T18:38:48-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/31/clinical-diagnostic-exome-sequencing 2017-04-06T22:14:31-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/30/advanced-learneng 2017-04-06T22:15:19-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/29/a-new-wave-for-hereditary-breast-and-ovarian-cancer 2017-03-02T21:22:08-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/28/straight-from-the-heart 2017-04-06T22:15:59-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/27/a-cross-border-conversion-clinical-approaches-to-hereditary-cancer-panel-use 2017-07-18T18:51:01-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/26/new-genes-on-the-block-meet-the-recent-additions-to-ambry-s-cancer-panels 2017-07-18T18:38:25-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/25/cystic-fibrosis-newborn-screening-what-you-need-to-know 2017-07-18T18:50:13-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/40/acmg-genomics-case-conference-family-centered-diagnostic-exome-sequencing-solved-undiagnosed-cases 2017-07-18T18:49:57-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/24/ambry-shares-whats-next-in-cardiovascular-genetics 2017-07-18T18:49:41-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/23/getting-to-the-heart-of-the-matter-an-overview-of-cardiovascular-genetics 2017-07-18T18:49:20-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/22/analyzing-historical-mutations-in-the-cftr-gene-reveals-a-high-number-of-reclassified-variants 2017-07-18T18:49:03-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/21/the-clinical-and-management-implications-of-diagnostic-exome-sequencing-a-deeper-look-at-the-scientific-evidence 2017-07-18T18:48:48-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/20/epilepsy-awareness-month-educational-webinar-featuring-2-epilepsy-support-groups 2017-07-18T18:48:29-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/19/helping-and-empowering-young-women-navigate-their-personal-genetic-journey 2017-07-18T18:48:11-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/18/the-basics-of-inborn-errors-of-metabolism-a-clinical-and-diagnostic-perspective 2017-07-18T18:47:53-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/17/parp-inhibitors-in-ovarian-cancer-treatment-the-changing-paradigm-for-cancer-therapy 2017-07-18T18:47:36-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/16/applications-of-diagnostic-exome-sequencing-among-patients-in-the-neonatal-intensive-care-unit 2017-07-18T18:47:17-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/15/the-utilization-of-exome-sequencing-in-the-pediatric-and-neonatal-clinical-settings 2017-07-18T18:47:02-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/14/syndromes-without-a-name-a-personal-look-inside-the-journey-for-a-diagnosis 2017-07-18T18:46:03-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/13/counseling-for-hereditary-sarcoma-a-clinical-and-genetic-overview 2017-07-18T18:45:46-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/12/utility-and-utilization-of-molecular-testing-for-hereditary-hemorrhagic-telangiectasia-hht 2017-03-02T20:07:09-08:00 daily 0.8 https://www.ambrygen.com/providers/webinar/11/ambry-brcaplus-validation-and-hereditary-multigene-panels-publications 2017-07-18T18:45:11-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/10/microarray-plus-exomenext-increasing-the-detection-rate 2017-07-18T18:44:52-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/9/cystic-fibrosis-translational-research-progress-and-clinical-partnerships 2017-07-18T18:44:35-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/8/exomenext-the-new-generation-of-diagnostic-exome-sequencing 2017-07-18T18:44:20-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/7/clinical-genetic-and-psychosocial-considerations-of-neurological-disorders-focus-on-intellectual-disability-and-autism 2017-07-18T18:44:01-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/6/update-on-genetic-and-diagnostic-testing-challenges-for-multiplex-kidney-cancer-families 2017-07-18T18:43:46-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/5/the-clinical-utility-of-hereditary-cancer-multi-gene-testing 2017-07-18T18:43:16-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/4/brca-genetic-testing-options 2017-07-18T18:42:50-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/3/brca-testing-overview 2017-07-18T18:42:20-07:00 daily 0.8 https://www.ambrygen.com/providers/webinar/1/autism-spectrum-disorders-and-the-genetic-link 2017-07-18T18:42:00-07:00 daily 0.8